<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <atom:link rel="self" type="application/rss+xml" href="https://escholarship.org/uc/ucsdsom_path_oapdeposits/rss"/>
    <ttl>720</ttl>
    <title>Recent ucsdsom_path_oapdeposits items</title>
    <link>https://escholarship.org/uc/ucsdsom_path_oapdeposits/rss</link>
    <description>Recent eScholarship items from Department of Pathology - Open Access Policy Deposits</description>
    <pubDate>Thu, 18 Jun 2026 16:04:36 +0000</pubDate>
    <item>
      <title>PrPC-facilitated cell signaling activates phospholipase Cɣ1 and triggers an Arc/Arg3.1 response in mouse and iPSC-derived human neurons</title>
      <link>https://escholarship.org/uc/item/5j33g0qx</link>
      <description>Synapse loss is an early feature of prion disease, yet the underlying drivers are poorly understood. We recently found evidence of neuronal hyperactivity and synaptic loss in prion-infected mice. Herein, we identified increased Arc/Arg3.1 in patients with prion disease, suggesting heightened neuronal activity also occurs in the human prion-affected brain. To determine the signaling events initiated by prion aggregates (PrPSc), we developed a disease model in which human iPSC-derived excitatory neurons are stimulated with a PrPSc-mimetic antibody, POM1, that binds cellular prion protein (PrPC). Within 2 h of POM1 exposure, we detected an Arc/Arg3.1 response together with transcriptomic changes previously reported in prion-infected mice. We identified altered phosphorylation of PLC-γ1, ERK1/2, and EGFR as additional PrPC-triggered cell signaling events. These results suggest that PrPC ligands, including PrPSc, trigger rapid signaling events linked to neuronal hyperactivity in human...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5j33g0qx</guid>
      <pubDate>Thu, 4 Jun 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Ojeda-Juarez, Daniel</name>
      </author>
      <author>
        <name>Funk, Gail</name>
      </author>
      <author>
        <name>McClatchy, Daniel B</name>
      </author>
      <author>
        <name>Richards, Emily</name>
      </author>
      <author>
        <name>Rajic, Alexander J</name>
      </author>
      <author>
        <name>Soldau, Katrin</name>
      </author>
      <author>
        <name>Geschwind, Michael D</name>
      </author>
      <author>
        <name>Chen, Xu</name>
      </author>
      <author>
        <name>Yates, John R</name>
      </author>
      <author>
        <name>Gonias, Steven L</name>
      </author>
      <author>
        <name>Sigurdson, Christina J</name>
      </author>
    </item>
    <item>
      <title>FAK inhibition in ovarian cancer releases omega-3 fatty acids to program CXCL13-producing anti-tumor resident peritoneal macrophages</title>
      <link>https://escholarship.org/uc/item/43j3k2w6</link>
      <description>High-grade serous ovarian cancer (HGSOC) is a lethal malignancy characterized by therapy resistance. Focal adhesion kinase (FAK) is highly expressed in HGSOC, yet its impact on tumor-immune communication remains incompletely defined. Using three syngeneic ovarian cancer models, we show that FAK inhibition (FAKi) increased macrophage CXCL13 expression and promoted peritoneal B cell infiltration. Combining FAKi with low-dose pegylated doxorubicin and anti-T cell immunoreceptor with Ig and ITIM domains (TIGIT) checkpoint blockade suppressed orthotopic ovarian tumor growth, extended survival, and induced tertiary lymphoid structures. Macrophage lineage factor GATA6 inactivation reduced CXCL13 expression, enhanced FAK-knockout tumor growth, and limited ascites B cell accumulation. Mechanistically, FAKi-treated or FAK-deficient tumor cells release exosomes enriched in omega-3 fatty acids that stimulated macrophage CXCL13 production. Exposure of macrophages to tumor-derived omega-3 lipids...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/43j3k2w6</guid>
      <pubDate>Fri, 15 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Chen, Xiao Lei</name>
        <uri>https://orcid.org/0000-0001-7998-9963</uri>
      </author>
      <author>
        <name>Tharp, Kevin M</name>
      </author>
      <author>
        <name>Ojalill, Marjaana</name>
      </author>
      <author>
        <name>Ozmadenci, Duygu</name>
      </author>
      <author>
        <name>Boyer, Antonia</name>
      </author>
      <author>
        <name>Haanen, Terrance J</name>
      </author>
      <author>
        <name>Lawson, Christine</name>
      </author>
      <author>
        <name>Lee, Hyojae J</name>
      </author>
      <author>
        <name>Xia, Marvin</name>
      </author>
      <author>
        <name>Tahon, Elise</name>
      </author>
      <author>
        <name>Zhang, Yichi</name>
      </author>
      <author>
        <name>Minor, Cray</name>
      </author>
      <author>
        <name>Khan, Safir Ullah</name>
      </author>
      <author>
        <name>Anderson, Colin C</name>
      </author>
      <author>
        <name>Nemkov, Travis</name>
      </author>
      <author>
        <name>Rose, Michael</name>
      </author>
      <author>
        <name>Estrada, Monica V</name>
      </author>
      <author>
        <name>Molinolo, Alfredo A</name>
      </author>
      <author>
        <name>Warren, Elias</name>
      </author>
      <author>
        <name>Penalosa, Patrick</name>
      </author>
      <author>
        <name>Eskander, Ramez N</name>
      </author>
      <author>
        <name>McHale, Michael T</name>
      </author>
      <author>
        <name>Wang, Shizhen E</name>
      </author>
      <author>
        <name>Connolly, Denise C</name>
      </author>
      <author>
        <name>Fisch, Kathleen M</name>
      </author>
      <author>
        <name>Stupack, Dwayne G</name>
      </author>
      <author>
        <name>Schlaepfer, David D</name>
        <uri>https://orcid.org/0000-0003-4814-9210</uri>
      </author>
    </item>
    <item>
      <title>Recommendations for HLA Genotyping Data Standards and Clinical Laboratory Staffing Considerations.</title>
      <link>https://escholarship.org/uc/item/6w3523kh</link>
      <description>The rapid advances in HLA genotyping technology and the massive amounts of associated data have created a demand for better and more efficient laboratory data management practices. However, while some standards have been developed, there is a need for comprehensive guidelines that include all laboratory data-related processes such as messaging, storage and retention, documentation, reporting, validation and quality control. An important consideration in developing these recommendations is the feasibility of application in a laboratory setting without posing a substantial staff and cost burden for implementation and long-term maintenance and the availability of publicly available tools. This article presents evidence-based recommendations for multiple laboratory general data practices, focusing on HLA genotyping data and associated meta-data. These recommendations are compiled by experts in the fields of histocompatibility and immunogenetics (H&amp;amp;I) and representation from multiple...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6w3523kh</guid>
      <pubDate>Thu, 30 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Spierings, Eric</name>
      </author>
      <author>
        <name>Brown, Nicholas</name>
      </author>
      <author>
        <name>Latham, Katy</name>
      </author>
      <author>
        <name>Robinson, James</name>
      </author>
      <author>
        <name>Melchers, Mark</name>
      </author>
      <author>
        <name>Askar, Medhat</name>
      </author>
      <author>
        <name>Morris, Gerald</name>
      </author>
      <author>
        <name>Weimer, Eric</name>
      </author>
      <author>
        <name>Maiers, Martin</name>
      </author>
      <author>
        <name>Madbouly, Abeer</name>
      </author>
    </item>
    <item>
      <title>Association of neurogenic orthostatic hypotension with cognitive decline in Parkinson’s disease: a longitudinal cohort study</title>
      <link>https://escholarship.org/uc/item/7123658z</link>
      <description>Neurogenic orthostatic hypotension (nOH), a common non-motor feature of Parkinson’s disease (PD), is defined as a sustained drop in blood pressure (BP) upon standing due to autonomic dysfunction. Although prior studies support an association between nOH and cognitive impairment, its longitudinal impact on cognitive decline in PD remains insufficiently explored. We aimed to determine to what extent baseline nOH is associated with an accelerated decline in global and exploratory domain-specific cognitive functions. A retrospective longitudinal cohort study was conducted using clinical data from patients with PD evaluated at the University of California San Diego movement disorders clinics between 2012 and 2024. Participants were classified as having nOH (nOH+) or without nOH (nOH−) based on initial orthostatic BP measurements (≥20 mmHg systolic BP and/or ≥10 mmHg diastolic BP reduction within 3 minutes of standing, with a blunted heart rate response [ΔHR/ΔSBP] &amp;lt; 0.5 bpm/mmHg)....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7123658z</guid>
      <pubDate>Thu, 23 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Bagheri, Neda</name>
      </author>
      <author>
        <name>Longardner, Katherine</name>
        <uri>https://orcid.org/0000-0001-5479-2590</uri>
      </author>
      <author>
        <name>Coughlin, David</name>
      </author>
    </item>
    <item>
      <title>Prevalence of Mycoplasma genitalium in a Southern California patient population</title>
      <link>https://escholarship.org/uc/item/7ds9r6h1</link>
      <description>Mycoplasma genitalium as a cause of genitourinary sexually transmitted disease symptoms often goes underdiagnosed in many patient populations. We investigated a patient population in Southern California at high risk for Chlamydia trachomatis (CT) and Neisseria gonorrhea (NG) infections to determine whether they also may be at high risk for Mycoplasma genitalium (MG) sexually transmitted infections that may be going untreated. We found that there was a relatively high prevalence of CT (13.9 %) and NG (9.0 %) in our population, but there was also a relatively high prevalence of undiagnosed MG infections (8.7 %). In this same patient population, there were few (0.5 %) subjects diagnosed with Trichomonas vaginalis (TV) infections; however, there were high numbers of coinfections identified for MG with CT and NG. We found high numbers of positive results in both symptomatic and asymptomatic individuals. We also identified that there were high numbers of subjects with genetic markers...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7ds9r6h1</guid>
      <pubDate>Thu, 26 Feb 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Tran, Anh</name>
      </author>
      <author>
        <name>Amamoto, Alicia</name>
      </author>
      <author>
        <name>Bates, Monica</name>
      </author>
      <author>
        <name>Leonard, Jesse</name>
      </author>
      <author>
        <name>Carrico, Victoria</name>
      </author>
      <author>
        <name>Pride, David T</name>
      </author>
    </item>
    <item>
      <title>Review: False Positive Urine Drug Screens</title>
      <link>https://escholarship.org/uc/item/1pk9t820</link>
      <description>Immunoassay-based urine drug screens are widely employed in clinical toxicology due to their speed, low cost, and ease of automation. However, these assays are inherently limited by antibody cross-reactivity, which can result in false-positive findings and incorrect interpretations with major implications for patient care, employment, and legal outcomes. This review updates prior literature by analyzing reported false-positive interferences published between 2013 and 2024 across commonly screened drug classes, including opioids, amphetamines, benzodiazepines, cannabinoids, barbiturates, phencyclidine (PCP), cocaine, ethanol, and ethyl glucuronide. A total of 61 studies met inclusion criteria from 569 unique publications retrieved via PubMed. Each report was categorized by level of evidence, ranging from single case reports to controlled spiking experiments. Despite advances in antibody specificity, immunoassay drug screens remain presumptive and require confirmation by orthogonal...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1pk9t820</guid>
      <pubDate>Thu, 26 Feb 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Saitman, Alec</name>
      </author>
      <author>
        <name>Fitzgerald, Robert L</name>
      </author>
      <author>
        <name>Lund, Kyle</name>
      </author>
      <author>
        <name>Suhandynata, Raymond T</name>
      </author>
      <author>
        <name>Menlyadiev, Marlen</name>
      </author>
    </item>
    <item>
      <title>Milk as a Transmission Vehicle for Highly Pathogenic Avian Influenza A (H5N1).</title>
      <link>https://escholarship.org/uc/item/8jw3v054</link>
      <description>Highly pathogenic avian influenza A (H5N1) (H5N1 hereafter) is an emerging pathogen in mammals. The recent recognition of H5N1 in dairy cattle increases opportunities for human exposure and infection and may accelerate a trajectory toward sustained human-to-human transmission. Furthermore, the presence of virus at high concentration in unpasteurized milk raises new risks for humans, especially infants and children. Milk has been identified as a vehicle for viral transmission in and between mammalian species, including humans. Sialic acids (SAs) found on cell surfaces are important mediators of species susceptibility to specific influenza strains and play an important role in viral tropism. New data demonstrate that SA receptors with α2,3 linkages capable of binding avian influenza strains are present in human mammary tissue. The presence of SA receptors that can bind avian influenza and a comparative analysis of viral transmission risk of raw and pasteurized milk in several mammalian...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8jw3v054</guid>
      <pubDate>Thu, 12 Feb 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Byington, Carrie L</name>
      </author>
      <author>
        <name>Stellwagen, Lisa</name>
      </author>
      <author>
        <name>Bode, Lars</name>
      </author>
      <author>
        <name>Hooshmand, Mitra</name>
      </author>
      <author>
        <name>Pizzo, Donald P</name>
      </author>
      <author>
        <name>Russo, Hana</name>
      </author>
      <author>
        <name>Gonias, Steven L</name>
      </author>
    </item>
    <item>
      <title>Comparison of six serum analyte workflows using routine liquid chromatography-tandem mass spectrometry methods at multiple laboratories with the Cobas i 601 analyzer, an automated mass spectrometry system</title>
      <link>https://escholarship.org/uc/item/25q0j4g0</link>
      <description>OBJECTIVES: Liquid chromatography-tandem mass spectrometry (LC-MS/MS) offers substantial analytical advantages over traditional immunoassay methods, including greater specificity and robustness. Conventional LC-MS/MS methods are labor-intensive, requiring highly trained, dedicated laboratory staff. The Cobas&lt;sup&gt;®&lt;/sup&gt; i 601 analyzer (Roche Diagnostics International Ltd., Rotkreuz, Switzerland) is an automated, random-access, mass spectrometry (MS) system designed to improve workflows and reduce turnaround times. This study evaluated turnaround times for analyses with the i 601 analyzer vs. routine LC-MS/MS using batch processing.
METHODS: We performed a workflow analysis for six sets of analytes (mycophenolic acid, antibiotics, antiepileptics, voriconazole, testosterone, and 25-hydroxyvitamin D) in seven laboratories across Europe, North America, and Asia. We recorded batch size, result turnaround times, and hands-on times (including quality control) for 93 batches analyzed...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/25q0j4g0</guid>
      <pubDate>Thu, 12 Feb 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Vermeersch, Pieter</name>
      </author>
      <author>
        <name>de Jonge, Robert</name>
      </author>
      <author>
        <name>Miyazawa, Takamaro</name>
      </author>
      <author>
        <name>Nybo, Mads</name>
      </author>
      <author>
        <name>Fruekilde, Palle</name>
      </author>
      <author>
        <name>Toole, Barry J</name>
      </author>
      <author>
        <name>Metz, Philippe</name>
      </author>
      <author>
        <name>Albrecht, Eva</name>
      </author>
      <author>
        <name>Slusarczyk, Karl</name>
      </author>
      <author>
        <name>Vogeser, Michael</name>
      </author>
      <author>
        <name>Fitzgerald, Robert L</name>
      </author>
    </item>
    <item>
      <title>Lung Cancer Cells Secrete Glutamine to Accumulate Tumor‐Associated Macrophages</title>
      <link>https://escholarship.org/uc/item/3g423467</link>
      <description>Tumor-associated macrophages (TAMs) are critical contributors to cancer progression and are often recruited by cancer cells to support a pro-tumorigenic microenvironment. Integrin αvβ3 is a known driver and marker of cancer stem-like properties, including tumor initiation, in various epithelial cancers. We have previously shown a positive correlation between αvβ3 expression and TAM infiltration across multiple tumor types; however, the mechanistic link remains undefined. Here, we demonstrated that integrin αvβ3 expression in non-small cell lung cancer (NSCLC) cells is both necessary and sufficient to drive TAM accumulation. In orthotopic murine and human NSCLC models, ectopic integrin αvβ3 expression increased TAM infiltration independently of T cells, whereas genetic deletion of integrin β3 significantly reduced TAM numbers and tumor burden. Mechanistically, integrin αvβ3 promotes glutamine secretion from NSCLC cells, which enhances the survival and/or differentiation of bone...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3g423467</guid>
      <pubDate>Fri, 16 Jan 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Reddy, Joshua P</name>
      </author>
      <author>
        <name>Clague, Rebecca A</name>
      </author>
      <author>
        <name>Peixoto, Beatriz P</name>
      </author>
      <author>
        <name>Bernstein, Sara</name>
      </author>
      <author>
        <name>Lauth, Emma E</name>
      </author>
      <author>
        <name>Takanohashi, Clara Y</name>
      </author>
      <author>
        <name>Kim, Sophie C</name>
      </author>
      <author>
        <name>Wettersten, Hiromi I</name>
        <uri>https://orcid.org/0000-0001-7144-3122</uri>
      </author>
    </item>
    <item>
      <title>A Clinical-Stage Cysteine Protease Inhibitor blocks SARS-CoV‑2 Infection of Human and Monkey Cells</title>
      <link>https://escholarship.org/uc/item/5c8073wg</link>
      <description>Host-cell cysteine proteases play an essential role in the processing of the viral spike protein of SARS coronaviruses. K777, an irreversible, covalent inactivator of cysteine proteases that has recently completed phase 1 clinical trials, reduced SARS-CoV-2 viral infectivity in several host cells: Vero E6 (EC&lt;sub&gt;50&lt;/sub&gt;&amp;lt; 74 nM), HeLa/ACE2 (4 nM), Caco-2 (EC&lt;sub&gt;90&lt;/sub&gt; = 4.3 μM), and A549/ACE2 (&amp;lt;80 nM). Infectivity of Calu-3 cells depended on the cell line assayed. If Calu-3/2B4 was used, EC&lt;sub&gt;50&lt;/sub&gt; was 7 nM, but in the ATCC Calu-3 cell line without ACE2 enrichment, EC&lt;sub&gt;50&lt;/sub&gt; was &amp;gt;10 μM. There was no toxicity to any of the host cell lines at 10-100 μM K777 concentration. Kinetic analysis confirmed that K777 was a potent inhibitor of human cathepsin L, whereas no inhibition of the SARS-CoV-2 cysteine proteases (papain-like and 3CL-like protease) was observed. Treatment of Vero E6 cells with a propargyl derivative of K777 as an activity-based probe identified...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5c8073wg</guid>
      <pubDate>Thu, 15 Jan 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Mellott, Drake M</name>
      </author>
      <author>
        <name>Tseng, Chien-Te</name>
      </author>
      <author>
        <name>Drelich, Aleksandra</name>
      </author>
      <author>
        <name>Fajtová, Pavla</name>
      </author>
      <author>
        <name>Chenna, Bala C</name>
      </author>
      <author>
        <name>Kostomiris, Demetrios H</name>
      </author>
      <author>
        <name>Hsu, Jason</name>
      </author>
      <author>
        <name>Zhu, Jiyun</name>
      </author>
      <author>
        <name>Taylor, Zane W</name>
      </author>
      <author>
        <name>Kocurek, Klaudia I</name>
      </author>
      <author>
        <name>Tat, Vivian</name>
      </author>
      <author>
        <name>Katzfuss, Ardala</name>
      </author>
      <author>
        <name>Li, Linfeng</name>
      </author>
      <author>
        <name>Giardini, Miriam A</name>
        <uri>https://orcid.org/0000-0002-6510-2409</uri>
      </author>
      <author>
        <name>Skinner, Danielle</name>
      </author>
      <author>
        <name>Hirata, Ken</name>
      </author>
      <author>
        <name>Yoon, Michael C</name>
        <uri>https://orcid.org/0000-0002-2900-5257</uri>
      </author>
      <author>
        <name>Beck, Sungjun</name>
      </author>
      <author>
        <name>Carlin, Aaron F</name>
        <uri>https://orcid.org/0000-0002-1669-8066</uri>
      </author>
      <author>
        <name>Clark, Alex E</name>
      </author>
      <author>
        <name>Beretta, Laura</name>
      </author>
      <author>
        <name>Maneval, Daniel</name>
      </author>
      <author>
        <name>Hook, Vivian</name>
      </author>
      <author>
        <name>Frueh, Felix</name>
      </author>
      <author>
        <name>Hurst, Brett L</name>
      </author>
      <author>
        <name>Wang, Hong</name>
      </author>
      <author>
        <name>Raushel, Frank M</name>
      </author>
      <author>
        <name>O’Donoghue, Anthony J</name>
      </author>
      <author>
        <name>de Siqueira-Neto, Jair Lage</name>
      </author>
      <author>
        <name>Meek, Thomas D</name>
      </author>
      <author>
        <name>McKerrow, James H</name>
      </author>
    </item>
    <item>
      <title>Per Se Driving Under the Influence of Cannabis Statutes and Blood Delta-9-Tetrahydrocannabinol Concentrations following Short-Term Cannabis Abstinence</title>
      <link>https://escholarship.org/uc/item/2gv9b7kp</link>
      <description>BACKGROUND: Several US states have per se laws using 2 or 5 ng/mL of delta-9-tetrahydrocannabinol (THC) as cutpoints for driving under the influence of cannabis, while some have zero-tolerance statutes. These cutpoints are considered prima facia evidence of driving impairment.
METHODS: In a cohort of people who regularly use cannabis (N = 190) we measured baseline concentrations of THC after instructing participants to abstain from cannabis for at least 48 hours. Baseline driving performance was evaluated using a driving simulator. We also measured blood THC concentrations serially following a smoking session (placebo or active cannabis).
RESULTS: Forty-three percent of the participants exceeded zero-tolerance statutes (≥0.5 ng/mL) at baseline. Twenty-four percent had baseline blood THC concentrations that were ≥2 ng/mL and 5.3% were ≥5 ng/mL. The maximum observed baseline blood concentration was 16.2 ng/mL. Six hours after smoking active cannabis, the median (interquartile range)...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2gv9b7kp</guid>
      <pubDate>Thu, 4 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Fitzgerald, Robert L</name>
      </author>
      <author>
        <name>Umlauf, Anya</name>
      </author>
      <author>
        <name>Suhandynata, Raymond T</name>
      </author>
      <author>
        <name>Grelotti, David J</name>
      </author>
      <author>
        <name>Huestis, Marilyn A</name>
      </author>
      <author>
        <name>Mastropietro, Kyle F</name>
      </author>
      <author>
        <name>Grant, Igor</name>
      </author>
      <author>
        <name>Marcotte, Thomas D</name>
      </author>
    </item>
    <item>
      <title>BRD2 bromodomain-mediated regulation of cell state plasticity modulates therapy response in glioblastoma</title>
      <link>https://escholarship.org/uc/item/2bd2p0rz</link>
      <description>BACKGROUND: Glioblastoma (GBM) displays remarkable cell state plasticity, a major contributor to therapeutic resistance and tumor progression. While epigenetic mechanisms play a central role in driving this plasticity, the key regulators remain poorly understood, and developing effective therapeutic strategies targeting them has been challenging.
METHODS: We investigated the role of BRD2, a key regulator of NF-κB-mediated mesenchymal (MES) transition, using GBM patient-derived xenograft cell lines, CRISPR-mediated knock-in/knockout approaches, RNA-seq, and in vitro and in vivo modeling. BET inhibitors were employed to target MES gene expression and sensitize GBM to radiation therapy.
RESULTS: We found that PTEN loss induces RelA chromatin localization and acetylation-mediated recruitment of BRD2 to the MES gene promoters. BRD2 binding is essential for maintaining MES gene expression and phenotype. Genetic ablation or loss-of-function mutation of BRD2 bromodomains reverses MES...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2bd2p0rz</guid>
      <pubDate>Thu, 4 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Vadla, Raghavendra</name>
      </author>
      <author>
        <name>Taylor, Brett</name>
      </author>
      <author>
        <name>Miyake, Yohei</name>
      </author>
      <author>
        <name>Lin, Benjamin</name>
      </author>
      <author>
        <name>Kawauchi, Daisuke</name>
      </author>
      <author>
        <name>Miki, Shunichiro</name>
      </author>
      <author>
        <name>Nathwani, Nidhi</name>
      </author>
      <author>
        <name>Jones, Brandon M</name>
      </author>
      <author>
        <name>Kaur, Yashpreet</name>
      </author>
      <author>
        <name>Banerjee, Abhinaba</name>
      </author>
      <author>
        <name>Pham, Philip</name>
      </author>
      <author>
        <name>Tsang, Jonathan</name>
      </author>
      <author>
        <name>Baldwin, Albert</name>
      </author>
      <author>
        <name>Nathanson, David A</name>
      </author>
      <author>
        <name>Pizzo, Donald P</name>
      </author>
      <author>
        <name>Miller, C Ryan</name>
      </author>
      <author>
        <name>Furnari, Frank B</name>
      </author>
    </item>
    <item>
      <title>Cannabidiol mitigates alcohol dependence and withdrawal with neuroprotective effects in the basolateral amygdala and striatum</title>
      <link>https://escholarship.org/uc/item/7626976q</link>
      <description>Alcohol use disorder (AUD) remains a pervasive public health issue with limited effective treatments. Cannabidiol (CBD), a non-psychotropic constituent of cannabis, shows promise in modulating addictive behaviors. This study investigated the effects of chronic CBD administration on alcohol dependence, withdrawal symptoms, and neurodegeneration using two complementary rodent models: chronic intermittent ethanol (CIE) exposure, which models established alcohol dependence, and ethanol vapor self-administration (EVSA), which captures the volitional aspects of alcohol intake. In the CIE model, CBD reduced alcohol self-administration during acute withdrawal without affecting alcohol metabolism or locomotor activity. CBD decreased motivation for alcohol, somatic withdrawal signs, withdrawal-induced anxiety-like behaviors, and mechanical sensitivity. During extinction, CBD attenuated alcohol-seeking behavior and stress-induced reinstatement. Electrophysiological recordings revealed that...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7626976q</guid>
      <pubDate>Mon, 1 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Dirik, Selen</name>
      </author>
      <author>
        <name>Doyle, Michelle R</name>
      </author>
      <author>
        <name>Wood, Courtney P</name>
      </author>
      <author>
        <name>Campo, Paola</name>
      </author>
      <author>
        <name>Martinez, Angelica R</name>
      </author>
      <author>
        <name>Fannon, McKenzie</name>
      </author>
      <author>
        <name>Balaguer, Maria G</name>
      </author>
      <author>
        <name>Seely, Spencer</name>
      </author>
      <author>
        <name>Montoya, Bryan A</name>
      </author>
      <author>
        <name>Cook, Gregory MR</name>
      </author>
      <author>
        <name>Palermo, Gabrielle M</name>
      </author>
      <author>
        <name>Lin, Junjie</name>
      </author>
      <author>
        <name>Sist, Madelyn D</name>
      </author>
      <author>
        <name>Naghshineh, Parsa K</name>
      </author>
      <author>
        <name>Lan, Zihang</name>
      </author>
      <author>
        <name>Rahman, Sara RMU</name>
      </author>
      <author>
        <name>Suhandynata, Raymond</name>
      </author>
      <author>
        <name>Schweitzer, Paul</name>
      </author>
      <author>
        <name>Kallupi, Marsida</name>
      </author>
      <author>
        <name>de Guglielmo, Giordano</name>
      </author>
    </item>
    <item>
      <title>Pathologist-like explainable AI for interpretable Gleason grading in prostate cancer</title>
      <link>https://escholarship.org/uc/item/8543h984</link>
      <description>The aggressiveness of prostate cancer is primarily assessed from histopathological data using the Gleason scoring system. Conventional artificial intelligence (AI) approaches can predict Gleason scores, but often lack explainability, which may limit clinical acceptance. Here, we present an alternative, inherently explainable AI that circumvents the need for post-hoc explainability methods. The model was trained on 1,015 tissue microarray core images, annotated with detailed pattern descriptions by 54 international pathologists following standardized guidelines. It uses pathologist-defined terminology and was trained using soft labels to capture data uncertainty. This approach enables robust Gleason pattern segmentation despite high interobserver variability. The model achieved comparable or superior performance to direct Gleason pattern segmentation (Dice score: 0.713±0.003$${0.713}_{\pm 0.003}$$ vs. 0.691±0.010$${0.691}_{\pm 0.010}$$) while providing interpretable outputs. We...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8543h984</guid>
      <pubDate>Thu, 23 Oct 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Mittmann, Gesa</name>
      </author>
      <author>
        <name>Laiouar-Pedari, Sara</name>
      </author>
      <author>
        <name>Mehrtens, Hendrik A</name>
      </author>
      <author>
        <name>Haggenmüller, Sarah</name>
      </author>
      <author>
        <name>Bucher, Tabea-Clara</name>
      </author>
      <author>
        <name>Chanda, Tirtha</name>
      </author>
      <author>
        <name>Gaisa, Nadine T</name>
      </author>
      <author>
        <name>Wagner, Mathias</name>
      </author>
      <author>
        <name>Klamminger, Gilbert Georg</name>
      </author>
      <author>
        <name>Rau, Tilman T</name>
      </author>
      <author>
        <name>Neppl, Christina</name>
      </author>
      <author>
        <name>Compérat, Eva Maria</name>
      </author>
      <author>
        <name>Gocht, Andreas</name>
      </author>
      <author>
        <name>Haemmerle, Monika</name>
      </author>
      <author>
        <name>Rupp, Niels J</name>
      </author>
      <author>
        <name>Westhoff, Jula</name>
      </author>
      <author>
        <name>Krücken, Irene</name>
      </author>
      <author>
        <name>Seidl, Maximilian</name>
      </author>
      <author>
        <name>Schürch, Christian M</name>
      </author>
      <author>
        <name>Bauer, Marcus</name>
      </author>
      <author>
        <name>Solass, Wiebke</name>
      </author>
      <author>
        <name>Tam, Yu Chun</name>
      </author>
      <author>
        <name>Weber, Florian</name>
      </author>
      <author>
        <name>Grobholz, Rainer</name>
      </author>
      <author>
        <name>Augustyniak, Jaroslaw</name>
      </author>
      <author>
        <name>Kalinski, Thomas</name>
      </author>
      <author>
        <name>Hörner, Christian</name>
      </author>
      <author>
        <name>Mertz, Kirsten D</name>
      </author>
      <author>
        <name>Döring, Constanze</name>
      </author>
      <author>
        <name>Erbersdobler, Andreas</name>
      </author>
      <author>
        <name>Deubler, Gabriele</name>
      </author>
      <author>
        <name>Bremmer, Felix</name>
      </author>
      <author>
        <name>Sommer, Ulrich</name>
      </author>
      <author>
        <name>Brodhun, Michael</name>
      </author>
      <author>
        <name>Griffin, Jon</name>
      </author>
      <author>
        <name>Lenon, Maria Sarah L</name>
      </author>
      <author>
        <name>Trpkov, Kiril</name>
      </author>
      <author>
        <name>Cheng, Liang</name>
      </author>
      <author>
        <name>Chen, Fei</name>
      </author>
      <author>
        <name>Levi, Angelique</name>
      </author>
      <author>
        <name>Cai, Guoping</name>
      </author>
      <author>
        <name>Nguyen, Tri Q</name>
      </author>
      <author>
        <name>Amin, Ali</name>
      </author>
      <author>
        <name>Cimadamore, Alessia</name>
      </author>
      <author>
        <name>Shabaik, Ahmed</name>
        <uri>https://orcid.org/0000-0003-1987-3453</uri>
      </author>
      <author>
        <name>Manucha, Varsha</name>
      </author>
      <author>
        <name>Ahmad, Nazeel</name>
      </author>
      <author>
        <name>Messias, Nidia</name>
      </author>
      <author>
        <name>Sanguedolce, Francesca</name>
      </author>
      <author>
        <name>Taheri, Diana</name>
      </author>
      <author>
        <name>Baraban, Ezra</name>
      </author>
      <author>
        <name>Jia, Liwei</name>
      </author>
      <author>
        <name>Shah, Rajal B</name>
      </author>
      <author>
        <name>Siadat, Farshid</name>
      </author>
      <author>
        <name>Swarbrick, Nicole</name>
      </author>
      <author>
        <name>Park, Kyung</name>
      </author>
      <author>
        <name>Hassan, Oudai</name>
      </author>
      <author>
        <name>Sakhaie, Siamak</name>
      </author>
      <author>
        <name>Downes, Michelle R</name>
      </author>
      <author>
        <name>Miyamoto, Hiroshi</name>
      </author>
      <author>
        <name>Williamson, Sean R</name>
      </author>
      <author>
        <name>Holland-Letz, Tim</name>
      </author>
      <author>
        <name>Wies, Christoph</name>
      </author>
      <author>
        <name>Schneider, Carolin V</name>
      </author>
      <author>
        <name>Kather, Jakob Nikolas</name>
      </author>
      <author>
        <name>Tolkach, Yuri</name>
      </author>
      <author>
        <name>Brinker, Titus J</name>
      </author>
    </item>
    <item>
      <title>Alveolar Macrophages Mimic Tumor Cells in Lung Tissue: A Diagnostic Pitfall in Cytology FNA and EBUS Specimens</title>
      <link>https://escholarship.org/uc/item/6zh0f839</link>
      <description>Fine-needle aspiration (FNA) or core needle biopsy via EBUS procedure is commonly used to assess suspicious lung nodules. Alveolar macrophages are commonly seen in these specimens. In cases when hypercellular specimens with large aggregates of alveolar macrophages are encountered, especially when they show epithelioid morphology, vacuolated cytoplasm, and significant cytological atypia, including marked anisonucleosis and intracytoplasmic inclusion, they can be mistakenly interpreted as "lesional cells" during rapid on-site evaluation (ROSE) and cease the EBUS procedure prematurely. It is important to keep in mind that epithelioid alveolar macrophages may mimic lung neuroendocrine tumor (NET), lung adenocarcinoma, or even metastatic process. Cytoplasmic pigmentation and immunohistochemistry analysis can be extremely useful to prevent a false diagnosis of malignancy.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6zh0f839</guid>
      <pubDate>Thu, 25 Sep 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Maciejewski, Joshua</name>
      </author>
      <author>
        <name>Hasteh, Farnaz</name>
      </author>
      <author>
        <name>Patel, Charmi</name>
      </author>
      <author>
        <name>Pezhouh, Maryam</name>
      </author>
      <author>
        <name>Hu, Jingjing</name>
      </author>
    </item>
    <item>
      <title>PolyIC as an adjuvant outperforms anti-VEGF in combination with anti-PD-L1 therapy in mouse liver tumor models</title>
      <link>https://escholarship.org/uc/item/9qt8v396</link>
      <description>BACKGROUND: Immune checkpoint inhibitors combined with antiangiogenic therapy have become the standard of care for advanced HCC, albeit with limited therapeutic benefit. Our previous studies demonstrated the immunomodulatory and antitumor effects of polyIC, a synthetic dsRNA. Here, we compared the efficacy of anti-programmed death ligand 1 (αPD-L1) plus polyIC versus αPD-L1 plus anti-vascular endothelial growth factor (αVEGF) in mouse tumor models.
METHODS: We established a primary liver tumor model using hydrodynamic tail vein injection of Ras/Myc oncogenes and a metastasized tumor model via intrasplenic injection of colon cancer cells. Flow cytometry and gene expression analysis were performed to assess immune profiles across treatment groups. Key factors contributing to antitumor efficacy were explored.
RESULTS: In both models, αPD-L1 plus polyIC demonstrated superior antitumor effects relative to αPD-L1 plus αVEGF. Unlike αVEGF, polyIC enhanced the immune response to αPD-L1...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9qt8v396</guid>
      <pubDate>Fri, 12 Sep 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Ji, Yichun</name>
      </author>
      <author>
        <name>Lu, Li-Chun</name>
      </author>
      <author>
        <name>Zhuang, Hao</name>
      </author>
      <author>
        <name>Liu, Yingluo</name>
      </author>
      <author>
        <name>Gao, Yiming</name>
      </author>
      <author>
        <name>Qin, Andre</name>
      </author>
      <author>
        <name>Lee, Jin</name>
      </author>
      <author>
        <name>Feng, Gen-Sheng</name>
      </author>
    </item>
    <item>
      <title>Spatial transcriptomics identifies disrupted circadian gene expression in a mouse model of Alzheimer’s disease</title>
      <link>https://escholarship.org/uc/item/13h3h7w8</link>
      <description>Abstract: 
Background: 
Disruptions in circadian rhythm are a common symptom of Alzheimer’s disease (AD), which occur early in disease progression and may contribute to the neurodegenerative process. However, the mechanisms that link alterations in rhythmic transcription and disease pathology are poorly understood. Here we used brain‐wide spatial transcriptomics to elucidate progressive disruptions in diurnal transcriptional rhythms in a mouse model of AD. 
Method: 
Using Visium spatial transcriptomic technology, we investigated transcriptional changes with spatiotemporal resolution in APP23 transgenic mice, which overexpress human APP with the Swedish mutation. Sagittal brain slices from APP23 and littermate control mice were collected at 4 Zeitgeber times (ZT). We used community detection to cluster the spatial locations according to shared patterns of gene expression, which corresponded to major anatomical brain regions. Pseudobulk profiles were computed for each cluster in...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/13h3h7w8</guid>
      <pubDate>Thu, 11 Sep 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Romero, Haylie K</name>
      </author>
      <author>
        <name>Gerber, Alon</name>
      </author>
      <author>
        <name>Akhmetova, Laila</name>
      </author>
      <author>
        <name>Mukamel, Eran A</name>
        <uri>https://orcid.org/0000-0003-3203-9535</uri>
      </author>
      <author>
        <name>Desplats, Paula</name>
        <uri>https://orcid.org/0000-0002-4758-4280</uri>
      </author>
    </item>
    <item>
      <title>The Emerging Roles of Metabolic Reprogramming in Non-Small Cell Lung Cancer Progression</title>
      <link>https://escholarship.org/uc/item/3h60q9fw</link>
      <description>Lung cancer remains a leading cause of cancer-related mortality due to its capacity for silent metastasis and the significant challenges in achieving effective treatment. Currently, targeted therapies and chemotherapies are the primary options for advanced or inoperable lung cancer; however, their efficacy is often undermined by the cancer's ability to develop resistance through both genetic and non-genetic mechanisms. This review explores recent advances in understanding metabolic reprogramming in non-small cell lung cancer (NSCLC), focusing on its critical role in cancer progression. NSCLC cells exhibit heterogeneous activation of metabolic pathways influenced by their oncogenic mutations. Notably, their metabolic phenotypes evolve in response to environmental stressors and therapeutic pressures. Moreover, NSCLC cells engage in metabolic crosstalk with their microenvironment to enhance survival, leveraging distinct metabolic adaptations at both primary and metastatic sites....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3h60q9fw</guid>
      <pubDate>Thu, 28 Aug 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Peixoto, Beatriz P</name>
      </author>
      <author>
        <name>Clague, Rebecca A</name>
      </author>
      <author>
        <name>Reddy, Joshua P</name>
      </author>
      <author>
        <name>Wettersten, Hiromi I</name>
        <uri>https://orcid.org/0000-0001-7144-3122</uri>
      </author>
    </item>
    <item>
      <title>Surveillance donor-specific antibody and pathologic antibody-mediated rejection testing in heart transplant patients in the contemporary era</title>
      <link>https://escholarship.org/uc/item/42d7z1dh</link>
      <description>BACKGROUND: Surveillance donor-specific antibody (DSA) and pathologic antibody-mediated rejection (pAMR) testing is recommended in the first year after heart transplantation (HTx) in adult patients. Whether pAMR testing adds prognostic information to contemporary DSA testing has not been fully studied.
METHODS: This was a single-center study of consecutive endomyocardial biopsies (EMB) performed between November 2010 and February 2023 in adult HTx patients. The primary objective was to evaluate whether pAMR testing contributes additional information to DSA testing to better predict overall survival. Secondary end-points included cardiac survival and allograft dysfunction.
RESULTS: A total of 6,033 EMBs from 544 HTx patients were reviewed for the study. The pAMR+/DSA+ patients had significantly lower overall (p&lt;sub&gt;c&lt;/sub&gt; =&amp;nbsp;0.013) and cardiac survival (p&lt;sub&gt;c&lt;/sub&gt; =&amp;nbsp;0.002), while the pAMR+/DSA- and pAMR-/DSA+ patients showed no difference in either outcome compared...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/42d7z1dh</guid>
      <pubDate>Thu, 14 Aug 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Cusi, Vincenzo</name>
      </author>
      <author>
        <name>Cardenas, Ashley</name>
      </author>
      <author>
        <name>Tada, Yuko</name>
        <uri>https://orcid.org/0000-0003-1410-9894</uri>
      </author>
      <author>
        <name>Vaida, Florin</name>
        <uri>https://orcid.org/0000-0002-2256-4611</uri>
      </author>
      <author>
        <name>Wettersten, Nicholas</name>
        <uri>https://orcid.org/0000-0002-6122-1152</uri>
      </author>
      <author>
        <name>Chak, Jennifer</name>
      </author>
      <author>
        <name>Pretorius, Victor</name>
      </author>
      <author>
        <name>Urey, Marcus Anthony</name>
        <uri>https://orcid.org/0000-0001-8311-5003</uri>
      </author>
      <author>
        <name>Morris, Gerald P</name>
        <uri>https://orcid.org/0000-0002-1097-4453</uri>
      </author>
      <author>
        <name>Lin, Grace</name>
        <uri>https://orcid.org/0000-0001-8018-5604</uri>
      </author>
      <author>
        <name>Kim, Paul J</name>
        <uri>https://orcid.org/0000-0002-1755-6182</uri>
      </author>
    </item>
    <item>
      <title>The Sialome of the Retina, Alteration in Age-Related Macular Degeneration Pathology, and Potential Impacts on Complement Factor H</title>
      <link>https://escholarship.org/uc/item/96f7k4cz</link>
      <description>Purpose: Little is known about sialic acids of the human retina, despite their integral role in self /non-self-discrimination by complement factor H (FH), the alternative complement pathway inhibitor.
Methods: A custom sialoglycan microarray was used to characterize the sialic acid-binding specificity of native FH or recombinant molecules where IgG Fc was fused to FH domains 16 to 20 (which contains a sialic acid-binding site), domains 6 and 7 (which contains a glycosaminoglycan-binding site), or the FH-related proteins (FHRs) 1 and 3. We analyzed macular and peripheral retinal tissue from postmortem ocular globes for the amount, type, and presentation (glycosidic linkage type) of sialic acid in individuals with age-related macular degeneration (AMD) and age-matched controls using fluorescent lectins and antibodies to detect sialic acid and endogenous FH. Released sialic acids from neural retina, retinal pigmented epithelium (RPE) cells, and the Bruch's membrane (BrM) were labeled...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/96f7k4cz</guid>
      <pubDate>Thu, 31 Jul 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Swan, Jaclyn</name>
      </author>
      <author>
        <name>Toomey, Christopher B</name>
      </author>
      <author>
        <name>Bergstrand, Max</name>
      </author>
      <author>
        <name>Cuello, Hector A</name>
      </author>
      <author>
        <name>Robie, Jesse</name>
      </author>
      <author>
        <name>Yu, Hai</name>
        <uri>https://orcid.org/0000-0002-4378-0532</uri>
      </author>
      <author>
        <name>Yuan, Yue</name>
      </author>
      <author>
        <name>Kooner, Anoopjit Singh</name>
      </author>
      <author>
        <name>Chen, Xi</name>
      </author>
      <author>
        <name>Shaughnessy, Jutamas</name>
      </author>
      <author>
        <name>Ram, Sanjay</name>
      </author>
      <author>
        <name>Varki, Ajit</name>
      </author>
      <author>
        <name>Gagneux, Pascal</name>
        <uri>https://orcid.org/0000-0001-9599-9838</uri>
      </author>
    </item>
    <item>
      <title>Comparative physiological anthropogeny: exploring molecular underpinnings of distinctly human phenotypes</title>
      <link>https://escholarship.org/uc/item/8sr070k3</link>
      <description>Anthropogeny is a classic term encompassing transdisciplinary investigations of the origins of the human species. Comparative anthropogeny is a systematic comparison of humans and other living nonhuman hominids (so-called "great apes"), aiming to identify distinctly human features in health and disease, with the overall goal of explaining human origins. We begin with a historical perspective, briefly describing how the field progressed from the earliest evolutionary insights to the current emphasis on in-depth molecular and genomic investigations of "human-specific" biology and an increased appreciation for cultural impacts on human biology. While many such genetic differences between humans and other hominids have been revealed over the last two decades, this information remains insufficient to explain the most distinctive phenotypic traits distinguishing humans from other living hominids. Here we undertake a complementary approach of "comparative physiological anthropogeny,"...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8sr070k3</guid>
      <pubDate>Thu, 31 Jul 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Vaill, Michael</name>
      </author>
      <author>
        <name>Kawanishi, Kunio</name>
      </author>
      <author>
        <name>Varki, Nissi</name>
      </author>
      <author>
        <name>Gagneux, Pascal</name>
        <uri>https://orcid.org/0000-0001-9599-9838</uri>
      </author>
      <author>
        <name>Varki, Ajit</name>
      </author>
    </item>
    <item>
      <title>Social, microbial, and immune factors linking bacterial vaginosis and infectious diseases</title>
      <link>https://escholarship.org/uc/item/6zd9g0vr</link>
      <description>Bacterial vaginosis (BV) is a polymicrobial condition of the vaginal microbiota associated with a variety of sexually transmitted infections, infections of maternal and fetal tissues during pregnancy, and even some infections outside of the reproductive tract, including the urinary tract and mouth. BV has also been associated with conditions in which the body generates prominent inflammatory reactions to microbes, including infections of the cervix and other upper genital tract tissues. For reasons still not understood, BV is a highly recurrent and often difficult-to-treat condition, complicating attempts to prevent these associated infections. An additional layer of complexity arises from the increasing awareness that the presence of BV-associated bacteria in the vagina is not always symptomatic or associated with adverse outcomes. In this concise Review, we summarize and synthesize three groups of factors grounded in the literature that may be fueling the associations between...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6zd9g0vr</guid>
      <pubDate>Thu, 31 Jul 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Gilbert, Nicole M</name>
      </author>
      <author>
        <name>Hernandez, Luis A Ramirez</name>
      </author>
      <author>
        <name>Berman, Daniela</name>
      </author>
      <author>
        <name>Morrill, Sydney</name>
      </author>
      <author>
        <name>Gagneux, Pascal</name>
        <uri>https://orcid.org/0000-0001-9599-9838</uri>
      </author>
      <author>
        <name>Lewis, Amanda L</name>
      </author>
    </item>
    <item>
      <title>Genetic and pharmacological targeting of nicotinic acetylcholine receptor action blocks tumor progression in mouse models of breast cancer</title>
      <link>https://escholarship.org/uc/item/5fr2h9w6</link>
      <description>Effective small molecule therapies are a major unmet need in triple-negative breast cancer. Therefore, we examined the mechanism of action of a novel cancer therapeutic target in preclinical mouse models focusing on the α7 nicotinic acetylcholine receptor (CHRNA7). E0771 breast tumor cells were implanted into CHRNA7KO mice to determine the role of CHRNA7, which is expressed in tumor-associated myeloid immune cells. We observed that tumor-bearing CHRNA7KO mice had decreased survival and increased tumor burden linked to a CHRNA7-mediated reduction in immune cell activation. Based on the tumor permissive phenotype of CHRNA7KO mice, we tested the effect of a small molecule agonist of CHRNA7, AR-R17779, in several mouse models of breast cancer. For example, in both the E0771 tumor model and PyMT tumor models, treatment with AR-R17779 increased survival. In the 4T1 breast tumor model, treatment with AR-R17779 also increased survival, with a well-defined reduction in primary tumor burden...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5fr2h9w6</guid>
      <pubDate>Thu, 31 Jul 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Heard, Matthew A</name>
      </author>
      <author>
        <name>Qian, Jin</name>
      </author>
      <author>
        <name>Sayeed, Sakeef</name>
      </author>
      <author>
        <name>Mechlowicz, Sereena</name>
      </author>
      <author>
        <name>Zhang, Qingyang</name>
      </author>
      <author>
        <name>Yeluri, Sudha</name>
      </author>
      <author>
        <name>Pool, Katie</name>
      </author>
      <author>
        <name>Yamane, Ryan</name>
      </author>
      <author>
        <name>Morris, Gerald P</name>
        <uri>https://orcid.org/0000-0002-1097-4453</uri>
      </author>
      <author>
        <name>Eliceiri, Brian P</name>
        <uri>https://orcid.org/0000-0003-1811-1916</uri>
      </author>
    </item>
    <item>
      <title>Evolution of Human Susceptibility to Alzheimer's Disease: A Review of Hypotheses and Comparative Evidence</title>
      <link>https://escholarship.org/uc/item/2w75c445</link>
      <description>Primates rely on memory to navigate both physical and social environments and in humans, loss of memory function leads to devastating consequences. Alzheimer's disease (AD) is a neurodegenerative disease which begins by impacting memory functioning and is ultimately fatal. AD is common across human populations and its prevalence is predicted to rise with increases in the aging population. Despite this, the full AD phenotype has not been observed in any other nonhuman primate species. While a significant amount of research has been devoted to understanding the immediate mechanisms involved in AD pathogenesis in humans, less research has focused on why humans are particularly vulnerable to neurodegenerative diseases like AD. Here we explore hypotheses on the evolution of distinct human susceptibility to AD and place these in the context of findings from comparative neuroanatomical and molecular studies and discuss recent evidence for evolutionary changes protective against AD in...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2w75c445</guid>
      <pubDate>Thu, 31 Jul 2025 00:00:00 +0000</pubDate>
      <author>
        <name>August, Isabel</name>
      </author>
      <author>
        <name>Gagneux, Pascal</name>
        <uri>https://orcid.org/0000-0001-9599-9838</uri>
      </author>
      <author>
        <name>Semendeferi, Katerina</name>
      </author>
      <author>
        <name>Marchetto, Maria Carolina</name>
      </author>
    </item>
    <item>
      <title>Correction: Current Strategies of Modeling Human Trophoblast Using Human Pluripotent Stem Cells in vitro</title>
      <link>https://escholarship.org/uc/item/4h58h4c9</link>
      <description>In the Reagents and Solutions section of the above-referenced article: 1.Matrigel:&amp;nbsp;In the paper, “Corning, cat. no. 356231” has been changed to “Corning, cat. no. 354234”. 2.1-Thioglycerol:&amp;nbsp;In the paper, “MilliporeSigma, cat. no. M1753” has been changed to “MilliporeSigma, cat. no. M6145”. The current version online now includes these&amp;nbsp;corrections and may be considered the authoritative version of record.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4h58h4c9</guid>
      <pubDate>Thu, 17 Jul 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Cheung, Virginia Chu</name>
      </author>
      <author>
        <name>Bui, Tony</name>
      </author>
      <author>
        <name>Soncin, Francesca</name>
      </author>
      <author>
        <name>Bai, Tao</name>
      </author>
      <author>
        <name>Kessler, John A</name>
      </author>
      <author>
        <name>Parast, Mana M</name>
      </author>
      <author>
        <name>Horii, Mariko</name>
        <uri>https://orcid.org/0000-0002-4996-6792</uri>
      </author>
    </item>
    <item>
      <title>Elucidating VEGF Biology: A Journey of Discovery and Clinical Translation</title>
      <link>https://escholarship.org/uc/item/7g92z9pj</link>
      <description>Elucidating VEGF Biology: A Journey of Discovery and Clinical Translation</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7g92z9pj</guid>
      <pubDate>Thu, 19 Jun 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Mori, Tommaso</name>
      </author>
      <author>
        <name>Kumar, Naresh</name>
      </author>
      <author>
        <name>Ferrara, Napoleone</name>
        <uri>https://orcid.org/0000-0001-8412-2889</uri>
      </author>
    </item>
    <item>
      <title>A dataset of chronic nicotine-induced genes in breast cancer cells</title>
      <link>https://escholarship.org/uc/item/9dh426t6</link>
      <description>These data show the differentially expressed genes (DEG) from HCC38 breast cancer cell line chronically exposed to nicotine versus vehicle control. Additional data is also provided from dynamic trajectory analysis, identifying the most dynamic genes due to chronic nicotine treatment. To produce this dataset, we first performed single cell RNA sequencing from HCC38 cells chronically treated with vehicle or nicotine, followed by scanpy analysis to yield 6 discrete cell clusters at conservative resolution. We then evaluated differential gene expression between chronic nicotine and control cells for each individual cluster or in the whole sample using PyDESeq2. For dynamic trajectory analysis, Velocyto (0.6) was used to estimate the spliced and unspliced counts for each gene between chronic nicotine-treated cells and vehicle, allowing computation of gene velocities. These data are useful for analysing the expression of individual genes or gene velocities either in the whole sample...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9dh426t6</guid>
      <pubDate>Thu, 22 May 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Mugisha, Samson</name>
      </author>
      <author>
        <name>Labhsetwar, Shreyas</name>
      </author>
      <author>
        <name>Dave, Devam</name>
      </author>
      <author>
        <name>Klemke, Richard</name>
        <uri>https://orcid.org/0000-0001-8230-2915</uri>
      </author>
      <author>
        <name>Desgrosellier, Jay S</name>
        <uri>https://orcid.org/0000-0001-8097-0143</uri>
      </author>
    </item>
    <item>
      <title>A case of hypoglossal nerve palsy with evolving cranial nerve involvement in renal cell carcinoma: a case report</title>
      <link>https://escholarship.org/uc/item/6m00s404</link>
      <description>BackgroundRenal cell carcinoma is a rare pediatric solid tumor that typically presents with hematuria, abdominal mass, or flank pain. It is uncommon for renal cell carcinoma to manifest with headache and isolated extra-urogenital symptoms. We present, to our knowledge, the first case of renal cell carcinoma with bony metastases, presenting initially as isolated cranial nerve twelve palsy. Although bony metastases can occur in renal cell carcinoma, skull-based metastases and cranial neuropathies are exceedingly rare, especially in the pediatric population.Case presentationWe describe the unusual presentation of renal cell carcinoma with bony skull-based metastases presenting initially as isolated hypoglossal nerve palsy, that progressed to multiple cranial neuropathies in a previously healthy 14-year-old female of Indian descent.ConclusionThe differential for hypoglossal nerve with evolving cranial nerves 9 and 10 involvement can be broad owing to the course of the nerve, the structures...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6m00s404</guid>
      <pubDate>Thu, 24 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Shams, Shadi</name>
      </author>
      <author>
        <name>Broughton, Abigail</name>
      </author>
      <author>
        <name>Lambeth, Katrina</name>
      </author>
      <author>
        <name>Trivedi, Aditi</name>
      </author>
      <author>
        <name>Wang, Dehua</name>
      </author>
      <author>
        <name>Choo, Sun</name>
      </author>
      <author>
        <name>Dove, Katherine</name>
      </author>
    </item>
    <item>
      <title>Zika but not Dengue virus infection limits NF-κB activity in human monocyte-derived dendritic cells and suppresses their ability to activate T cells</title>
      <link>https://escholarship.org/uc/item/66z3b5jz</link>
      <description>Understanding flavivirus immunity is critical for the development of pan-flavivirus vaccines. Dendritic cells (DC) coordinate antiviral innate and adaptive immune responses, and they can be targeted by flaviviruses as a mechanism of immune evasion. Using an unbiased genome-wide approach designed to specifically identify flavivirus-modulated pathways, we found that, while dengue virus (DENV) robustly activates DCs, Zika virus (ZIKV) causes minimal activation of genes involved in DC activation, maturation, and antigen presentation, reducing cytokine secretion and the stimulation of allogeneic and peptide-specific T cell responses. Mechanistically, ZIKV inhibits DC maturation by suppressing NF-κB p65 recruitment and the subsequent transcription of proinflammatory and DC maturation-related genes. Thus, we identify a divergence in the effects of ZIKV and DENV on the host T cell response, highlighting the need to factor such differences into the design of anti-flavivirus vaccines.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/66z3b5jz</guid>
      <pubDate>Sat, 12 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Wang, Ying-Ting</name>
      </author>
      <author>
        <name>Branche, Emilie</name>
      </author>
      <author>
        <name>Xie, Jialei</name>
      </author>
      <author>
        <name>McMillan, Rachel E</name>
      </author>
      <author>
        <name>Ana-Sosa-Batiz, Fernanda</name>
      </author>
      <author>
        <name>Lu, Hsueh-Han</name>
      </author>
      <author>
        <name>Li, Qin Hui</name>
      </author>
      <author>
        <name>Clark, Alex E</name>
      </author>
      <author>
        <name>Valls Cuevas, Joan M</name>
      </author>
      <author>
        <name>Viramontes, Karla M</name>
      </author>
      <author>
        <name>Garretson, Aaron F</name>
        <uri>https://orcid.org/0000-0003-3855-4482</uri>
      </author>
      <author>
        <name>dos Santos Alves, Rúbens Prince</name>
      </author>
      <author>
        <name>Heinz, Sven</name>
        <uri>https://orcid.org/0000-0002-4665-1007</uri>
      </author>
      <author>
        <name>Benner, Christopher</name>
        <uri>https://orcid.org/0000-0002-4618-0719</uri>
      </author>
      <author>
        <name>Carlin, Aaron F</name>
        <uri>https://orcid.org/0000-0002-1669-8066</uri>
      </author>
      <author>
        <name>Shresta, Sujan</name>
      </author>
    </item>
    <item>
      <title>Over‐Expression of RNA Processing, Heat Shock, and DNA Repair Proteins in Breast Tumor Compared to Normal Tissue</title>
      <link>https://escholarship.org/uc/item/7cx8m6v8</link>
      <description>This study identifies the main changes in protein expression in human breast tumors compared to normal breast tissue. Malignant tumors (32) and normal breast tissue samples (23), from formaldehyde-fixed, paraffin-embedded specimens are subjected to discovery proteomics using liquid chromatography/tandem mass spectrometry, with spectral counts for quantitation. The dataset contains 1406 proteins. Differential expression is measured using a method that takes advantage of estimates of the percentage of tumor on a slide. This analysis shows that the major classes of proteins over-expressed by tumors are RNA-binding, heat shock and DNA repair proteins. RNA-binding proteins, including heterogeneous nuclear ribonucleoproteins (HNRNPs), SR splice factors (SRSF) and elongation factors form the largest group. Comparison with results from another study demonstrates that the RNA-binding proteins are associated specifically with malignant transformation, rather than with cell proliferation....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7cx8m6v8</guid>
      <pubDate>Fri, 11 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Yen, Ten‐Yang</name>
      </author>
      <author>
        <name>Wong, Richard</name>
      </author>
      <author>
        <name>Pizzo, Donald</name>
      </author>
      <author>
        <name>Thein, Moe</name>
      </author>
      <author>
        <name>Macher, Bruce A</name>
      </author>
      <author>
        <name>Timpe, Leslie C</name>
      </author>
    </item>
    <item>
      <title>Emerging role of immunogenic cell death in cancer immunotherapy</title>
      <link>https://escholarship.org/uc/item/7861k3pc</link>
      <description>Cancer immunotherapy, such as immune checkpoint blockade (ICB), has emerged as a groundbreaking approach for effective cancer treatment. Despite its considerable potential, clinical studies have indicated that the current response rate to cancer immunotherapy is suboptimal, primarily attributed to low immunogenicity in certain types of malignant tumors. Immunogenic cell death (ICD) represents a form of regulated cell death (RCD) capable of enhancing tumor immunogenicity and activating tumor-specific innate and adaptive immune responses in immunocompetent hosts. Therefore, gaining a deeper understanding of ICD and its evolution is crucial for developing more effective cancer therapeutic strategies. This review focuses exclusively on both historical and recent discoveries related to ICD modes and their mechanistic insights, particularly within the context of cancer immunotherapy. Our recent findings are also highlighted, revealing a mode of ICD induction facilitated by atypical...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7861k3pc</guid>
      <pubDate>Fri, 11 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Arimoto, Kei-ichiro</name>
      </author>
      <author>
        <name>Miyauchi, Sayuri</name>
        <uri>https://orcid.org/0009-0000-8439-7751</uri>
      </author>
      <author>
        <name>Liu, Mengdan</name>
      </author>
      <author>
        <name>Zhang, Dong-Er</name>
      </author>
    </item>
    <item>
      <title>Enzymatically Inactive Tissue-Type Plasminogen Activator Reverses Disease Progression in the Dextran Sulfate Sodium Mouse Model of Inflammatory Bowel Disease</title>
      <link>https://escholarship.org/uc/item/6f1672xm</link>
      <description>Enzymatically inactive tissue-type plasminogen activator (EI-tPA) does not activate fibrinolysis, but interacts with the N-methyl-d-aspartate receptor (NMDA-R) and low-density lipoprotein receptor-related protein-1 (LRP1) in macrophages to block innate immune system responses mediated by toll-like receptors. Herein, we examined the ability of EI-tPA to treat colitis in mice, induced by dextran sulfate sodium. In two separate studies, designed to generate colitis of differing severity, a single dose of EI-tPA administered after inflammation established significantly improved disease parameters. EI-tPA-treated mice demonstrated improved weight gain. Stools improved in character and became hemoccult negative. Abdominal tenderness decreased. Colon shortening significantly decreased in EI-tPA-treated mice, suggesting attenuation of irreversible tissue damage and remodeling. Furthermore, histopathologic evidence of disease decreased in the distal 25% of the colon in EI-tPA-treated mice....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6f1672xm</guid>
      <pubDate>Fri, 11 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Das, Lipsa</name>
      </author>
      <author>
        <name>Banki, Michael A</name>
      </author>
      <author>
        <name>Azmoon, Pardis</name>
        <uri>https://orcid.org/0000-0002-1512-5581</uri>
      </author>
      <author>
        <name>Pizzo, Donald</name>
      </author>
      <author>
        <name>Gonias, Steven L</name>
      </author>
    </item>
    <item>
      <title>Neuronal Ndst1 depletion accelerates prion protein clearance and slows neurodegeneration in prion infection</title>
      <link>https://escholarship.org/uc/item/690468f1</link>
      <description>Select prion diseases are characterized by widespread cerebral plaque-like deposits of amyloid fibrils enriched in heparan sulfate (HS), a abundant extracellular matrix component. HS facilitates fibril formation in vitro, yet how HS impacts fibrillar plaque growth within the brain is unclear. Here we found that prion-bound HS chains are highly sulfated, and that the sulfation is essential for accelerating prion conversion in vitro. Using conditional knockout mice to deplete the HS sulfation enzyme, Ndst1 (N-deacetylase / N-sulfotransferase) from neurons or astrocytes, we investigated how reducing HS sulfation impacts survival and prion aggregate distribution during a prion infection. Neuronal Ndst1-depleted mice survived longer and showed fewer and smaller parenchymal plaques, shorter fibrils, and increased vascular amyloid, consistent with enhanced aggregate transit toward perivascular drainage channels. The prolonged survival was strain-dependent, affecting mice infected with...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/690468f1</guid>
      <pubDate>Fri, 11 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Aguilar-Calvo, Patricia</name>
      </author>
      <author>
        <name>Malik, Adela</name>
      </author>
      <author>
        <name>Sandoval, Daniel R</name>
      </author>
      <author>
        <name>Barback, Christopher</name>
      </author>
      <author>
        <name>Orrù, Christina D</name>
      </author>
      <author>
        <name>Standke, Heidi G</name>
      </author>
      <author>
        <name>Thomas, Olivia R</name>
      </author>
      <author>
        <name>Dwyer, Chrissa A</name>
      </author>
      <author>
        <name>Pizzo, Donald P</name>
      </author>
      <author>
        <name>Bapat, Jaidev</name>
      </author>
      <author>
        <name>Soldau, Katrin</name>
      </author>
      <author>
        <name>Ogawa, Ryotaro</name>
      </author>
      <author>
        <name>Riley, Mckenzie B</name>
      </author>
      <author>
        <name>Nilsson, K Peter R</name>
      </author>
      <author>
        <name>Kraus, Allison</name>
      </author>
      <author>
        <name>Caughey, Byron</name>
      </author>
      <author>
        <name>Iliff, Jeffrey J</name>
      </author>
      <author>
        <name>Vera, David R</name>
      </author>
      <author>
        <name>Esko, Jeffrey D</name>
      </author>
      <author>
        <name>Sigurdson, Christina J</name>
      </author>
    </item>
    <item>
      <title>The Role of PI3k-Gamma Modulation in Bacterial Infection: A Review of the Literature and Selected Experimental Observations</title>
      <link>https://escholarship.org/uc/item/6406q13m</link>
      <description>&lt;b&gt;Background:&lt;/b&gt; Phosphoinositide 3-kinase is a potent target for cancer therapy due to its significant role in the regulation of cellular growth and proliferation. Dysregulation of the PI3k signaling cascade can constitutively activate growth pathways to trigger the progression of cancer, resulting in the development of multiple inhibitors as cancer therapeutics. &lt;b&gt;Objectives&lt;/b&gt;: The wide array of cells expressing PI3k also include immune cells, and the inhibition of these receptors has shown promise in combating inflammation and infectious disease, a relationship we sought to examine further. &lt;b&gt;Methods&lt;/b&gt;: We infected wild-type and PI3kγ knockout murine macrophages as well as PI3kγ inhibitor-treated THP-1 human macrophage-like cells with &lt;i&gt;Staphylococcus aureus&lt;/i&gt; and quantified inflammation through gene expression analysis, protein secretion assays, and immunofluorescence imaging. &lt;b&gt;Results&lt;/b&gt;: We observed that knockout of PI3kγ in murine macrophages alongside pharmacological...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6406q13m</guid>
      <pubDate>Fri, 11 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Sun, Daniel</name>
      </author>
      <author>
        <name>Hoffman, Alexandria</name>
      </author>
      <author>
        <name>Askarian, Fatemeh</name>
      </author>
      <author>
        <name>Bjånes, Elisabet</name>
      </author>
      <author>
        <name>Lin, Eric X</name>
      </author>
      <author>
        <name>Varner, Judith</name>
        <uri>https://orcid.org/0000-0002-9251-0600</uri>
      </author>
      <author>
        <name>Nizet, Victor</name>
      </author>
    </item>
    <item>
      <title>Circadian alterations during early stages of Alzheimer's disease are associated with aberrant cycles of DNA methylation in BMAL1</title>
      <link>https://escholarship.org/uc/item/3v48f7ks</link>
      <description>INTRODUCTION: Circadian alterations are prevalent in Alzheimer's disease (AD) and may contribute to cognitive impairment, behavioral symptoms, and neurodegeneration. Epigenetic mechanisms regulate the circadian clock, and changes in DNA methylation have been reported in AD brains, but the pathways that mediate circadian deregulation in AD are incompletely understood. We hypothesized that aberrant DNA methylation may affect circadian rhythms in AD.
METHODS: We investigated DNA methylation, transcription, and expression of BMAL1, a positive regulator of the circadian clock, in cultured fibroblasts and brain samples from two independent cohorts of aging and AD.
RESULTS: DNA methylation modulated rhythmic expression of clock genes in cultured fibroblasts. Moreover, rhythmic methylation of BMAL1 was altered in AD brains and fibroblasts and correlated with transcription cycles.
DISCUSSION: Our results indicate that cycles of DNA methylation contribute to the regulation of BMAL1 rhythms...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3v48f7ks</guid>
      <pubDate>Fri, 11 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Cronin, Peter</name>
      </author>
      <author>
        <name>McCarthy, Michael J</name>
        <uri>https://orcid.org/0000-0001-6219-4945</uri>
      </author>
      <author>
        <name>Lim, Andrew SP</name>
      </author>
      <author>
        <name>Salmon, David P</name>
      </author>
      <author>
        <name>Galasko, Douglas</name>
      </author>
      <author>
        <name>Masliah, Eliezer</name>
      </author>
      <author>
        <name>De Jager, Philip L</name>
      </author>
      <author>
        <name>Bennett, David A</name>
      </author>
      <author>
        <name>Desplats, Paula</name>
        <uri>https://orcid.org/0000-0002-4758-4280</uri>
      </author>
    </item>
    <item>
      <title>TDP‐43 Pathology Exacerbates Cognitive Decline in Primary Age‐Related Tauopathy</title>
      <link>https://escholarship.org/uc/item/3br9f63m</link>
      <description>OBJECTIVE: Primary age-related tauopathy (PART) refers to tau neurofibrillary tangles restricted largely to the medial temporal lobe in the absence of significant beta-amyloid plaques. PART has been associated with cognitive impairment, but contributions from concomitant limbic age-related TDP-43 encephalopathy neuropathologic change (LATE-NC) are underappreciated.
METHODS: We compare prevalence of LATE-NC and vascular copathologies in age- and Braak-matched patients with PART (n&amp;nbsp;=&amp;nbsp;45, Braak stage I-IV, Thal phase 0-2) or early stage Alzheimer disease neuropathologic change (ADNC; n&amp;nbsp;=&amp;nbsp;51, Braak I-IV, Thal 3-5), and examine their influence on clinical and cognitive decline.
RESULTS: Concomitant LATE-NC and vascular pathology were equally common, and cognition was equally impaired, in PART (Mini-Mental State Examination [MMSE]&amp;nbsp;=&amp;nbsp;24.8&amp;nbsp;± 6.9) and ADNC (MMSE&amp;nbsp;=&amp;nbsp;24.2&amp;nbsp;± 6.0). Patients with LATE-NC were more impaired than those without...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3br9f63m</guid>
      <pubDate>Fri, 11 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Smirnov, Denis S</name>
      </author>
      <author>
        <name>Salmon, David P</name>
      </author>
      <author>
        <name>Galasko, Douglas</name>
      </author>
      <author>
        <name>Edland, Steven D</name>
        <uri>https://orcid.org/0000-0002-1153-7335</uri>
      </author>
      <author>
        <name>Pizzo, Donald P</name>
      </author>
      <author>
        <name>Goodwill, Vanessa</name>
      </author>
      <author>
        <name>Hiniker, Annie</name>
      </author>
    </item>
    <item>
      <title>Serine-129 phosphorylation of α-synuclein is an activity-dependent trigger for physiologic protein-protein interactions and synaptic function</title>
      <link>https://escholarship.org/uc/item/3938j6zw</link>
      <description>Phosphorylation of α-synuclein at the serine-129 site (α-syn Ser129P) is an established pathologic hallmark of synucleinopathies and a therapeutic target. In physiologic states, only a fraction of α-syn is phosphorylated at this site, and most studies have focused on the pathologic roles of this post-translational modification. We found that unlike wild-type (WT) α-syn, which is widely expressed throughout the brain, the overall pattern of α-syn Ser129P is restricted, suggesting intrinsic regulation. Surprisingly, preventing Ser129P blocked activity-dependent synaptic attenuation by α-syn-thought to reflect its normal function. Exploring mechanisms, we found that neuronal activity augments Ser129P, which is a trigger for protein-protein interactions that are necessary for mediating α-syn function at the synapse. AlphaFold2-driven modeling and membrane-binding simulations suggest a scenario where Ser129P induces conformational changes that facilitate interactions with binding partners....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3938j6zw</guid>
      <pubDate>Fri, 11 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Parra-Rivas, Leonardo A</name>
      </author>
      <author>
        <name>Madhivanan, Kayalvizhi</name>
      </author>
      <author>
        <name>Aulston, Brent D</name>
      </author>
      <author>
        <name>Wang, Lina</name>
      </author>
      <author>
        <name>Prakashchand, Dube Dheeraj</name>
      </author>
      <author>
        <name>Boyer, Nicholas P</name>
      </author>
      <author>
        <name>Saia-Cereda, Veronica M</name>
      </author>
      <author>
        <name>Branes-Guerrero, Kristen</name>
      </author>
      <author>
        <name>Pizzo, Donald P</name>
      </author>
      <author>
        <name>Bagchi, Pritha</name>
      </author>
      <author>
        <name>Sundar, VS</name>
      </author>
      <author>
        <name>Tang, Yong</name>
      </author>
      <author>
        <name>Das, Utpal</name>
      </author>
      <author>
        <name>Scott, David A</name>
      </author>
      <author>
        <name>Rangamani, Padmini</name>
      </author>
      <author>
        <name>Ogawa, Yuki</name>
      </author>
      <author>
        <name>Roy, Subhojit</name>
      </author>
    </item>
    <item>
      <title>Distinctive patterns of DNA methylation associated with Parkinson disease</title>
      <link>https://escholarship.org/uc/item/3782d2c7</link>
      <description>Parkinson disease (PD) is a multifactorial neurodegenerative disorder with high incidence in the elderly, where environmental and genetic factors are involved in etiology. In addition, epigenetic mechanisms, including deregulation of DNA methylation have been recently associated to PD. As accurate diagnosis cannot be achieved pre-mortem, identification of early pathological changes is crucial to enable therapeutic interventions before major neuropathological damage occurs. Here we investigated genome-wide DNA methylation in brain and blood samples from PD patients and observed a distinctive pattern of methylation involving many genes previously associated to PD, therefore supporting the role of epigenetic alterations as a molecular mechanism in neurodegeneration. Importantly, we identified concordant methylation alterations in brain and blood, suggesting that blood might hold promise as a surrogate for brain tissue to detect DNA methylation in PD and as a source for biomarker...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3782d2c7</guid>
      <pubDate>Fri, 11 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Masliah, Eliezer</name>
      </author>
      <author>
        <name>Dumaop, Wilmar</name>
      </author>
      <author>
        <name>Galasko, Douglas</name>
      </author>
      <author>
        <name>Desplats, Paula</name>
        <uri>https://orcid.org/0000-0002-4758-4280</uri>
      </author>
    </item>
    <item>
      <title>Reprogramming of tumor-associated macrophages via NEDD4-mediated CSF1R degradation by targeting USP18</title>
      <link>https://escholarship.org/uc/item/1471k9k1</link>
      <description>Tumor-associated myeloid cells modulate the tumor microenvironment and affect tumor progression. Type I interferon (IFN-I) has multiple effects on tumors and immune response, and ubiquitin-specific peptidase 18 (USP18) functions as a negative regulator of IFN-I signal transduction. This study aims to examine the function of IFN-I in myeloid cells during tumor progression. Here, we show that deletion of USP18 in myeloid cells suppresses tumor progression. Enhanced IFN-I signaling and blocked USP18 expression prompt downregulation of colony stimulating factor 1 receptor (CSF1R) and polarization of tumor-associated macrophages toward pro-inflammatory phenotypes. Further in&amp;nbsp;vitro experiments reveal that downregulation of CSF1R is mediated by ubiquitin-proteasome degradation via E3 ligase neural precursor cell-expressed, developmentaly downregulated 4 (NEDD4) and the IFN-induced increase in ubiquitin E2 ubiquitin-conjugating enzyme H5. USP18 impairs ubiquitination and subsequent...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1471k9k1</guid>
      <pubDate>Fri, 11 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Miyauchi, Sayuri</name>
        <uri>https://orcid.org/0009-0000-8439-7751</uri>
      </author>
      <author>
        <name>Arimoto, Kei-ichiro</name>
      </author>
      <author>
        <name>Liu, Mengdan</name>
      </author>
      <author>
        <name>Zhang, Yue</name>
      </author>
      <author>
        <name>Zhang, Dong-Er</name>
        <uri>https://orcid.org/0000-0003-2541-6443</uri>
      </author>
    </item>
    <item>
      <title>Alterations in gut microbiome composition, function, and rhythmicity are modulated by time‐restricted feeding in Alzheimer’s disease mice accompanying rescue of brain pathology and memory</title>
      <link>https://escholarship.org/uc/item/5359r5jh</link>
      <description>Abstract: 
Background: 
Studies using Alzheimer’s disease (AD) models suggest that gut bacteria contribute to amyloid pathology and systemic inflammation. Further, gut‐derived metabolites serve critical roles in regulating cholesterol, blood‐brain barrier permeability, neuroinflammation, and circadian rhythms. Recent studies from the Alzheimer’s Disease Neuroimaging Initiative have shown that serum‐based gut‐derived metabolites are associated with AD biomarkers and cognitive impairment. We recently reported a time‐restricted feeding (TRF) intervention that restored brain transcription, increased Aβ clearance, reduced amyloid deposition, and improved memory deficits in AD mice (PMID:37607543). Here we investigated gut microbiome alterations in the APP23 mouse stool and terminal ileum and evaluated the role of the microbiome and metabolome in the beneficial effects of TRF. 
Methods: 
Adult male and female APP23 transgenic (TG) and littermate non‐transgenic (NTG) mice (n = 3‐4/sex/genotype/condition)...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5359r5jh</guid>
      <pubDate>Thu, 10 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Whittaker, Daniel S</name>
        <uri>https://orcid.org/0000-0002-4293-5192</uri>
      </author>
      <author>
        <name>Maissy, Erica S</name>
      </author>
      <author>
        <name>Richter, R Alexander</name>
      </author>
      <author>
        <name>Zuffa, Simone</name>
        <uri>https://orcid.org/0000-0001-7237-3402</uri>
      </author>
      <author>
        <name>Ramos, Stephany Z Flores</name>
      </author>
      <author>
        <name>Zarrinpar, Amir</name>
        <uri>https://orcid.org/0000-0001-6423-5982</uri>
      </author>
      <author>
        <name>Desplats, Paula</name>
        <uri>https://orcid.org/0000-0002-4758-4280</uri>
      </author>
    </item>
    <item>
      <title>A Descriptive 5‐Year Analysis of the Demographics and Therapies for Patients With Immune Thrombotic Thrombocytopenic Purpura in the USA: A Multicenter Study of 390 Disease Episodes From 2017 to 2021</title>
      <link>https://escholarship.org/uc/item/6669n8rz</link>
      <description>Immune thrombotic thrombocytopenic purpura (iTTP) is characterized by microangiopathic hemolytic anemia, thrombocytopenia, and microvascular occlusion secondary to acquired ADAMTS13 deficiency. Contemporary data regarding iTTP treatment practices in the US, including the use of caplacizumab, are lacking. We aimed to characterize the demographics and therapies, including medications and apheresis practices, in patients with iTTP in the US. We retrospectively analyzed iTTP cases at 15 sites in the US that provide comprehensive care for patients with iTTP. The time-period assessed was from January 1, 2017 to December 31, 2021. Our primary objective was to analyze data by iTTP episode, inclusive of initial episodes and relapses. A total of 390 iTTP episodes were reported for 280 unique individuals (187 females, 93 males). Thirty-day mortality was 3.7% (14/374), and 6-month mortality was 7.4% (27/367). TPE details were reported for 343 episodes, among which 261 underwent at least one...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6669n8rz</guid>
      <pubDate>Mon, 7 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Jacobs, Jeremy W</name>
      </author>
      <author>
        <name>Adkins, Brian D</name>
      </author>
      <author>
        <name>Booth, Garrett S</name>
      </author>
      <author>
        <name>Stanek, Caroline G</name>
      </author>
      <author>
        <name>Allen, Elizabeth S</name>
      </author>
      <author>
        <name>Grossman, Brenda J</name>
      </author>
      <author>
        <name>Stephens, Laura D</name>
        <uri>https://orcid.org/0000-0002-9101-9326</uri>
      </author>
      <author>
        <name>Crowe, Elizabeth P</name>
      </author>
      <author>
        <name>Daou, Laetitia</name>
      </author>
      <author>
        <name>Marques, Marisa B</name>
      </author>
      <author>
        <name>Siniard, Rance C</name>
      </author>
      <author>
        <name>Wallace, Lisa R</name>
      </author>
      <author>
        <name>Yamada, Chisa</name>
      </author>
      <author>
        <name>Duque, Miriam Andrea</name>
      </author>
      <author>
        <name>Wu, Yanyun</name>
      </author>
      <author>
        <name>Aljuboori, Omar</name>
      </author>
      <author>
        <name>Harrington, Thomas J</name>
      </author>
      <author>
        <name>Byrnes, Diana M</name>
      </author>
      <author>
        <name>Eichbaum, Quentin</name>
      </author>
      <author>
        <name>Villalba, Cristina A Figueroa</name>
      </author>
      <author>
        <name>Juskewitch, Justin E</name>
      </author>
      <author>
        <name>Klapper, Ellen</name>
      </author>
      <author>
        <name>Perez‐Alvarez, Ingrid</name>
      </author>
      <author>
        <name>Klein, Monica S</name>
      </author>
      <author>
        <name>Aldarweesh, Fatima</name>
      </author>
      <author>
        <name>Alkhateb, Rahaf</name>
      </author>
      <author>
        <name>Parsons, Meredith G</name>
      </author>
      <author>
        <name>Schlueter, Annette J</name>
      </author>
      <author>
        <name>Tormey, Christopher A</name>
      </author>
      <author>
        <name>Wheeler, Allison P</name>
      </author>
      <author>
        <name>Powers, Amy A</name>
      </author>
      <author>
        <name>Webb, Christopher B</name>
      </author>
      <author>
        <name>Yates, Sean G</name>
      </author>
      <author>
        <name>Bloch, Evan M</name>
      </author>
      <author>
        <name>Raval, Jay S</name>
      </author>
    </item>
    <item>
      <title>Tracheal nodularity and paratracheal soft tissue nodule: post-radioactive iodine treatment changes with peculiar visual and pathologic findings in a case of metastatic follicular variant papillary thyroid carcinoma: a case report</title>
      <link>https://escholarship.org/uc/item/3n7162m1</link>
      <description>BackgroundFollicular variant papillary thyroid carcinoma is a distinct subtype of papillary thyroid carcinoma that can occasionally present with aggressive features, including distant metastases and extrathyroidal extension. While radioactive iodine ablation is a well-established treatment for residual disease, its post-treatment effects on tracheal and paratracheal structures remain poorly characterized.Case presentationA 22-year-old male individual of Taiwanese descent presented with an enlarged neck mass and was diagnosed with follicular variant papillary thyroid carcinoma. He underwent thyroidectomy, modified radical neck dissection, and postoperative radioactive iodine-131 ablation (100&amp;nbsp;mCi). A total of 1 year later, a chest computed tomography revealed a paratracheal soft tissue nodule and tracheal nodularity. Bronchoscopy with endobronchial ultrasound-guided sampling identified multiple 2–3&amp;nbsp;mm submucosal tracheal nodules containing white exudate. Cytopathologic...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3n7162m1</guid>
      <pubDate>Thu, 3 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Sievers, Benjamin L</name>
      </author>
      <author>
        <name>Shi, Wangpan</name>
      </author>
      <author>
        <name>Hu, Jingjing</name>
      </author>
      <author>
        <name>Miller, Russell</name>
      </author>
      <author>
        <name>Patel, Niral M</name>
      </author>
      <author>
        <name>Van Nostrand, Keriann</name>
      </author>
      <author>
        <name>Cheng, George Z</name>
      </author>
      <author>
        <name>Choe, Charles H</name>
      </author>
      <author>
        <name>Muñoz Pineda, Jorge Alberto</name>
      </author>
    </item>
    <item>
      <title>The single-cell immune profile throughout gestation and its potential value for identifying women at risk for spontaneous preterm birth</title>
      <link>https://escholarship.org/uc/item/1z98t6n2</link>
      <description>Precisely timed immune adaptations, observed in the maternal circulation, underpin the notion of an immune clock of human pregnancy that supports its successful progression and completion at delivery. This immune clock is divided into three immunological phases, with the first phase starting at the time of conception and implantation, shifting into the second phase that supports homeostasis and tolerance throughout pregnancy, and culminating in the last phase of labor and parturition. Disruptions of this immune clock are reported in pregnancy complications such as spontaneous preterm birth. However, our understanding of the immune clock preceding spontaneous preterm birth remains scattered. In this review, we describe the chronology of maternal immune cell adaptations during healthy pregnancies and highlight its disruption in spontaneous preterm birth. With a focus on single-cell cytometric, proteomic and transcriptomic approaches, we review recent studies of term and spontaneous...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1z98t6n2</guid>
      <pubDate>Thu, 3 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Feyaerts, Dorien</name>
      </author>
      <author>
        <name>Diop, Maïgane</name>
      </author>
      <author>
        <name>Galaz, Jose</name>
      </author>
      <author>
        <name>Einhaus, Jakob F</name>
      </author>
      <author>
        <name>Arck, Petra C</name>
      </author>
      <author>
        <name>Diemert, Anke</name>
      </author>
      <author>
        <name>Winn, Virginia D</name>
      </author>
      <author>
        <name>Parast, Mana</name>
      </author>
      <author>
        <name>Gyamfi-Bannerman, Cynthia</name>
      </author>
      <author>
        <name>Prins, Jelmer R</name>
      </author>
      <author>
        <name>Gomez-Lopez, Nardhy</name>
      </author>
      <author>
        <name>Stelzer, Ina A</name>
        <uri>https://orcid.org/0000-0002-9974-4661</uri>
      </author>
    </item>
    <item>
      <title>Gender Composition of Invited Speakers and Session Chairs at American Society for Apheresis Annual Meetings Between 2019 and 2024</title>
      <link>https://escholarship.org/uc/item/1434r0c1</link>
      <description>Disparities persist throughout medicine, including among conference speakership invitations. The National Institutes of Health have highlighted the importance of diversity at academic conferences. We assessed the gender composition of speakers at the American Society for Apheresis (ASFA) annual meeting. We assessed all session chairs and speakers at the annual ASFA meeting from 2019 to 2024. Two authors independently assessed individuals' genders. The primary outcome was the gender composition of all session chairs and speakers by position. Subset analyzes were performed to assess the gender composition of unique individuals (i.e., examining the total number of unique men and women, independent of the number of sessions at which they spoke) and by professional degree. 820 positions (665 speaker positions and 155 chair positions) were identified; women comprised significantly more positions than men [64.3%, 528/820 (95% CI 61.1%-67.6%) vs. 35.6% 292/820 (32.4%-38.9%); p &amp;lt; 0.0001]....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1434r0c1</guid>
      <pubDate>Thu, 3 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Jacobs, Jeremy W</name>
      </author>
      <author>
        <name>Allen, Elizabeth S</name>
        <uri>https://orcid.org/0000-0002-1004-3851</uri>
      </author>
      <author>
        <name>Stephens, Laura D</name>
        <uri>https://orcid.org/0000-0002-9101-9326</uri>
      </author>
      <author>
        <name>Adkins, Brian D</name>
      </author>
      <author>
        <name>Woo, Jennifer S</name>
      </author>
      <author>
        <name>Wheeler, Allison P</name>
      </author>
      <author>
        <name>Sharma, Deva</name>
      </author>
      <author>
        <name>Miller, Yvette M</name>
      </author>
      <author>
        <name>Booth, Garrett S</name>
      </author>
    </item>
    <item>
      <title>Pregnancy as an opportunity to explore brain-immune connections in mental health</title>
      <link>https://escholarship.org/uc/item/091993dm</link>
      <description>Pregnancy's effects on the brain, behavior, and hormones provide a unique opportunity to study how the immune system integrates these adaptations and influences mental health.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/091993dm</guid>
      <pubDate>Thu, 3 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Gumusoglu, Serena B</name>
      </author>
      <author>
        <name>Stelzer, Ina A</name>
        <uri>https://orcid.org/0000-0002-9974-4661</uri>
      </author>
    </item>
    <item>
      <title>Effects of dietary supplementation of creatine on fetal development in gilts at d 60 and d 90 of gestation</title>
      <link>https://escholarship.org/uc/item/0nr1p67x</link>
      <description>BackgroundThe creatine-creatine kinase-phosphocreatine (Cr-CK-PCr) system maintains intracellular ratios of ATP/ADP for support of cellular functions and has been characterized at the placental-uterine interface of rodents, primates, swine and sheep, and thus may support fetal development. This study determined effects of dietary supplementation of creatine (Cr) to gestating gilts on fetal development, the number and ratio of primary and secondary muscle fibers, and on protein expression in endometrium and fetal biceps-femoris muscle, respectively in fetal pigs on d 60 and d 90 of gestation.MethodsReproductively mature gilts were synchronized to estrus using Matrix, observed for estrus (d 0), and artificially inseminated 12&amp;nbsp;h and 36&amp;nbsp;h later. Gilts were individually housed and fed 0.86&amp;nbsp;kg of 14% crude protein diet twice daily that meets nutritional requirements for pregnant gilts. Gilts were assigned to either basal diet control (CON) group, or Cr supplemented group...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0nr1p67x</guid>
      <pubDate>Wed, 2 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Lopez, Arianna N</name>
      </author>
      <author>
        <name>Olivarez, Maddison A</name>
      </author>
      <author>
        <name>Stenhouse, Claire</name>
      </author>
      <author>
        <name>Moses, Robyn M</name>
      </author>
      <author>
        <name>Newton, Makenzie G</name>
      </author>
      <author>
        <name>Sah, Nirvay</name>
        <uri>https://orcid.org/0000-0002-2788-3646</uri>
      </author>
      <author>
        <name>Seo, Heewon</name>
      </author>
      <author>
        <name>Cain, Joseph</name>
      </author>
      <author>
        <name>Lefevre, Carli</name>
      </author>
      <author>
        <name>Ross, Alexandria</name>
      </author>
      <author>
        <name>Ryan, Patrick</name>
      </author>
      <author>
        <name>Wiegert, Jeffrey G</name>
      </author>
      <author>
        <name>Wu, Guoyao</name>
      </author>
      <author>
        <name>Johnson, Gregory A</name>
      </author>
      <author>
        <name>Bazer, Fuller W</name>
      </author>
    </item>
    <item>
      <title>Enhanced suppression of Stenotrophomonas maltophilia by a three-phage cocktail: genomic insights and kinetic profiling</title>
      <link>https://escholarship.org/uc/item/1bj288g8</link>
      <description>&lt;i&gt;Stenotrophomonas maltophilia&lt;/i&gt; is an understudied, gram-negative, aerobic bacterium that is widespread in the environment and increasingly a cause of opportunistic infections. Treating &lt;i&gt;S. maltophilia&lt;/i&gt; remains difficult, leading to an increase in disease severity and higher hospitalization rates in people with cystic fibrosis, cancer, and other immunocompromised health conditions. The lack of effective antibiotics has led to renewed interest in phage therapy; however, there remains a great need for well-characterized phages, especially against &lt;i&gt;S. maltophilia&lt;/i&gt;. In response to an oncology patient with a sepsis infection, we collected 18 phages from Southern California wastewater influent that exhibit different plaque morphology against &lt;i&gt;S. maltophilia&lt;/i&gt; host strain B28B. We hypothesized that, when combined into a cocktail, genetically diverse phages would give rise to distinct lytic infection kinetics that would enhance bacterial killing when compared to the...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1bj288g8</guid>
      <pubDate>Tue, 1 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Monsibais, Alisha N</name>
      </author>
      <author>
        <name>Tea, Olivia</name>
      </author>
      <author>
        <name>Ghatbale, Pooja</name>
      </author>
      <author>
        <name>Dunham, Sage JB</name>
      </author>
      <author>
        <name>Zünd, Mirjam</name>
      </author>
      <author>
        <name>Phan, Jennifer</name>
      </author>
      <author>
        <name>Lam, Karen</name>
      </author>
      <author>
        <name>Paulson, McKenna</name>
      </author>
      <author>
        <name>Tran, Natalie</name>
      </author>
      <author>
        <name>Suder, Diana S</name>
        <uri>https://orcid.org/0000-0002-6226-8390</uri>
      </author>
      <author>
        <name>Blanc, Alisha N</name>
      </author>
      <author>
        <name>Samillano, Cyril</name>
      </author>
      <author>
        <name>Suh, Joy</name>
      </author>
      <author>
        <name>Atif, Hanna</name>
      </author>
      <author>
        <name>Vien, Ethan</name>
      </author>
      <author>
        <name>Nguyen, Ryan</name>
      </author>
      <author>
        <name>Vo, Allene</name>
      </author>
      <author>
        <name>Gonen, Shane</name>
        <uri>https://orcid.org/0000-0002-4829-3151</uri>
      </author>
      <author>
        <name>Pride, David</name>
      </author>
      <author>
        <name>Whiteson, Katrine</name>
        <uri>https://orcid.org/0000-0002-5423-6014</uri>
      </author>
    </item>
    <item>
      <title>Eganelisib combined with immune checkpoint inhibitor therapy and chemotherapy in frontline metastatic triple-negative breast cancer triggers macrophage reprogramming, immune activation and extracellular matrix reorganization in the tumor microenvironment</title>
      <link>https://escholarship.org/uc/item/2ps661kt</link>
      <description>BACKGROUND: Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer with a poor prognosis particularly in the metastatic setting. Treatments with anti-programmed cell death protein-1/programmed death-ligand 1 (PD-L1) immune checkpoint inhibitors (ICI) in combination with chemotherapies have demonstrated promising clinical benefit in metastatic TNBC (mTNBC) but there is still an unmet need, particularly for patients with PD-L1 negative tumors. Mechanisms of resistance to ICIs in mTNBC include the presence of immunosuppressive tumor-associated macrophages (TAMs) in the tumor microenvironment (TME). Eganelisib is a potent and selective, small molecule PI3K-γ inhibitor that was shown in preclinical studies to reshape the TME by reducing myeloid cell recruitment to tumors and reprogramming TAMs from an immune-suppressive to an immune-activating phenotype and enhancing activity of ICIs. These studies provided rationale for the clinical evaluation of eganelisib...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2ps661kt</guid>
      <pubDate>Mon, 24 Mar 2025 00:00:00 +0000</pubDate>
      <author>
        <name>O'Connell, Brenda C</name>
      </author>
      <author>
        <name>Hubbard, Charley</name>
      </author>
      <author>
        <name>Zizlsperger, Nora</name>
      </author>
      <author>
        <name>Fitzgerald, Donna</name>
      </author>
      <author>
        <name>Kutok, Jeffrey L</name>
      </author>
      <author>
        <name>Varner, Judith</name>
        <uri>https://orcid.org/0000-0002-9251-0600</uri>
      </author>
      <author>
        <name>Ilaria, Robert</name>
      </author>
      <author>
        <name>Cobleigh, Melody A</name>
      </author>
      <author>
        <name>Juric, Dejan</name>
      </author>
      <author>
        <name>Tkaczuk, Kate HR</name>
      </author>
      <author>
        <name>Elias, Anthony</name>
      </author>
      <author>
        <name>Lee, Arielle</name>
      </author>
      <author>
        <name>Dakhil, Shaker</name>
      </author>
      <author>
        <name>Hamilton, Erika</name>
      </author>
      <author>
        <name>Soliman, Hatem</name>
      </author>
      <author>
        <name>Peluso, Stephane</name>
      </author>
    </item>
    <item>
      <title>Chronic, Low-Dose Methamphetamine Reveals Sexual Dimorphism of Memory Performance, Histopathology, and Gene Expression Affected by HIV-1 Tat Protein in a Transgenic Model of NeuroHIV</title>
      <link>https://escholarship.org/uc/item/7924f58g</link>
      <description>Methamphetamine (METH) use is frequent among people with HIV (PWH) and appears to increase the risk of neuronal injury and neurocognitive impairment (NCI). This study explored in vivo the effects of a 12 week (long-term), low-dose METH regimen in a transgenic animal model of neuroHIV with inducible expression of HIV-1 transactivator of transcription (Tat). Seven months after transient Tat induction and five months after METH exposure ended, we detected behavioral changes in the Barnes maze (BM) spatial memory task in the Tat and METH groups but not the combined Tat + METH group. The novel object recognition (NOR) task revealed that Tat extinguished discrimination in female animals with and without METH, although METH alone slightly improved NOR. In contrast, in males, Tat, METH, and Tat + METH all compromised NOR. Neuropathological examination detected sex-dependent and brain region-specific changes of pre-synaptic terminals, neurites, and activation of astrocytes and microglia....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7924f58g</guid>
      <pubDate>Thu, 13 Mar 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Harahap-Carrillo, Indira S</name>
      </author>
      <author>
        <name>Fok, Dominic</name>
      </author>
      <author>
        <name>Wong, Frances</name>
      </author>
      <author>
        <name>Malik, Gabriel</name>
      </author>
      <author>
        <name>Maung, Ricky</name>
      </author>
      <author>
        <name>Qiu, Xinru</name>
      </author>
      <author>
        <name>Ojeda-Juárez, Daniel</name>
      </author>
      <author>
        <name>Thaney, Victoria E</name>
      </author>
      <author>
        <name>Sanchez, Ana B</name>
      </author>
      <author>
        <name>Godzik, Adam</name>
      </author>
      <author>
        <name>Roberts, Amanda J</name>
      </author>
      <author>
        <name>Kaul, Marcus</name>
      </author>
    </item>
    <item>
      <title>Ciliary Neurotrophic Factor Reverses Aberrant Mitochondrial Bioenergetics Through the JAK/STAT Pathway in Cultured Sensory Neurons Derived from Streptozotocin-Induced Diabetic Rodents</title>
      <link>https://escholarship.org/uc/item/3gh6b024</link>
      <description>Mitochondrial dysfunction occurs in sensory neurons and contributes to diabetic neuropathy. Ciliary neurotrophic factor (CNTF) stimulates axon regeneration in type 1 diabetic rodents and prevents deficits in axonal caliber, nerve conduction, and thermal sensation. We tested the hypothesis that CNTF enhances sensory neuron function in diabetes through JAK/STAT (Janus kinase/signal transducers and activators of transcription) signaling to normalize impaired mitochondrial bioenergetics. The effect of CNTF on gene expression and neurite outgrowth of cultured adult dorsal root ganglia (DRG) sensory neurons derived from control and streptozotocin (STZ)-induced diabetic rodents was quantified. Polarization status and bioenergetics profile of mitochondria from cultured sensory neurons were determined. CNTF treatment prevented reduced STAT3 phosphorylation (Tyr 705) in DRG of STZ-diabetic mice and also enhanced STAT3 phosphorylation in rat DRG cultures. CNTF normalized polarization status...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3gh6b024</guid>
      <pubDate>Mon, 10 Mar 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Chowdhury, Subir Roy</name>
      </author>
      <author>
        <name>Saleh, Ali</name>
      </author>
      <author>
        <name>Akude, Eli</name>
      </author>
      <author>
        <name>Smith, Darrell R</name>
      </author>
      <author>
        <name>Morrow, Dwane</name>
      </author>
      <author>
        <name>Tessler, Lori</name>
      </author>
      <author>
        <name>Calcutt, Nigel A</name>
      </author>
      <author>
        <name>Fernyhough, Paul</name>
      </author>
    </item>
    <item>
      <title>A multi-cohort genome-wide association study in African ancestry individuals reveals risk loci for primary open-angle glaucoma</title>
      <link>https://escholarship.org/uc/item/1kw989nk</link>
      <description>Primary open-angle glaucoma (POAG), the leading cause of irreversible blindness worldwide, disproportionately affects individuals of African ancestry. We conducted a genome-wide association study (GWAS) for POAG in 11,275 individuals of African ancestry (6,003 cases; 5,272 controls). We detected 46 risk loci associated with POAG at genome-wide significance. Replication and post-GWAS analyses, including functionally informed fine-mapping, multiple trait co-localization, and in silico validation, implicated two previously undescribed variants (rs1666698 mapping to DBF4P2; rs34957764 mapping to ROCK1P1) and one previously associated variant (rs11824032 mapping to ARHGEF12) as likely causal. For individuals of African ancestry, a polygenic risk score (PRS) for POAG from our mega-analysis (African ancestry individuals) outperformed a PRS from summary statistics of a much larger GWAS derived from European ancestry individuals. This study quantifies the genetic architecture similarities...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1kw989nk</guid>
      <pubDate>Fri, 7 Mar 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Verma, Shefali S</name>
      </author>
      <author>
        <name>Gudiseva, Harini V</name>
      </author>
      <author>
        <name>Chavali, Venkata RM</name>
      </author>
      <author>
        <name>Salowe, Rebecca J</name>
      </author>
      <author>
        <name>Bradford, Yuki</name>
      </author>
      <author>
        <name>Guare, Lindsay</name>
      </author>
      <author>
        <name>Lucas, Anastasia</name>
      </author>
      <author>
        <name>Collins, David W</name>
      </author>
      <author>
        <name>Vrathasha, Vrathasha</name>
      </author>
      <author>
        <name>Nair, Rohini M</name>
      </author>
      <author>
        <name>Rathi, Sonika</name>
      </author>
      <author>
        <name>Zhao, Bingxin</name>
      </author>
      <author>
        <name>He, Jie</name>
      </author>
      <author>
        <name>Lee, Roy</name>
      </author>
      <author>
        <name>Zenebe-Gete, Selam</name>
      </author>
      <author>
        <name>Bowman, Anita S</name>
      </author>
      <author>
        <name>McHugh, Caitlin P</name>
      </author>
      <author>
        <name>Zody, Michael C</name>
      </author>
      <author>
        <name>Pistilli, Maxwell</name>
      </author>
      <author>
        <name>Khachatryan, Naira</name>
      </author>
      <author>
        <name>Daniel, Ebenezer</name>
      </author>
      <author>
        <name>Murphy, Windell</name>
      </author>
      <author>
        <name>Henderer, Jeffrey</name>
      </author>
      <author>
        <name>Center, Regeneron Genetics</name>
      </author>
      <author>
        <name>Kinzy, Tyler G</name>
      </author>
      <author>
        <name>Iyengar, Sudha K</name>
      </author>
      <author>
        <name>Peachey, Neal S</name>
      </author>
      <author>
        <name>Program, VA Million Veteran</name>
      </author>
      <author>
        <name>Taylor, Kent D</name>
      </author>
      <author>
        <name>Guo, Xiuqing</name>
      </author>
      <author>
        <name>Chen, Yii-Der Ida</name>
      </author>
      <author>
        <name>Zangwill, Linda</name>
        <uri>https://orcid.org/0000-0002-1143-5224</uri>
      </author>
      <author>
        <name>Girkin, Christopher</name>
      </author>
      <author>
        <name>Ayyagari, Radha</name>
        <uri>https://orcid.org/0000-0002-6804-7740</uri>
      </author>
      <author>
        <name>Liebmann, Jeffrey</name>
      </author>
      <author>
        <name>Chuka-Okosa, Chimd M</name>
      </author>
      <author>
        <name>Williams, Susan E</name>
      </author>
      <author>
        <name>Akafo, Stephen</name>
      </author>
      <author>
        <name>Budenz, Donald L</name>
      </author>
      <author>
        <name>Olawoye, Olusola O</name>
      </author>
      <author>
        <name>Ramsay, Michele</name>
      </author>
      <author>
        <name>Ashaye, Adeyinka</name>
      </author>
      <author>
        <name>Akpa, Onoja M</name>
      </author>
      <author>
        <name>Aung, Tin</name>
      </author>
      <author>
        <name>Wiggs, Janey L</name>
      </author>
      <author>
        <name>Ross, Ahmara G</name>
      </author>
      <author>
        <name>Cui, Qi N</name>
      </author>
      <author>
        <name>Addis, Victoria</name>
      </author>
      <author>
        <name>Lehman, Amanda</name>
      </author>
      <author>
        <name>Miller-Ellis, Eydie</name>
      </author>
      <author>
        <name>Sankar, Prithvi S</name>
      </author>
      <author>
        <name>Williams, Scott M</name>
      </author>
      <author>
        <name>Ying, Gui-shuang</name>
      </author>
      <author>
        <name>Bailey, Jessica Cooke</name>
      </author>
      <author>
        <name>Rotter, Jerome I</name>
        <uri>https://orcid.org/0000-0001-7191-1723</uri>
      </author>
      <author>
        <name>Weinreb, Robert</name>
        <uri>https://orcid.org/0000-0001-9553-3202</uri>
      </author>
      <author>
        <name>Khor, Chiea Chuen</name>
      </author>
      <author>
        <name>Hauser, Michael A</name>
      </author>
      <author>
        <name>Ritchie, Marylyn D</name>
      </author>
      <author>
        <name>O’Brien, Joan M</name>
      </author>
    </item>
    <item>
      <title>A bacterial sialidase mediates early-life colonization by a pioneering gut commensal</title>
      <link>https://escholarship.org/uc/item/3vf4f0gx</link>
      <description>The early microbial colonization of the gastrointestinal tract can have long-term impacts on development and health. Keystone species, including Bacteroides spp., are prominent in early life and play crucial roles in maintaining the structure of the intestinal ecosystem. However, the process by which a resilient community is curated during early life remains inadequately understood. Here, we show that a single sialidase, NanH, in Bacteroides fragilis mediates stable occupancy of the intestinal mucosa in early life and regulates a commensal colonization program. This program is triggered by sialylated glycans, including those found in human milk oligosaccharides and intestinal mucus. NanH is required for vertical transmission from dams to pups and promotes B.&amp;nbsp;fragilis dominance during early life. Furthermore, NanH facilitates commensal resilience and recovery after antibiotic treatment in a defined microbial community. Collectively, our study reveals a co-evolutionary mechanism...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3vf4f0gx</guid>
      <pubDate>Tue, 4 Mar 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Buzun, Ekaterina</name>
      </author>
      <author>
        <name>Hsu, Chia-Yun</name>
      </author>
      <author>
        <name>Sejane, Kristija</name>
      </author>
      <author>
        <name>Oles, Renee E</name>
      </author>
      <author>
        <name>Vasquez Ayala, Adriana</name>
      </author>
      <author>
        <name>Loomis, Luke R</name>
      </author>
      <author>
        <name>Zhao, Jiaqi</name>
      </author>
      <author>
        <name>Rossitto, Leigh-Ana</name>
      </author>
      <author>
        <name>McGrosso, Dominic M</name>
      </author>
      <author>
        <name>Gonzalez, David J</name>
      </author>
      <author>
        <name>Bode, Lars</name>
      </author>
      <author>
        <name>Chu, Hiutung</name>
      </author>
    </item>
    <item>
      <title>Early Alzheimer’s Disease with frequent neuritic plaques harbors neocortical tau seeds distinct from primary age-related tauopathy</title>
      <link>https://escholarship.org/uc/item/42v8h4cc</link>
      <description>Tau neurofibrillary tangles (NFTs) in the presence of amyloid-β (Aβ) plaques are required for the diagnosis of Alzheimer’s Disease (AD) and closely track with cognitive impairment, yet cognitively normal aged individuals frequently exhibit NFTs arising from tau seed accumulation. This may suggest that not all tau species are equally pathogenic and raises the question of whether unidentified tau modifications augment tau seeding activity and neurodegeneration in AD. We investigated how biochemical modifications of tau relate to clinicopathological outcomes in a cohort of 38 patients with Braak-matched AD neuropathologic change (ADNC) or primary age-related tauopathy (PART), a 3R/4R tauopathy with identical tau filament&amp;nbsp;core structure to ADNC but with little to no Aβ deposition. We comprehensively measured tau histologic density, seeding activity using real-time quaking induced conversion (RT-QuIC) seed amplification assays, and select post-translational modifications (PTMs)...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/42v8h4cc</guid>
      <pubDate>Mon, 3 Mar 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Browne, Danielle F</name>
      </author>
      <author>
        <name>Smirnov, Denis S</name>
      </author>
      <author>
        <name>Coughlin, David G</name>
        <uri>https://orcid.org/0000-0003-4111-0102</uri>
      </author>
      <author>
        <name>Peng, Iris</name>
      </author>
      <author>
        <name>Standke, Heidi G</name>
      </author>
      <author>
        <name>Kim, Yongya</name>
      </author>
      <author>
        <name>Pizzo, Donald P</name>
      </author>
      <author>
        <name>Unapanta, Alexandra</name>
      </author>
      <author>
        <name>Andreasson, Thea</name>
      </author>
      <author>
        <name>Hiniker, Annie</name>
      </author>
      <author>
        <name>Kraus, Allison</name>
      </author>
    </item>
    <item>
      <title>Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19</title>
      <link>https://escholarship.org/uc/item/232910xd</link>
      <description>BACKGROUND: Persistent mortality in adults hospitalized due to acute COVID-19 justifies pursuit of disease mechanisms and potential therapies. The aim was to evaluate which virus and host response factors were associated with mortality risk among participants in Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3) trials.
METHODS: A secondary analysis of 2625 adults hospitalized for acute SARS-CoV-2 infection randomized to 1 of 5 antiviral products or matched placebo in 114 centers on 4 continents. Uniform, site-level collection of participant baseline clinical variables was performed. Research laboratories assayed baseline upper respiratory swabs for SARS-CoV-2 viral RNA and plasma for anti-SARS-CoV-2 antibodies, SARS-CoV-2 nucleocapsid antigen (viral Ag), and interleukin-6 (IL-6). Associations between factors and time to mortality by 90 days were assessed using univariate and multivariable Cox proportional hazards models.
RESULTS: Viral Ag ≥4500 ng/L (vs &amp;lt;200 ng/L; adjusted...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/232910xd</guid>
      <pubDate>Mon, 3 Mar 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Aggarwal, Neil R</name>
      </author>
      <author>
        <name>Nordwall, Jacquie</name>
      </author>
      <author>
        <name>Braun, Dominique L</name>
      </author>
      <author>
        <name>Chung, Lucy</name>
      </author>
      <author>
        <name>Coslet, Jordan</name>
      </author>
      <author>
        <name>Der, Tatyana</name>
      </author>
      <author>
        <name>Eriobu, Nnakelu</name>
      </author>
      <author>
        <name>Ginde, Adit A</name>
      </author>
      <author>
        <name>Hayanga, Awori J</name>
      </author>
      <author>
        <name>Highbarger, Helene</name>
      </author>
      <author>
        <name>Holodniy, Mark</name>
      </author>
      <author>
        <name>Horcajada, Juan P</name>
      </author>
      <author>
        <name>Jain, Mamta K</name>
      </author>
      <author>
        <name>Kim, Kami</name>
      </author>
      <author>
        <name>Laverdure, Sylvain</name>
      </author>
      <author>
        <name>Lundgren, Jens</name>
      </author>
      <author>
        <name>Natarajan, Ven</name>
      </author>
      <author>
        <name>Nguyen, Hien H</name>
      </author>
      <author>
        <name>Pett, Sarah L</name>
      </author>
      <author>
        <name>Phillips, Andrew</name>
      </author>
      <author>
        <name>Poulakou, Garyphallia</name>
      </author>
      <author>
        <name>Price, David A</name>
      </author>
      <author>
        <name>Robinson, Philip</name>
      </author>
      <author>
        <name>Rogers, Angela J</name>
      </author>
      <author>
        <name>Sandkovsky, Uriel</name>
      </author>
      <author>
        <name>Shaw-Saliba, Katy</name>
      </author>
      <author>
        <name>Sturek, Jeffrey M</name>
      </author>
      <author>
        <name>Trautner, Barbara W</name>
      </author>
      <author>
        <name>Waters, Michael</name>
      </author>
      <author>
        <name>Reilly, Cavan</name>
      </author>
      <author>
        <name>Sahner, David</name>
      </author>
      <author>
        <name>Tierney, John</name>
      </author>
      <author>
        <name>Vogel, Susan E</name>
      </author>
      <author>
        <name>Herpin, Betsey R</name>
      </author>
      <author>
        <name>Smolskis, Mary C</name>
      </author>
      <author>
        <name>McKay, Laura A</name>
      </author>
      <author>
        <name>Cahill, Kelly</name>
      </author>
      <author>
        <name>Crew, Page</name>
      </author>
      <author>
        <name>Sardana, Ratna</name>
      </author>
      <author>
        <name>Raim, Sharon Segal</name>
      </author>
      <author>
        <name>Hensely, Lisa</name>
      </author>
      <author>
        <name>Lorenzo, Johsua</name>
      </author>
      <author>
        <name>Mock, Rebecca</name>
      </author>
      <author>
        <name>Zuckerman, Judith</name>
      </author>
      <author>
        <name>Atri, Negin</name>
      </author>
      <author>
        <name>Miller, Mark</name>
      </author>
      <author>
        <name>Vallee, David</name>
      </author>
      <author>
        <name>Chung, Lucy</name>
      </author>
      <author>
        <name>Kang, Nayon</name>
      </author>
      <author>
        <name>Barrett, Kevin</name>
      </author>
      <author>
        <name>Adam, Stacey J</name>
      </author>
      <author>
        <name>Read, Sarah</name>
      </author>
      <author>
        <name>Draghia-Akli, Ruxandra</name>
      </author>
      <author>
        <name>Currier, Judy</name>
      </author>
      <author>
        <name>Hughes, Eric</name>
      </author>
      <author>
        <name>Harrigan, Rachel H</name>
      </author>
      <author>
        <name>Amos, Laura</name>
      </author>
      <author>
        <name>Carlsen, Amy</name>
      </author>
      <author>
        <name>Carter, Anita</name>
      </author>
      <author>
        <name>Collins, Gary</name>
      </author>
      <author>
        <name>Davis, Bionca</name>
      </author>
      <author>
        <name>Denning, Eileen</name>
      </author>
      <author>
        <name>DuChene, Alain</name>
      </author>
      <author>
        <name>Eckroth, Kate</name>
      </author>
      <author>
        <name>Engen, Nicole</name>
      </author>
      <author>
        <name>Frase, Alex</name>
      </author>
      <author>
        <name>Gandits, Greg</name>
      </author>
      <author>
        <name>Grund, Birgit</name>
      </author>
      <author>
        <name>Harrison, Merrie</name>
      </author>
      <author>
        <name>Hurlbut, Nancy</name>
      </author>
      <author>
        <name>Kaiser, Payton</name>
      </author>
      <author>
        <name>Koopmeiners, Joseph</name>
      </author>
      <author>
        <name>Larson, Gregg</name>
      </author>
      <author>
        <name>Meger, Sue</name>
      </author>
      <author>
        <name>Mistry, Shweta Sharma</name>
      </author>
      <author>
        <name>Murray, Thomas</name>
      </author>
      <author>
        <name>Nelson, Ray</name>
      </author>
      <author>
        <name>Quan, Kien</name>
      </author>
      <author>
        <name>Quan, Siu Fun</name>
      </author>
      <author>
        <name>Reilly, Cavan</name>
      </author>
      <author>
        <name>Siegel, Lianne</name>
      </author>
      <author>
        <name>Thompson, Greg</name>
      </author>
      <author>
        <name>Vock, David</name>
      </author>
      <author>
        <name>Walski, Jamie</name>
      </author>
      <author>
        <name>Gelijns, Annetine C</name>
      </author>
      <author>
        <name>Moskowitz, Alan J</name>
      </author>
      <author>
        <name>Bagiella, Emilia</name>
      </author>
      <author>
        <name>Moquete, Ellen</name>
      </author>
      <author>
        <name>O'Sullivan, Karen</name>
      </author>
      <author>
        <name>Marks, Mary E</name>
      </author>
      <author>
        <name>Accardi, Evan</name>
      </author>
      <author>
        <name>Kinzel, Emily</name>
      </author>
      <author>
        <name>Burris, Sarah</name>
      </author>
      <author>
        <name>Bedoya, Gabriela</name>
      </author>
      <author>
        <name>Gupta, Lola</name>
      </author>
      <author>
        <name>Overbey, Jessica R</name>
      </author>
      <author>
        <name>Santos, Milerva</name>
      </author>
      <author>
        <name>Gillinov, Marc A</name>
      </author>
      <author>
        <name>Miller, Marissa A</name>
      </author>
      <author>
        <name>Taddei-Peters, Wendy C</name>
      </author>
    </item>
    <item>
      <title>TDP-43 mediates SREBF2-regulated gene expression required for oligodendrocyte myelination</title>
      <link>https://escholarship.org/uc/item/9q89z38k</link>
      <description>Cholesterol metabolism operates autonomously within the central nervous system (CNS), where the majority of cholesterol resides in myelin. We demonstrate that TDP-43, the pathological signature protein for amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), influences cholesterol metabolism in oligodendrocytes. TDP-43 binds directly to mRNA of SREBF2, the master transcription regulator for cholesterol metabolism, and multiple mRNAs encoding proteins responsible for cholesterol biosynthesis and uptake, including HMGCR, HMGCS1, and LDLR. TDP-43 depletion leads to reduced SREBF2 and LDLR expression, and cholesterol levels in vitro and in vivo. TDP-43-mediated changes in cholesterol levels can be restored by reintroducing SREBF2 or LDLR. Additionally, cholesterol supplementation rescues demyelination caused by TDP-43 deletion. Furthermore, oligodendrocytes harboring TDP-43 pathology from FTD patients show reduced HMGCR and HMGCS1, and coaggregation of LDLR and TDP-43....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9q89z38k</guid>
      <pubDate>Fri, 28 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Ho, Wan Yun</name>
      </author>
      <author>
        <name>Chang, Jer-Cherng</name>
      </author>
      <author>
        <name>Lim, Kenneth</name>
      </author>
      <author>
        <name>Cazenave-Gassiot, Amaury</name>
      </author>
      <author>
        <name>Nguyen, Aivi T</name>
      </author>
      <author>
        <name>Foo, Juat Chin</name>
      </author>
      <author>
        <name>Muralidharan, Sneha</name>
      </author>
      <author>
        <name>Viera-Ortiz, Ashley</name>
      </author>
      <author>
        <name>Ong, Sarah JM</name>
      </author>
      <author>
        <name>Hor, Jin Hui</name>
      </author>
      <author>
        <name>Agrawal, Ira</name>
      </author>
      <author>
        <name>Hoon, Shawn</name>
      </author>
      <author>
        <name>Arogundade, Olubankole Aladesuyi</name>
      </author>
      <author>
        <name>Rodriguez, Maria J</name>
      </author>
      <author>
        <name>Lim, Su Min</name>
      </author>
      <author>
        <name>Kim, Seung Hyun</name>
      </author>
      <author>
        <name>Ravits, John</name>
        <uri>https://orcid.org/0000-0001-6521-4649</uri>
      </author>
      <author>
        <name>Ng, Shi-Yan</name>
      </author>
      <author>
        <name>Wenk, Markus R</name>
      </author>
      <author>
        <name>Lee, Edward B</name>
      </author>
      <author>
        <name>Tucker-Kellogg, Greg</name>
      </author>
      <author>
        <name>Ling, Shuo-Chien</name>
      </author>
    </item>
    <item>
      <title>FUS-dependent microRNA deregulations identify TRIB2 as a druggable target for ALS motor neurons</title>
      <link>https://escholarship.org/uc/item/7zd3r7t8</link>
      <description>MicroRNAs (miRNAs) modulate mRNA expression, and their deregulation contributes to various diseases including amyotrophic lateral sclerosis (ALS). As fused in sarcoma (FUS) is a causal gene for ALS and regulates biogenesis of miRNAs, we systematically analyzed the miRNA repertoires in spinal cords and hippocampi from ALS-FUS mice to understand how FUS-dependent miRNA deregulation contributes to ALS. miRNA profiling identified differentially expressed miRNAs between different central nervous system (CNS) regions as well as disease states. Among the up-regulated miRNAs, miR-1197 targets the pro-survival pseudokinase &lt;i&gt;Trib2&lt;/i&gt;. A reduced &lt;i&gt;TRIB2&lt;/i&gt; expression was observed in iPSC-derived motor neurons from ALS patients. Pharmacological stabilization of TRIB2 protein with a clinically approved cancer drug rescues the survival of iPSC-derived human motor neurons, including those from a sporadic ALS patient. Collectively, our data indicate that miRNA profiling can be used to probe...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7zd3r7t8</guid>
      <pubDate>Fri, 28 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Ho, Wan Yun</name>
      </author>
      <author>
        <name>Chak, Li-Ling</name>
      </author>
      <author>
        <name>Hor, Jin-Hui</name>
      </author>
      <author>
        <name>Liu, Fujia</name>
      </author>
      <author>
        <name>Diaz-Garcia, Sandra</name>
      </author>
      <author>
        <name>Chang, Jer-Cherng</name>
      </author>
      <author>
        <name>Sanford, Emma</name>
      </author>
      <author>
        <name>Rodriguez, Maria J</name>
      </author>
      <author>
        <name>Alagappan, Durgadevi</name>
      </author>
      <author>
        <name>Lim, Su Min</name>
      </author>
      <author>
        <name>Cho, Yik-Lam</name>
      </author>
      <author>
        <name>Shimizu, Yuji</name>
      </author>
      <author>
        <name>Sun, Alfred Xuyang</name>
      </author>
      <author>
        <name>Tyan, Sheue-Houy</name>
      </author>
      <author>
        <name>Koo, Edward</name>
      </author>
      <author>
        <name>Kim, Seung Hyun</name>
      </author>
      <author>
        <name>Ravits, John</name>
        <uri>https://orcid.org/0000-0001-6521-4649</uri>
      </author>
      <author>
        <name>Ng, Shi-Yan</name>
      </author>
      <author>
        <name>Okamura, Katsutomo</name>
      </author>
      <author>
        <name>Ling, Shuo-Chien</name>
      </author>
    </item>
    <item>
      <title>Current and Future Directions in Developing Effective Treatments for PRPH2-Associated Retinal Diseases: A Workshop Report</title>
      <link>https://escholarship.org/uc/item/2783883g</link>
      <description>Purpose and Methods: A workshop of affected individuals and their families, clinicians, researchers, and industry representatives was convened in March 2023 to define the knowledge landscape of peripherin 2 (PRPH2) biology and identify challenges and opportunities towards developing PRPH2-associated inherited retinal disease (IRD) treatments.
Results: The results of an online survey and presentations from affected individuals and their family members revealed disease characteristics and impacts on daily living. Scientific sessions highlighted the significant heterogeneity in clinical presentation of PRPH2-related retinopathy; PRPH2's crucial function in rod and cone outer segment formation and maintenance; the usefulness of existing animal and cellular models for understanding disease pathophysiology; and possible therapeutic approaches for autosomal dominant PRPH2-associated IRDs, including gene-specific therapies and gene-agnostic approaches. Priority gaps identified by the...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2783883g</guid>
      <pubDate>Fri, 28 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Ayyagari, Radha</name>
        <uri>https://orcid.org/0000-0002-6804-7740</uri>
      </author>
      <author>
        <name>Borooah, Shyamanga</name>
      </author>
      <author>
        <name>Durham, Todd</name>
      </author>
      <author>
        <name>Gelfman, Claire</name>
      </author>
      <author>
        <name>Bowman, Angela</name>
      </author>
    </item>
    <item>
      <title>MFRP in Early Onset Retinal Degeneration: Clinical and Molecular Perspectives</title>
      <link>https://escholarship.org/uc/item/5dm4f7ft</link>
      <description>The membrane-frizzled related protein (MFRP) is a retinal pigment epithelium (RPE) and ciliary epithelium-expressed gene of unknown function. Interest in MFRP stems from clinical manifestations that range from acute-angle closure glaucoma to microphthalmia and Retinitis pigmentosa in patients with MFRP mutations. Furthermore, the genetic ablation of Mfrp in mice results in an early-onset retinal disease with visible degeneration around 1mo of age and primary rod photoreceptor loss. Yet, little is known regarding the exact role of MFRP in the RPE, its underlying contribution to pathology, and the impacted mechanisms at the early stages of MFRP-related disease. This review presents a current overview of MFRP studies and poses outstanding questions that are crucial for understanding the involvement of MFRP in early-onset retinal degeneration. Such insight could pave the way for deciphering the molecular mechanisms associated with MFRP that are impacted during early stages in the...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5dm4f7ft</guid>
      <pubDate>Thu, 27 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Woodard, DaNae R</name>
      </author>
      <author>
        <name>Ayyagari, Radha</name>
        <uri>https://orcid.org/0000-0002-6804-7740</uri>
      </author>
    </item>
    <item>
      <title>In vitro resensitization of multidrug-resistant clinical isolates of Enterococcus faecium and E. faecalis through phage-antibiotic synergy</title>
      <link>https://escholarship.org/uc/item/3jc4g4jx</link>
      <description>Bacteriophages are an increasingly attractive option for the treatment of antibiotic-resistant infections, but their efficacy is difficult to discern due to the confounding effects of antibiotics. Phages are generally delivered in conjunction with antibiotics, and thus, when patients improve, it is unclear whether the phages, antibiotics, or both are responsible. This question is particularly relevant for enterococcus infections, as limited data suggest phages might restore antibiotic efficacy against resistant strains. Enterococci can develop high-level resistance to vancomycin, a primary treatment. We assessed clinical and laboratory isolates of &lt;i&gt;Enterococcus faecium&lt;/i&gt; and &lt;i&gt;Enterococcus faecalis&lt;/i&gt; to determine whether we could observe synergistic interactions between phages and antibiotics. We identified synergy between multiple phages and antibiotics including linezolid, ampicillin, and vancomycin. Notably, antibiotic susceptibility did not predict synergistic interactions...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3jc4g4jx</guid>
      <pubDate>Thu, 27 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Ghatbale, Pooja</name>
      </author>
      <author>
        <name>Sah, Govind Prasad</name>
      </author>
      <author>
        <name>Dunham, Sage</name>
      </author>
      <author>
        <name>Khong, Ethan</name>
      </author>
      <author>
        <name>Blanc, Alisha</name>
      </author>
      <author>
        <name>Monsibais, Alisha</name>
      </author>
      <author>
        <name>Garcia, Andrew</name>
      </author>
      <author>
        <name>Schooley, Robert T</name>
      </author>
      <author>
        <name>Güemes, Ana G Cobián</name>
      </author>
      <author>
        <name>Whiteson, Katrine</name>
        <uri>https://orcid.org/0000-0002-5423-6014</uri>
      </author>
      <author>
        <name>Pride, David T</name>
      </author>
    </item>
    <item>
      <title>Prevalence of detectable HIV-DNA and HIV-RNA in cerebrospinal fluid of youth with perinatal HIV and impaired cognition on antiretroviral therapy</title>
      <link>https://escholarship.org/uc/item/43b579z0</link>
      <description>OBJECTIVE: Central nervous system (CNS) HIV infection can impact cognition and may be an obstacle to cure in adolescents and young adults with perinatal HIV (AYAPHIV). IMPAACT2015 enrolled AYAPHIV on suppressive antiretroviral therapy (ART) with cognitive impairment to detect and quantify HIV in blood and cerebrospinal fluid (CSF).
DESIGN: IMPAACT2015 was a U.S.-based multi-site, exploratory, observational study.
METHODS: Cognitive impairment was defined as NIH Toolbox Fluid Cognition Composite score (FCCS) more than 1 standard deviation below age-adjusted normative group mean. Cell-free HIV-RNA and cell-associated HIV pol/gag -DNA and 10 biomarkers of inflammation/neuronal injury were measured in paired CSF and blood. ART exposure concentrations were quantified in hair.
RESULTS: Among 24 participants, 20 had successful CSF collection and 18 also met viral suppression criteria. Nine of 18 (50%) were female sex-at-birth, and 14 of 18 (78%) were black. Median (range) age was 20 years...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/43b579z0</guid>
      <pubDate>Fri, 21 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Wagner, Thor A</name>
      </author>
      <author>
        <name>Tierney, Camlin</name>
      </author>
      <author>
        <name>Huang, Sharon</name>
      </author>
      <author>
        <name>Nichols, Sharon</name>
      </author>
      <author>
        <name>Malee, Kathleen M</name>
      </author>
      <author>
        <name>Montañez, Nicole A</name>
      </author>
      <author>
        <name>Coletti, Anne</name>
      </author>
      <author>
        <name>Spiegel, Hans ML</name>
      </author>
      <author>
        <name>Krotje, Chelsea</name>
      </author>
      <author>
        <name>Bone, Frederic</name>
      </author>
      <author>
        <name>Wilkins, Megan</name>
      </author>
      <author>
        <name>Abuogi, Lisa</name>
      </author>
      <author>
        <name>Purswani, Murli</name>
      </author>
      <author>
        <name>Bearden, Allison</name>
      </author>
      <author>
        <name>Wiznia, Andrew</name>
      </author>
      <author>
        <name>Agwu, Allison</name>
      </author>
      <author>
        <name>Chadwick, Ellen G</name>
      </author>
      <author>
        <name>Richman, Douglas</name>
        <uri>https://orcid.org/0000-0003-0962-9254</uri>
      </author>
      <author>
        <name>Gandhi, Monica</name>
      </author>
      <author>
        <name>Mehta, Patrick</name>
      </author>
      <author>
        <name>Macatangay, Bernard</name>
      </author>
      <author>
        <name>Spector, Stephen A</name>
      </author>
      <author>
        <name>Spudich, Serena</name>
      </author>
      <author>
        <name>Persaud, Deborah</name>
      </author>
      <author>
        <name>Chahroudi, Ann</name>
      </author>
      <author>
        <name>Team, for the IMPAACT2015 Protocol</name>
      </author>
    </item>
    <item>
      <title>The Corkscrew Technique for Removing a Fibular Strut Allograft From the Proximal Humerus</title>
      <link>https://escholarship.org/uc/item/3gp8s4qc</link>
      <description>A fibular strut allograft is a reliable option for augmentation in open reduction internal fixation (ORIF) of proximal humerus fractures, but techniques to remove a fibular strut during revision shoulder arthroplasty are limited.&amp;nbsp;Currently published techniques on extracting fibular strut grafts from humeral shafts include using a Midas burr, flexible osteotomes, humeral shaft osteotomy, and reaming. To our knowledge there has not been a technique that uses a corkscrew to remove the fibular strut from the proximal humerus in preparation for revision shoulder arthroplasty. This is a case report and description of a simple and reproducible technique that can be implemented in the setting of conversion from a proximal humerus lateral locking plate with fibular strut allograft to shoulder arthroplasty.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3gp8s4qc</guid>
      <pubDate>Mon, 17 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Skura, Brian</name>
      </author>
      <author>
        <name>Glazier, Matthew T</name>
      </author>
      <author>
        <name>Schuette, Hayden B</name>
      </author>
      <author>
        <name>Passias, Braden J</name>
      </author>
      <author>
        <name>Chang, Iou-Ren</name>
      </author>
      <author>
        <name>Verre, John</name>
      </author>
      <author>
        <name>Mehta, Sanjay</name>
        <uri>https://orcid.org/0000-0002-2028-8158</uri>
      </author>
      <author>
        <name>Taylor, Benjamin C</name>
      </author>
    </item>
    <item>
      <title>Adenosine diphosphate stimulates VEGF-independent choroidal endothelial cell proliferation: A potential escape from anti-VEGF therapy</title>
      <link>https://escholarship.org/uc/item/5zs5k0w6</link>
      <description>We hypothesized that a strategy employing tissue-specific endothelial cells (EC) might facilitate the identification of tissue- or organ-specific vascular functions of ubiquitous metabolites. An unbiased approach was employed to identify water-soluble small molecules with mitogenic activity on choroidal EC. We identified adenosine diphosphate (ADP) as a candidate, following biochemical purification from mouse EL4 lymphoma extracts. ADP stimulated the growth of bovine choroidal EC (BCEC) and other bovine or human eye-derived EC. ADP induced rapid phosphorylation of extracellular signal-regulated kinase in a dose- and time-dependent manner. ADP-induced BCEC proliferation could be blocked by pretreatment with specific antagonists of the purinergic receptor P2Y1 but not with a vascular endothelial growth factor (VEGF) inhibitor, indicating that the EC mitogenic effects of ADP are not mediated by stimulation of the VEGF pathway. Intravitreal administration of ADP expanded the neovascular...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5zs5k0w6</guid>
      <pubDate>Fri, 14 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Biswas, Nilima</name>
      </author>
      <author>
        <name>Mori, Tommaso</name>
      </author>
      <author>
        <name>Nagaraj, Naresh Kumar Ragava Chetty</name>
      </author>
      <author>
        <name>Xin, Hong</name>
      </author>
      <author>
        <name>Diemer, Tanja</name>
      </author>
      <author>
        <name>Li, Pin</name>
      </author>
      <author>
        <name>Su, Yongxuan</name>
      </author>
      <author>
        <name>Piermarocchi, Carlo</name>
      </author>
      <author>
        <name>Ferrara, Napoleone</name>
        <uri>https://orcid.org/0000-0001-8412-2889</uri>
      </author>
    </item>
    <item>
      <title>Robustness of a Restriction Spectrum Imaging (RSI) quantitative MRI biomarker for prostate cancer: assessing for systematic bias due to age, race, ethnicity, prostate volume, medication use, or imaging acquisition parameters</title>
      <link>https://escholarship.org/uc/item/3480p381</link>
      <description>Introduction Prostate multiparametric magnetic resonance imaging (mpMRI) has greatly improved the detection of clinically significant prostate cancer (csPCa). However, the limited number of expert sub-specialist radiologists capable of interpreting conventional prostate mpMRI is a bottleneck for universal access to this healthcare advance. A reliable and reproducible quantitative imaging biomarker could facilitate implementation of accurate prostate MRI at clinical sites with limited experience, thus ensuring more equitable patient care. Restriction Spectrum Imaging restriction score (RSIrs) is an MRI biomarker that has shown the ability to enhance the qualitative and quantitative interpretation of prostate MRI. However, patient-level factors (age, race, ethnicity, prostate volume, and 5-alpha-reductase inhibitor (5-ARI) use) and acquisition-level factors (scanner manufacturer/model and protocol parameters) can affect prostate mpMRI, and their impact on quantitative RSIrs is unknown....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3480p381</guid>
      <pubDate>Fri, 14 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>D, Deondre</name>
      </author>
      <author>
        <name>Domingo, Mariluz Rojo</name>
      </author>
      <author>
        <name>Conlin, Christopher C</name>
      </author>
      <author>
        <name>Matthews, Ian</name>
      </author>
      <author>
        <name>Kallis, Karoline</name>
      </author>
      <author>
        <name>Baxter, Madison T</name>
      </author>
      <author>
        <name>Ollison, Courtney</name>
      </author>
      <author>
        <name>Song, Yuze</name>
      </author>
      <author>
        <name>Xu, George</name>
      </author>
      <author>
        <name>Zhong, Allison Y</name>
      </author>
      <author>
        <name>Bagrodia, Aditya</name>
        <uri>https://orcid.org/0000-0002-3358-1193</uri>
      </author>
      <author>
        <name>Barrett, Tristan</name>
      </author>
      <author>
        <name>Cooperberg, Matthew</name>
      </author>
      <author>
        <name>Feng, Felix</name>
      </author>
      <author>
        <name>Hahn, Michael E</name>
      </author>
      <author>
        <name>Harisinghani, Mukesh</name>
      </author>
      <author>
        <name>Hollenberg, Gary</name>
      </author>
      <author>
        <name>Javier-Desloges, Juan</name>
      </author>
      <author>
        <name>Kamran, Sophia C</name>
      </author>
      <author>
        <name>Kane, Christopher J</name>
      </author>
      <author>
        <name>Kessler, Dimitri</name>
      </author>
      <author>
        <name>Kuperman, Joshua</name>
      </author>
      <author>
        <name>Lee, Kang-Lung</name>
      </author>
      <author>
        <name>Levine, Jonathan</name>
      </author>
      <author>
        <name>Liss, Michael A</name>
      </author>
      <author>
        <name>Margolis, Daniel JA</name>
      </author>
      <author>
        <name>Murphy, Paul M</name>
      </author>
      <author>
        <name>Nakrour, Nabih</name>
      </author>
      <author>
        <name>Ohliger, Michael A</name>
      </author>
      <author>
        <name>Osinski, Thomas</name>
      </author>
      <author>
        <name>Pamatmat, Anthony James</name>
      </author>
      <author>
        <name>Pompa, Isabella R</name>
      </author>
      <author>
        <name>Rakow-Penner, Rebecca</name>
        <uri>https://orcid.org/0000-0002-2566-1978</uri>
      </author>
      <author>
        <name>Roberts, Jacob L</name>
        <uri>https://orcid.org/0009-0008-7746-7633</uri>
      </author>
      <author>
        <name>Santhosh, Karan</name>
      </author>
      <author>
        <name>Shabaik, Ahmed S</name>
        <uri>https://orcid.org/0000-0003-1987-3453</uri>
      </author>
      <author>
        <name>Song, David</name>
      </author>
      <author>
        <name>Tempany, Clare M</name>
      </author>
      <author>
        <name>Trecarten, Shaun</name>
      </author>
      <author>
        <name>Wehrli, Natasha</name>
      </author>
      <author>
        <name>Weinberg, Eric P</name>
      </author>
      <author>
        <name>Woolen, Sean</name>
      </author>
      <author>
        <name>Dale, Anders M</name>
      </author>
      <author>
        <name>Seibert, Tyler M</name>
      </author>
    </item>
    <item>
      <title>Ablation of Htra1 leads to sub-RPE deposits and photoreceptor abnormalities</title>
      <link>https://escholarship.org/uc/item/4c78p8sp</link>
      <description>The high-temperature requirement A1 (HTRA1), a serine protease, has been demonstrated to play a pivotal role in the extracellular matrix (ECM) and has been reported to be associated with the pathogenesis of age-related macular degeneration (AMD). To delineate its role in the retina, the phenotype of homozygous Htra1-KO (Htra1-/-) mice was characterized to examine the effect of Htra1 loss on the retina and retinal pigment epithelium (RPE) with age. The ablation of Htra1 led to a significant reduction in rod and cone photoreceptor function, primary cone abnormalities followed by rods, and atrophy in the RPE compared with WT mice. Ultrastructural analysis of Htra1-/- mice revealed RPE and Bruch's membrane (BM) abnormalities, including the presence of sub-RPE deposits at 5 months (m) that progressed with age accompanied by increased severity of pathology. Htra1-/- mice also displayed alterations in key markers for inflammation, autophagy, and lipid metabolism in the retina. These...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4c78p8sp</guid>
      <pubDate>Thu, 13 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Biswas, Pooja</name>
      </author>
      <author>
        <name>Woodard, DaNae R</name>
      </author>
      <author>
        <name>Hollingsworth, TJ</name>
      </author>
      <author>
        <name>Khan, Naheed W</name>
      </author>
      <author>
        <name>Lazaro, Danielle R</name>
      </author>
      <author>
        <name>Berry, Anne Marie</name>
      </author>
      <author>
        <name>Dagar, Manisha</name>
      </author>
      <author>
        <name>Pan, Yang</name>
      </author>
      <author>
        <name>Garland, Donita</name>
      </author>
      <author>
        <name>Shaw, Peter X</name>
      </author>
      <author>
        <name>Oka, Chio</name>
      </author>
      <author>
        <name>Iwata, Takeshi</name>
      </author>
      <author>
        <name>Jablonski, Monica M</name>
      </author>
      <author>
        <name>Ayyagari, Radha</name>
        <uri>https://orcid.org/0000-0002-6804-7740</uri>
      </author>
    </item>
    <item>
      <title>Diagnostic modalities in the mediastinum and the role of bronchoscopy in mediastinal assessment: a narrative review</title>
      <link>https://escholarship.org/uc/item/9jf9d28r</link>
      <description>Background and Objective: Diagnosis of pathology in the mediastinum has proven quite challenging, given the wide variability of both benign and malignant diseases that affect a diverse array of structures. This complexity has led to the development of many different non-invasive and invasive diagnostic modalities. Historically, diagnosis of the mediastinum has relied on different imaging modalities such as chest X-ray, computed tomography (CT), magnetic resonance imaging, and positron emission topography. Once a suspicious lesion was identified with one of these techniques, the gold standard for diagnosis was mediastinoscopy for diagnosis and staging of disease. More recently, many minimally invasive techniques such as CT-guided biopsy, endobronchial ultrasound with transbronchial needle aspiration, and endoscopic ultrasound with fine needle aspiration have revolutionized the diagnosis of the mediastinum. This review provides a comprehensive analysis of all the modalities available...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9jf9d28r</guid>
      <pubDate>Mon, 3 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Dollin, Yonatan</name>
      </author>
      <author>
        <name>Pineda, Jorge A Munoz</name>
      </author>
      <author>
        <name>Sung, Lily</name>
      </author>
      <author>
        <name>Hasteh, Farnaz</name>
      </author>
      <author>
        <name>Fortich, Monica</name>
      </author>
      <author>
        <name>Lopez, Amanda</name>
      </author>
      <author>
        <name>Van Nostrand, Keriann</name>
      </author>
      <author>
        <name>Patel, Niral M</name>
      </author>
      <author>
        <name>Miller, Russell</name>
      </author>
      <author>
        <name>Cheng, George</name>
      </author>
    </item>
    <item>
      <title>Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB</title>
      <link>https://escholarship.org/uc/item/90m6q5tk</link>
      <description>The Arf GTPase family is involved in a wide range of cellular regulation including membrane trafficking and organelle–structure assembly. Here, we have generated a proximity interaction network for the Arf family using the miniTurboID approach combined with TMT‐based quantitative mass spectrometry. Our interactome confirmed known interactions and identified many novel interactors that provide leads for defining Arf pathway cell biological functions. We explored the unexpected finding that phospholipase D1 (PLD1) preferentially interacts with two closely related but poorly studied Arf family GTPases, ARL11 and ARL14, showing that PLD1 is activated by ARL11/14 and may recruit these GTPases to membrane vesicles, and that PLD1 and ARL11 collaborate to promote macrophage phagocytosis. Moreover, ARL5A and ARL5B were found to interact with and recruit phosphatidylinositol 4‐kinase beta (PI4KB) at trans‐Golgi, thus promoting PI4KB's function in PI4P synthesis and protein secretion.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/90m6q5tk</guid>
      <pubDate>Mon, 3 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Li, Fu‐Long</name>
      </author>
      <author>
        <name>Wu, Zhengming</name>
      </author>
      <author>
        <name>Gao, Yong‐Qi</name>
      </author>
      <author>
        <name>Bowling, Forrest Z</name>
      </author>
      <author>
        <name>Franklin, J Matthew</name>
      </author>
      <author>
        <name>Hu, Chongze</name>
      </author>
      <author>
        <name>Suhandynata, Raymond T</name>
      </author>
      <author>
        <name>Frohman, Michael A</name>
      </author>
      <author>
        <name>Airola, Michael V</name>
      </author>
      <author>
        <name>Zhou, Huilin</name>
      </author>
      <author>
        <name>Guan, Kun‐Liang</name>
        <uri>https://orcid.org/0000-0003-1892-0174</uri>
      </author>
    </item>
    <item>
      <title>Concatemer-assisted stoichiometry analysis: targeted mass spectrometry for protein quantification</title>
      <link>https://escholarship.org/uc/item/83p9x8mq</link>
      <description>Large multiprotein machines are central to many biological processes. However, stoichiometric determination of protein complex subunits in their native states presents a significant challenge. This study addresses the limitations of current tools in accuracy and precision by introducing concatemer-assisted stoichiometry analysis (CASA). CASA leverages stable isotope-labeled concatemers and liquid chromatography-parallel reaction monitoring-mass spectrometry (LC-PRM-MS) to achieve robust quantification of proteins with sub-femtomole sensitivity. As a proof of concept, CASA was applied to study budding yeast kinetochores. Stoichiometries were determined for ex vivo reconstituted kinetochore components, including the canonical H3 nucleosomes, centromeric (Cse4&lt;sup&gt;CENP-A&lt;/sup&gt;) nucleosomes, centromere proximal factors (Cbf1 and CBF3 complex), inner kinetochore proteins (Mif2&lt;sup&gt;CENP-C&lt;/sup&gt;, Ctf19&lt;sup&gt;CCAN&lt;/sup&gt; complex), and outer kinetochore proteins (KMN network). Absolute quantification...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/83p9x8mq</guid>
      <pubDate>Mon, 3 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Cai, Jiaxi</name>
      </author>
      <author>
        <name>Quan, Yun</name>
      </author>
      <author>
        <name>Zhang, Cindy Yuxuan</name>
      </author>
      <author>
        <name>Wang, Ziyi</name>
      </author>
      <author>
        <name>Hinshaw, Stephen M</name>
      </author>
      <author>
        <name>Zhou, Huilin</name>
      </author>
      <author>
        <name>Suhandynata, Raymond T</name>
      </author>
    </item>
    <item>
      <title>Sequence specificity of an essential nuclear localization sequence in Mcm3</title>
      <link>https://escholarship.org/uc/item/0sb2563s</link>
      <description>Proteins with nuclear localization sequences (NLSs) are directed into the cell nucleus through interactions between the NLS and importin proteins. NLSs are generally short motifs rich in basic amino acids; however, identifying NLSs can be challenging due to the lack of a universally conserved sequence. In this study, we characterized the sequence specificity of an essential and conserved NLS in Mcm3, a subunit of the replicative DNA helicase. Through mutagenesis and AlphaFold 3 (AF3) modeling, we demonstrate that the precise positioning of basic residues within the NLS is critical for nuclear transport of Mcm3 through optimal interactions with importin. Disrupting these interactions impairs the nuclear import of Mcm3, resulting in defective chromatin loading of the MCM complex and poor cell growth. Our results provide a structure-guided framework for predicting and analyzing monopartite NLSs, which, despite lacking a single consensus sequence, retain key characteristics shared...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0sb2563s</guid>
      <pubDate>Mon, 3 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Wang, Ziyi</name>
      </author>
      <author>
        <name>Zhang, Yun Jing</name>
      </author>
      <author>
        <name>Zhang, Qian-yi</name>
      </author>
      <author>
        <name>Bilsborrow, Kate</name>
      </author>
      <author>
        <name>Leslie, Matthew</name>
      </author>
      <author>
        <name>Suhandynata, Raymond T</name>
      </author>
      <author>
        <name>Zhou, Huilin</name>
      </author>
    </item>
    <item>
      <title>Development of an Open-Source Dataset of Flat-Mounted Images for the Murine Oxygen–Induced Retinopathy Model of Ischemic Retinopathy</title>
      <link>https://escholarship.org/uc/item/3gz9n4z9</link>
      <description>Purpose: To describe an open-source dataset of flat-mounted retinal images and vessel segmentations from mice subject to the oxygen-induced retinopathy (OIR) model.
Methods: Flat-mounted retinal images from mice killed at postnatal days 12 (P12), P17, and P25 used in prior OIR studies were compiled. Mice subjected to normoxic conditions were killed at P12, P17, and P25, and their retinas were flat-mounted for imaging. Major blood vessels from the OIR images were manually segmented by four graders (JSC, HKR, KBL, JM), with cross-validation performed to ensure similar grading.
Results: Overall, 1170 images were included in this dataset. Of these images, 111 were of normoxic mice retina, and 1048 were mice subject to OIR. The majority of images from OIR mice were obtained at P17. The 50 images obtained from an external dataset, OIRSeg, did not have age labels. All images were manually segmented and used in the training or testing of a previously published deep learning algorithm.
Conclusions:...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3gz9n4z9</guid>
      <pubDate>Fri, 31 Jan 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Marra, Kyle V</name>
      </author>
      <author>
        <name>Chen, Jimmy S</name>
      </author>
      <author>
        <name>Robles-Holmes, Hailey K</name>
      </author>
      <author>
        <name>Ly, Kristine B</name>
      </author>
      <author>
        <name>Miller, Joseph</name>
      </author>
      <author>
        <name>Wei, Guoqin</name>
      </author>
      <author>
        <name>Aguilar, Edith</name>
      </author>
      <author>
        <name>Bucher, Felicitas</name>
      </author>
      <author>
        <name>Ideguchi, Yoichi</name>
      </author>
      <author>
        <name>Kalaw, Fritz Gerald P</name>
        <uri>https://orcid.org/0000-0002-3940-2272</uri>
      </author>
      <author>
        <name>Lin, Andrew C</name>
      </author>
      <author>
        <name>Ferrara, Napoleone</name>
        <uri>https://orcid.org/0000-0001-8412-2889</uri>
      </author>
      <author>
        <name>Campbell, J Peter</name>
      </author>
      <author>
        <name>Friedlander, Martin</name>
      </author>
      <author>
        <name>Nudleman, Eric</name>
      </author>
    </item>
    <item>
      <title>Targeting Pancreatic Cancer Cell Stemness by Blocking Fibronectin-Binding Integrins on Cancer-Associated Fibroblasts</title>
      <link>https://escholarship.org/uc/item/2vw28975</link>
      <description>ABSTRACT: Cancer-associated fibroblasts (CAF) generate an extracellular matrix (ECM) which provides a repository for factors that promote pancreatic cancer progression. In this study, we establish that CAF contribution to pancreatic tumor initiation, i.e., stemness, depends on fibronectin (FN) as a scaffold required for assembly of a collagen-containing fibrotic ECM with a critical dependence on the FN-binding integrins, α5β1 and αvβ3. CAF matrix assembly can be prevented by knockdown of FN, integrin α5, or integrin β3 or by a bispecific antibody with dual recognition of α5β1 and αvβ3 that can also destabilize a preexisting matrix. In mice, the ability of CAFs to produce a stiff collagenous matrix and accelerate tumor initiation can be blocked by knockdown of FN or FN-binding integrins or systemic treatment with the α5β1/αvβ3 bispecific antibody. Together, these results reveal that dual targeting of the FN-binding integrins, α5β1 and αvβ3, can block the ability of CAFs and their...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2vw28975</guid>
      <pubDate>Fri, 31 Jan 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Wu, Chengsheng</name>
      </author>
      <author>
        <name>Von Schalscha, Tami</name>
      </author>
      <author>
        <name>Sansanwal, Diva</name>
      </author>
      <author>
        <name>Qian, Chen</name>
      </author>
      <author>
        <name>Jiang, Qinlin</name>
      </author>
      <author>
        <name>Shepard, Ryan M</name>
      </author>
      <author>
        <name>Wettersten, Hiromi I</name>
        <uri>https://orcid.org/0000-0001-7144-3122</uri>
      </author>
      <author>
        <name>McCormack, Stephen J</name>
      </author>
      <author>
        <name>Weis, Sara M</name>
        <uri>https://orcid.org/0009-0008-3137-4239</uri>
      </author>
      <author>
        <name>Cheresh, David A</name>
      </author>
    </item>
    <item>
      <title>S100A8/A9 innate immune signaling as a distinct mechanism driving progression of smoking-related breast cancers</title>
      <link>https://escholarship.org/uc/item/1hw7r6jw</link>
      <description>Smoking plays an underappreciated role in breast cancer progression, increasing recurrence and mortality in patients. Here, we show that S100A8/A9 innate immune signaling is a molecular mechanism that identifies smoking-related breast cancers and underlies their enhanced malignancy. In contrast to acute exposure, chronic nicotine increased tumorigenicity and reprogrammed breast cancer cells to express innate immune response genes. This required the α7 nicotinic acetylcholine receptor, which elicited dynamic changes in cell differentiation, proliferation, and expression of secreted cytokines, such as S100A8 and S100A9, as assessed by unbiased scRNA-seq. Indeed, pharmacologic or genetic inhibition of S100A8/A9-RAGE receptor signaling blocked nicotine’s tumor-promoting effects. We also discovered Syntaphilin (SNPH) as an S100A8/A9-dependent gene enriched specifically in estrogen receptor-negative (ER-) cancers from former smokers, linking this response to patient disease. Together,...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1hw7r6jw</guid>
      <pubDate>Thu, 30 Jan 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Mugisha, Samson</name>
      </author>
      <author>
        <name>Baba, Shahnawaz A</name>
      </author>
      <author>
        <name>Labhsetwar, Shreyas</name>
      </author>
      <author>
        <name>Dave, Devam</name>
      </author>
      <author>
        <name>Zakeri, Aran</name>
      </author>
      <author>
        <name>Klemke, Richard</name>
        <uri>https://orcid.org/0000-0001-8230-2915</uri>
      </author>
      <author>
        <name>Desgrosellier, Jay S</name>
        <uri>https://orcid.org/0000-0001-8097-0143</uri>
      </author>
    </item>
    <item>
      <title>SARS-CoV-2 Serology Status Detected by Commercialized Platforms Distinguishes Previous Infection and Vaccination Adaptive Immune Responses</title>
      <link>https://escholarship.org/uc/item/8sj2q0h0</link>
      <description>BACKGROUND: The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected over 110 million individuals and led to 2.5 million deaths worldwide. As more individuals are vaccinated, the clinical performance and utility of SARS-CoV-2 serology platforms needs to be evaluated.
METHODS: The ability of 4 commercial SARS-CoV-2 serology platforms to detect previous infection or vaccination were evaluated using a cohort of 53 patients who were SARS-CoV-2 PCR positive, 89 SARS-CoV-2-vaccinated healthcare workers (Pfizer or Moderna), and 127 patients who were SARS-CoV-2 negative. Serology results were compared to a cell-based SARS-CoV-2 pseudovirus (PSV) neutralizing antibodies assay.
RESULTS: The Roche S-(spike) antibody and Diazyme neutralizing antibodies (NAbs) assays detected adaptive immune response in 100.0% and 90.1% of vaccinated individuals who received 2 doses of vaccine (initial and booster), respectively. The Roche N-(nucleocapsid) antibody assay and Diazyme IgG...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8sj2q0h0</guid>
      <pubDate>Tue, 21 Jan 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Suhandynata, Raymond T</name>
      </author>
      <author>
        <name>Bevins, Nicholas J</name>
      </author>
      <author>
        <name>Tran, Jenny T</name>
      </author>
      <author>
        <name>Huang, Deli</name>
      </author>
      <author>
        <name>Hoffman, Melissa A</name>
      </author>
      <author>
        <name>Lund, Kyle</name>
      </author>
      <author>
        <name>Kelner, Michael J</name>
      </author>
      <author>
        <name>McLawhon, Ronald W</name>
      </author>
      <author>
        <name>Gonias, Steven L</name>
      </author>
      <author>
        <name>Nemazee, David</name>
      </author>
      <author>
        <name>Fitzgerald, Robert L</name>
      </author>
    </item>
    <item>
      <title>Multi-Platform Comparison of SARS-CoV-2 Serology Assays for the Detection of COVID-19</title>
      <link>https://escholarship.org/uc/item/7p6241tg</link>
      <description>BACKGROUND: COVID-19 is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel beta-coronavirus that is responsible for the 2019 coronavirus pandemic. Acute infections should be diagnosed by polymerase chain reaction (PCR) based tests, but serology tests can demonstrate previous exposure to the virus.
METHODS: We compared the performance of the Diazyme, Roche, and Abbott SARS-CoV-2 serology assays using 179 negative participants to determine negative percentage agreement (NPA) and in 60 SARS-CoV-2 PCR-confirmed positive patients to determine positive percentage agreement (PPA) at 3 different time frames following a positive SARS-CoV-2 PCR result.
RESULTS: At ≥15 days, the PPA (95% CI) was 100 (86.3-100)% for the Diazyme IgM/IgG panel, 96.0 (79.7-99.9)% for the Roche total Ig assay, and 100 (86.3-100)% for the Abbott IgG assay. The NPA (95% CI) was 98.3 (95.2-99.7)% for the Diazyme IgM/IgG panel, 99.4 (96.9-100)% for the Roche total Ig assay, and 98.9...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7p6241tg</guid>
      <pubDate>Tue, 21 Jan 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Suhandynata, Raymond T</name>
      </author>
      <author>
        <name>Hoffman, Melissa A</name>
      </author>
      <author>
        <name>Kelner, Michael J</name>
      </author>
      <author>
        <name>McLawhon, Ronald W</name>
      </author>
      <author>
        <name>Reed, Sharon L</name>
      </author>
      <author>
        <name>Fitzgerald, Robert L</name>
      </author>
    </item>
    <item>
      <title>Acetylcholine Regulates Pulmonary Pathology During Viral Infection and Recovery</title>
      <link>https://escholarship.org/uc/item/4px1b1s9</link>
      <description>INTRODUCTION: This study was designed to explore the role of acetylcholine (ACh) in pulmonary viral infection and recovery. Inflammatory control is critical to recovery from respiratory viral infection. ACh secreted from non-neuronal sources, including lymphocytes, plays an important, albeit underappreciated, role in regulating immune-mediated inflammation.
METHODS: ACh and lymphocyte cholinergic status in the lungs were measured over the course of influenza infection and recovery. The role of ACh was examined by inhibiting ACh synthesis in vivo. Pulmonary inflammation was monitored by Iba1 immunofluorescence, using a novel automated algorithm. Tissue repair was monitored histologically.
RESULTS: Pulmonary ACh remained constant through the early stage of infection and increased during the peak of the acquired immune response. As the concentration of ACh increased, cholinergic lymphocytes appeared in the BAL and lungs. Cholinergic capacity was found primarily in CD4 T cells, but...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4px1b1s9</guid>
      <pubDate>Tue, 21 Jan 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Horkowitz, Alexander P</name>
      </author>
      <author>
        <name>Schwartz, Ashley V</name>
      </author>
      <author>
        <name>Alvarez, Carlos A</name>
      </author>
      <author>
        <name>Herrera, Edgar B</name>
      </author>
      <author>
        <name>Thoman, Marilyn L</name>
      </author>
      <author>
        <name>Chatfield, Dale A</name>
      </author>
      <author>
        <name>Osborn, Kent G</name>
      </author>
      <author>
        <name>Feuer, Ralph</name>
      </author>
      <author>
        <name>George, Uduak Z</name>
      </author>
      <author>
        <name>Phillips, Joy A</name>
      </author>
    </item>
    <item>
      <title>A eukaryotic-like ubiquitination system in bacterial antiviral defence</title>
      <link>https://escholarship.org/uc/item/3x69z048</link>
      <description>Ubiquitination pathways have crucial roles in protein homeostasis, signalling and innate immunity1–3. In these pathways, an enzymatic cascade of E1, E2 and E3 proteins conjugates ubiquitin or a ubiquitin-like protein (Ubl) to target-protein lysine residues4. Bacteria encode ancient relatives of E1 and Ubl proteins involved in sulfur metabolism5,6, but these proteins do not mediate Ubl–target conjugation, leaving open the question of whether bacteria can perform ubiquitination-like protein conjugation. Here we demonstrate that a bacterial operon associated with phage defence islands encodes a complete ubiquitination pathway. Two structures of a bacterial E1–E2–Ubl complex reveal striking architectural parallels with canonical eukaryotic ubiquitination machinery. The bacterial E1 possesses an amino-terminal inactive adenylation domain and a carboxy-terminal active adenylation domain with a mobile α-helical insertion containing the catalytic cysteine (CYS domain). One structure reveals...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3x69z048</guid>
      <pubDate>Tue, 21 Jan 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Chambers, Lydia R</name>
      </author>
      <author>
        <name>Ye, Qiaozhen</name>
        <uri>https://orcid.org/0000-0002-3942-4121</uri>
      </author>
      <author>
        <name>Cai, Jiaxi</name>
      </author>
      <author>
        <name>Gong, Minheng</name>
      </author>
      <author>
        <name>Ledvina, Hannah E</name>
      </author>
      <author>
        <name>Zhou, Huilin</name>
      </author>
      <author>
        <name>Whiteley, Aaron T</name>
      </author>
      <author>
        <name>Suhandynata, Raymond T</name>
      </author>
      <author>
        <name>Corbett, Kevin D</name>
        <uri>https://orcid.org/0000-0001-5854-2388</uri>
      </author>
    </item>
    <item>
      <title>Ultrasensitive detection of intact SARS-CoV-2 particles in complex biofluids using microfluidic affinity capture</title>
      <link>https://escholarship.org/uc/item/0b74z8fb</link>
      <description>Measuring virus in biofluids is complicated by confounding biomolecules coisolated with viral nucleic acids. To address this, we developed an affinity-based microfluidic device for specific capture of intact severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Our approach used an engineered angiotensin-converting enzyme 2 to capture intact virus from plasma and other complex biofluids. Our device leverages a staggered herringbone pattern, nanoparticle surface coating, and processing conditions to achieve detection of as few as 3 viral copies per milliliter. We further validated our microfluidic assay on 103 plasma, 36 saliva, and 29 stool samples collected from unique patients with COVID-19, showing SARS-CoV-2 detection in 72% of plasma samples. Longitudinal monitoring in the plasma revealed our device's capacity for ultrasensitive detection of active viral infections over time. Our technology can be adapted to target other viruses using relevant cell entry molecules...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0b74z8fb</guid>
      <pubDate>Thu, 16 Jan 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Rabe, Daniel C</name>
      </author>
      <author>
        <name>Choudhury, Adarsh</name>
      </author>
      <author>
        <name>Lee, Dasol</name>
      </author>
      <author>
        <name>Luciani, Evelyn G</name>
      </author>
      <author>
        <name>Ho, Uyen K</name>
      </author>
      <author>
        <name>Clark, Alex E</name>
      </author>
      <author>
        <name>Glasgow, Jeffrey E</name>
      </author>
      <author>
        <name>Veiga, Sara</name>
      </author>
      <author>
        <name>Michaud, William A</name>
      </author>
      <author>
        <name>Capen, Diane</name>
      </author>
      <author>
        <name>Flynn, Elizabeth A</name>
      </author>
      <author>
        <name>Hartmann, Nicola</name>
      </author>
      <author>
        <name>Garretson, Aaron F</name>
        <uri>https://orcid.org/0000-0003-3855-4482</uri>
      </author>
      <author>
        <name>Muzikansky, Alona</name>
      </author>
      <author>
        <name>Goldberg, Marcia B</name>
      </author>
      <author>
        <name>Kwon, Douglas S</name>
      </author>
      <author>
        <name>Yu, Xu</name>
      </author>
      <author>
        <name>Carlin, Aaron F</name>
        <uri>https://orcid.org/0000-0002-1669-8066</uri>
      </author>
      <author>
        <name>Theriault, Yves</name>
      </author>
      <author>
        <name>Wells, James A</name>
      </author>
      <author>
        <name>Lennerz, Jochen K</name>
      </author>
      <author>
        <name>Lai, Peggy S</name>
      </author>
      <author>
        <name>Rabi, Sayed Ali</name>
      </author>
      <author>
        <name>Hoang, Anh N</name>
      </author>
      <author>
        <name>Boland, Genevieve M</name>
      </author>
      <author>
        <name>Stott, Shannon L</name>
      </author>
    </item>
    <item>
      <title>JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma</title>
      <link>https://escholarship.org/uc/item/0bv8s4mq</link>
      <description>Unleashing antitumor T cell activity by checkpoint inhibitor immunotherapy is effective in cancer patients, but clinical responses are limited. Cytokine signaling through the Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway correlates with checkpoint immunotherapy resistance. We report a phase I clinical trial of the JAK inhibitor ruxolitinib with anti-PD-1 antibody nivolumab in Hodgkin lymphoma patients relapsed or refractory following checkpoint inhibitor immunotherapy. The combination yielded a best overall response rate of 53% (10/19). Ruxolitinib significantly reduced neutrophil-to-lymphocyte ratios and percentages of myeloid suppressor cells but increased numbers of cytokine-producing T cells. Ruxolitinib rescued the function of exhausted T cells and enhanced the efficacy of immune checkpoint blockade in preclinical solid tumor and lymphoma models. This synergy was characterized by a switch from suppressive to immunostimulatory myeloid cells,...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0bv8s4mq</guid>
      <pubDate>Mon, 6 Jan 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Zak, Jaroslav</name>
      </author>
      <author>
        <name>Pratumchai, Isaraphorn</name>
      </author>
      <author>
        <name>Marro, Brett S</name>
      </author>
      <author>
        <name>Marquardt, Kristi L</name>
      </author>
      <author>
        <name>Zavareh, Reza Beheshti</name>
      </author>
      <author>
        <name>Lairson, Luke L</name>
      </author>
      <author>
        <name>Oldstone, Michael BA</name>
      </author>
      <author>
        <name>Varner, Judith A</name>
        <uri>https://orcid.org/0000-0002-9251-0600</uri>
      </author>
      <author>
        <name>Hegerova, Livia</name>
      </author>
      <author>
        <name>Cao, Qing</name>
      </author>
      <author>
        <name>Farooq, Umar</name>
      </author>
      <author>
        <name>Kenkre, Vaishalee P</name>
      </author>
      <author>
        <name>Bachanova, Veronika</name>
      </author>
      <author>
        <name>Teijaro, John R</name>
      </author>
    </item>
    <item>
      <title>Genomic surveillance reveals dynamic shifts in the connectivity of COVID-19 epidemics</title>
      <link>https://escholarship.org/uc/item/2bc8z2t0</link>
      <description>The maturation of genomic surveillance in the past decade has enabled tracking of the emergence and spread of epidemics at an unprecedented level. During the COVID-19 pandemic, for example, genomic data revealed that local epidemics varied considerably in the frequency of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineage importation and persistence, likely due to a combination of COVID-19 restrictions and changing connectivity. Here, we show that local COVID-19 epidemics are driven by regional transmission, including across international boundaries, but can become increasingly connected to distant locations following the relaxation of public health interventions. By integrating genomic, mobility, and epidemiological data, we find abundant transmission occurring between both adjacent and distant locations, supported by dynamic mobility patterns. We find that changing connectivity significantly influences local COVID-19 incidence. Our findings demonstrate a complex...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2bc8z2t0</guid>
      <pubDate>Sat, 4 Jan 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Matteson, Nathaniel L</name>
      </author>
      <author>
        <name>Hassler, Gabriel W</name>
      </author>
      <author>
        <name>Kurzban, Ezra</name>
      </author>
      <author>
        <name>Schwab, Madison A</name>
      </author>
      <author>
        <name>Perkins, Sarah A</name>
      </author>
      <author>
        <name>Gangavarapu, Karthik</name>
      </author>
      <author>
        <name>Levy, Joshua I</name>
      </author>
      <author>
        <name>Parker, Edyth</name>
      </author>
      <author>
        <name>Pride, David</name>
      </author>
      <author>
        <name>Hakim, Abbas</name>
      </author>
      <author>
        <name>De Hoff, Peter</name>
      </author>
      <author>
        <name>Cheung, Willi</name>
      </author>
      <author>
        <name>Castro-Martinez, Anelizze</name>
      </author>
      <author>
        <name>Rivera, Andrea</name>
      </author>
      <author>
        <name>Veder, Anthony</name>
        <uri>https://orcid.org/0009-0000-6708-9538</uri>
      </author>
      <author>
        <name>Rivera, Ariana</name>
        <uri>https://orcid.org/0009-0001-8732-8863</uri>
      </author>
      <author>
        <name>Wauer, Cassandra</name>
      </author>
      <author>
        <name>Holmes, Jacqueline</name>
      </author>
      <author>
        <name>Wilson, Jedediah</name>
      </author>
      <author>
        <name>Ngo, Shayla N</name>
      </author>
      <author>
        <name>Plascencia, Ashley</name>
      </author>
      <author>
        <name>Lawrence, Elijah S</name>
      </author>
      <author>
        <name>Smoot, Elizabeth W</name>
      </author>
      <author>
        <name>Eisner, Emily R</name>
      </author>
      <author>
        <name>Tsai, Rebecca</name>
      </author>
      <author>
        <name>Chacón, Marisol</name>
      </author>
      <author>
        <name>Baer, Nathan A</name>
      </author>
      <author>
        <name>Seaver, Phoebe</name>
      </author>
      <author>
        <name>Salido, Rodolfo A</name>
      </author>
      <author>
        <name>Aigner, Stefan</name>
        <uri>https://orcid.org/0000-0002-9511-3328</uri>
      </author>
      <author>
        <name>Ngo, Toan T</name>
      </author>
      <author>
        <name>Barber, Tom</name>
      </author>
      <author>
        <name>Ostrander, Tyler</name>
      </author>
      <author>
        <name>Fielding-Miller, Rebecca</name>
        <uri>https://orcid.org/0000-0002-5099-0589</uri>
      </author>
      <author>
        <name>Simmons, Elizabeth H</name>
        <uri>https://orcid.org/0000-0002-0646-3458</uri>
      </author>
      <author>
        <name>Zazueta, Oscar E</name>
      </author>
      <author>
        <name>Serafin-Higuera, Idanya</name>
      </author>
      <author>
        <name>Sanchez-Alavez, Manuel</name>
      </author>
      <author>
        <name>Moreno-Camacho, Jose L</name>
      </author>
      <author>
        <name>García-Gil, Abraham</name>
      </author>
      <author>
        <name>Murphy Schafer, Ashleigh R</name>
      </author>
      <author>
        <name>McDonald, Eric</name>
      </author>
      <author>
        <name>Corrigan, Jeremy</name>
      </author>
      <author>
        <name>Malone, John D</name>
      </author>
      <author>
        <name>Stous, Sarah</name>
      </author>
      <author>
        <name>Shah, Seema</name>
      </author>
      <author>
        <name>Moshiri, Niema</name>
        <uri>https://orcid.org/0000-0003-2209-8128</uri>
      </author>
      <author>
        <name>Weiss, Alana</name>
      </author>
      <author>
        <name>Anderson, Catelyn</name>
      </author>
      <author>
        <name>Aceves, Christine M</name>
      </author>
      <author>
        <name>Spencer, Emily G</name>
      </author>
      <author>
        <name>Hufbauer, Emory C</name>
      </author>
      <author>
        <name>Lee, Justin J</name>
      </author>
      <author>
        <name>King, Alison J</name>
      </author>
      <author>
        <name>Ramesh, Karthik S</name>
      </author>
      <author>
        <name>Nguyen, Kelly N</name>
      </author>
      <author>
        <name>Saucedo, Kieran</name>
      </author>
      <author>
        <name>Robles-Sikisaka, Refugio</name>
      </author>
      <author>
        <name>Fisch, Kathleen M</name>
        <uri>https://orcid.org/0000-0002-0117-7444</uri>
      </author>
      <author>
        <name>Gonias, Steven L</name>
      </author>
      <author>
        <name>Birmingham, Amanda</name>
        <uri>https://orcid.org/0000-0002-4117-3317</uri>
      </author>
      <author>
        <name>McDonald, Daniel</name>
      </author>
      <author>
        <name>Karthikeyan, Smruthi</name>
      </author>
      <author>
        <name>Martin, Natasha K</name>
      </author>
      <author>
        <name>Schooley, Robert T</name>
      </author>
      <author>
        <name>Negrete, Agustin J</name>
      </author>
      <author>
        <name>Reyna, Horacio J</name>
      </author>
      <author>
        <name>Chavez, Jose R</name>
      </author>
      <author>
        <name>Garcia, Maria L</name>
      </author>
      <author>
        <name>Cornejo-Bravo, Jose M</name>
      </author>
      <author>
        <name>Becker, David</name>
      </author>
      <author>
        <name>Isaksson, Magnus</name>
      </author>
      <author>
        <name>Washington, Nicole L</name>
      </author>
      <author>
        <name>Lee, William</name>
      </author>
      <author>
        <name>Garfein, Richard S</name>
        <uri>https://orcid.org/0000-0003-3663-7153</uri>
      </author>
      <author>
        <name>Luna-Ruiz Esparza, Marco A</name>
      </author>
      <author>
        <name>Alcántar-Fernández, Jonathan</name>
      </author>
      <author>
        <name>Henson, Benjamin</name>
      </author>
      <author>
        <name>Jepsen, Kristen</name>
      </author>
      <author>
        <name>Olivares-Flores, Beatriz</name>
      </author>
      <author>
        <name>Barrera-Badillo, Gisela</name>
      </author>
      <author>
        <name>Lopez-Martínez, Irma</name>
      </author>
      <author>
        <name>Ramírez-González, José E</name>
      </author>
      <author>
        <name>Flores-León, Rita</name>
      </author>
      <author>
        <name>Kingsmore, Stephen F</name>
      </author>
      <author>
        <name>Sanders, Alison</name>
      </author>
      <author>
        <name>Pradenas, Allorah</name>
      </author>
      <author>
        <name>White, Benjamin</name>
      </author>
      <author>
        <name>Matthews, Gary</name>
      </author>
      <author>
        <name>Hale, Matt</name>
      </author>
      <author>
        <name>McLawhon, Ronald W</name>
      </author>
      <author>
        <name>Reed, Sharon L</name>
      </author>
      <author>
        <name>Winbush, Terri</name>
      </author>
      <author>
        <name>McHardy, Ian H</name>
      </author>
      <author>
        <name>Fielding, Russel A</name>
      </author>
      <author>
        <name>Nicholson, Laura</name>
      </author>
      <author>
        <name>Quigley, Michael M</name>
      </author>
      <author>
        <name>Harding, Aaron</name>
      </author>
      <author>
        <name>Mendoza, Art</name>
      </author>
      <author>
        <name>Bakhtar, Omid</name>
      </author>
    </item>
    <item>
      <title>Virus nanotechnology for intratumoural immunotherapy</title>
      <link>https://escholarship.org/uc/item/0bh3698c</link>
      <description>Viruses can be designed to be tools and carrier vehicles for intratumoural immunotherapy. Their nanometre-scale size and shape allow for functionalization with or encapsulation of medical cargoes and tissue-specific ligands. Importantly, immunotherapies may particularly benefit from the inherent immunomodulatory properties of viruses. For example, mammalian viruses have already been tested for oncolytic virotherapy, and bacteriophages and plant viruses can be engineered for immunotherapeutic treatment approaches. In this Review, we discuss how viruses — including oncolytic viruses, immunomodulatory plant viruses and bacteriophages — and virus-like particles can be designed for intratumoural immunotherapy to elicit anti-tumour immunity and induce systemic anti-tumour responses at distant non-injected sites. We further highlight the engineering of viruses and virus-like particles as drug-delivery systems, and outline key translational challenges and clinical opportunities.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0bh3698c</guid>
      <pubDate>Sat, 4 Jan 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Omole, Anthony O</name>
      </author>
      <author>
        <name>Zhao, Zhongchao</name>
        <uri>https://orcid.org/0000-0002-3736-6677</uri>
      </author>
      <author>
        <name>Chang-Liao, Sabrina</name>
      </author>
      <author>
        <name>Affonso de Oliveira, Jessica Fernanda</name>
        <uri>https://orcid.org/0000-0002-5474-2355</uri>
      </author>
      <author>
        <name>Boone, Christine E</name>
      </author>
      <author>
        <name>Sutorus, Lucas</name>
      </author>
      <author>
        <name>Sack, Markus</name>
      </author>
      <author>
        <name>Varner, Judith</name>
        <uri>https://orcid.org/0000-0002-9251-0600</uri>
      </author>
      <author>
        <name>Fiering, Steven N</name>
      </author>
      <author>
        <name>Steinmetz, Nicole F</name>
      </author>
    </item>
    <item>
      <title>Inflammatory phenotype modulation in the respiratory tract and systemic circulation of e-cigarette users: a pilot study</title>
      <link>https://escholarship.org/uc/item/1sv0x090</link>
      <description>Over 40 million people use e-cigarettes worldwide, but the impact of chronic e-cigarette use on health has not been adequately defined. In particular, effects of e-cigarette aerosol inhalation on inflammation and host defenses across the body are not fully understood. We conducted a longitudinal cohort pilot study to explore changes in the inflammatory state and monocyte function of e-cigarette users (&lt;i&gt;n&lt;/i&gt; = 20) versus healthy controls (&lt;i&gt;n&lt;/i&gt; = 13) and to evaluate effects of e-cigarette use reduction on the same. Saliva, sputum, and blood were obtained from e-cigarette users at baseline and after a 2-wk intervention of decreased e-cigarette use. Overall, across 38 proteins quantified by multiplex, airway samples from e-cigarette users tended to have decreased levels of immunomodulatory proteins relative to healthy controls, whereas levels of cytokines, chemokines, and growth factors in the circulation tended to be elevated. Specifically, e-cigarette users had lower levels...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1sv0x090</guid>
      <pubDate>Mon, 30 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Sayed, Ibrahim M</name>
      </author>
      <author>
        <name>Masso-Silva, Jorge A</name>
      </author>
      <author>
        <name>Mittal, Ankita</name>
      </author>
      <author>
        <name>Patel, Arjun</name>
      </author>
      <author>
        <name>Lin, Erica</name>
      </author>
      <author>
        <name>Moshensky, Alex</name>
      </author>
      <author>
        <name>Shin, John</name>
      </author>
      <author>
        <name>Bojanowski, Christine M</name>
      </author>
      <author>
        <name>Das, Soumita</name>
      </author>
      <author>
        <name>Akuthota, Praveen</name>
      </author>
      <author>
        <name>Crotty Alexander, Laura E</name>
        <uri>https://orcid.org/0000-0002-5091-2660</uri>
      </author>
    </item>
    <item>
      <title>Rate-Dependent Depression of the Hoffmann Reflex: Practical Applications in Painful Diabetic Neuropathy</title>
      <link>https://escholarship.org/uc/item/6996v5q9</link>
      <description>Measurement of the rate-dependent depression (RDD) of the Hoffmann (H) reflex, a technique developed over half a century ago, is founded on repeated stimulation of the H-reflex with tracking of sequentially evoked H-wave amplitudes in the resulting electromyogram. RDD offers insight into the integrity of spinal reflex pathways and spinal inhibitory regulation. Initially, RDD was predominantly utilized in the mechanistic exploration and evaluation of movement disorders characterized by spasticity symptoms, as may occur following spinal cord injury. However, there is increasing recognition that sensory input from the periphery is modified at the spinal level before ascending to the higher central nervous system and that some pain states can arise from, or be exaggerated by, disruption of spinal processing via a mechanism termed spinal disinhibition. This, along with the urgent clinical need to identify biological markers of pain generator and/or amplifier sites to facilitate targeted...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6996v5q9</guid>
      <pubDate>Tue, 24 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Han, Lu</name>
      </author>
      <author>
        <name>Calcutt, Nigel A</name>
        <uri>https://orcid.org/0000-0001-8458-8195</uri>
      </author>
      <author>
        <name>Zhou, Xiajun</name>
      </author>
    </item>
    <item>
      <title>Paying to publish: A cross-sectional analysis of article processing charges and journal characteristics among 87 pathology journals</title>
      <link>https://escholarship.org/uc/item/2qk2k020</link>
      <description>Article processing charges are increasingly being levied on authors via publication fees to provide open access to readers. These charges may impose challenges to early career physicians seeking to publish research&amp;nbsp;but pathology journal article processing charges have not been investigated to date. We aimed to quantify pathology journal article processing charges and investigate the potential associated factors. We performed a cross-sectional analysis of manuscript article processing charges among the 87 pathology journals in the "Pathology" category in Journal Citation Reports (Clarivate) and associated journal variables: publication model (open access vs hybrid), impact factor, year founded, journal location, journal publisher, medical society affiliation, whether the journal is published in print vs online, and subscription cost to institutions. Most (70.1&amp;nbsp;%, 61/87) journals were hybrid, while 29.9&amp;nbsp;% (26/87) were open access. Overall, the median cost to publish...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2qk2k020</guid>
      <pubDate>Mon, 16 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Clark, Landon M</name>
      </author>
      <author>
        <name>Wang, Dayle K</name>
      </author>
      <author>
        <name>Adkins, Brian D</name>
      </author>
      <author>
        <name>Fitzhugh, Valerie A</name>
      </author>
      <author>
        <name>Walker, Philip D</name>
      </author>
      <author>
        <name>Khan, Shazia S</name>
      </author>
      <author>
        <name>Fadare, Oluwole</name>
      </author>
      <author>
        <name>Stephens, Laura D</name>
        <uri>https://orcid.org/0000-0002-9101-9326</uri>
      </author>
      <author>
        <name>Coogan, Alice C</name>
      </author>
      <author>
        <name>Booth, Garrett S</name>
      </author>
      <author>
        <name>Jacobs, Jeremy W</name>
      </author>
    </item>
    <item>
      <title>The anaphase-promoting complex controls a ubiquitination-phosphoprotein axis in chromatin during neurodevelopment</title>
      <link>https://escholarship.org/uc/item/9bf368q8</link>
      <description>Mutations in the degradative ubiquitin ligase anaphase-promoting complex (APC) alter neurodevelopment by impairing proteasomal protein clearance, but our understanding of their molecular and cellular pathogenesis remains limited. Here, we employ the proteomic-based discovery of APC substrates in APC mutant mouse brain and human cell lines and identify the chromosome-passenger complex (CPC), topoisomerase 2a (Top2a), and Ki-67 as major chromatin factors targeted by the APC during neuronal differentiation. These substrates accumulate in phosphorylated form, suggesting that they fail to be eliminated after mitosis during terminal differentiation. The accumulation of the CPC kinase Aurora B within constitutive heterochromatin and hyperphosphorylation of its target histone 3 are corrected in the mutant brain by pharmacologic Aurora B inhibition. Surprisingly, the reduction of Ki-67, but not H3S10ph, rescued the function of constitutive heterochromatin in APC mutant neurons. These results...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9bf368q8</guid>
      <pubDate>Thu, 12 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Ledvin, Leya</name>
      </author>
      <author>
        <name>Gassaway, Brandon M</name>
      </author>
      <author>
        <name>Tawil, Jonathan</name>
      </author>
      <author>
        <name>Urso, Olivia</name>
      </author>
      <author>
        <name>Pizzo, Donald</name>
      </author>
      <author>
        <name>Welsh, Kaeli A</name>
      </author>
      <author>
        <name>Bolhuis, Derek L</name>
      </author>
      <author>
        <name>Fisher, Daniel</name>
      </author>
      <author>
        <name>Bonni, Azad</name>
      </author>
      <author>
        <name>Gygi, Steven P</name>
      </author>
      <author>
        <name>Brown, Nicholas G</name>
      </author>
      <author>
        <name>Ferguson, Cole J</name>
      </author>
    </item>
    <item>
      <title>MAP kinase kinase 1 (MEK1) within extracellular vesicles inhibits tumour growth by promoting anti‐tumour immunity</title>
      <link>https://escholarship.org/uc/item/3ns7f1ft</link>
      <description>Extracellular vesicles (EVs) mediate intercellular communication in many physiologic processes and can modulate immune responses in individuals with cancer. Most studies of EVs in cancer have focused on their tumour promoting properties. Whether and how EVs might mediate tumour regression besides carrying antigens has not been well characterized. Using a mouse model of highly immunogenic regressor versus poorly immunogenic progressor tumour cells, we have characterized the role of EVs in activating macrophages and promoting tumour rejection. We found that the signalling molecule MAP2K1 (MEK1) is enriched in EVs secreted by regressor relative to progressor cells. Progressor EVs engineered to have levels of MEK1 similar to regressor EVs could inhibit tumour growth by indirectly promoting adaptive immunity in both syngeneic and 3rd party tumours. This effect required MEK1 activity and could occur by activating macrophages to promote adaptive immune responses against the tumour via...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3ns7f1ft</guid>
      <pubDate>Fri, 6 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Searles, Stephen C</name>
      </author>
      <author>
        <name>Chen, Wei‐Shan</name>
      </author>
      <author>
        <name>Yee, Jarrod D</name>
      </author>
      <author>
        <name>Lee, Preston</name>
      </author>
      <author>
        <name>Lee, Calvin K</name>
      </author>
      <author>
        <name>Caron, Christine</name>
      </author>
      <author>
        <name>Mousovich‐Neto, Felippe</name>
      </author>
      <author>
        <name>Matei, Irina</name>
      </author>
      <author>
        <name>Lyden, David</name>
      </author>
      <author>
        <name>Bui, Jack D</name>
      </author>
    </item>
    <item>
      <title>Macromolecular fraction and magnetization exchange rate acquired with UTE-MRI differ in the tibial bone of diabetic rats: a feasibility study</title>
      <link>https://escholarship.org/uc/item/2vb735mf</link>
      <description>Motivation: Increased risk of fractures in patients with type-2 diabetes mellitus (T2DM) despite higher average bone mineral density is unexplained with routine diagnostic tools like DEXA and CT. Goal(s): This study aimed to examine the feasibility of using ultrashort echo time (UTE) magnetization transfer (MT) modeling to detect the potential differences between T2DM and normal rats. Approach: The macromolecular fraction (MMF) and proton exchange rate (kab) from UTE-MT modeling on the tibial bone of Zucker diabetic fatty (ZDF) and Zucker lean (ZL) rats were compared. Results: There was a significant difference in MMF and kab measures between the two groups. Impact: The MMF and kab measures can detect potential  bone alternations related to T2DM which may help to better understand the  pathogenesis of T2DM bone fractures.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2vb735mf</guid>
      <pubDate>Thu, 5 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Moazamian, Dina</name>
      </author>
      <author>
        <name>Shin, Soo Hyun</name>
      </author>
      <author>
        <name>Jerban, Saeed</name>
      </author>
      <author>
        <name>Tyarani, Alireza</name>
      </author>
      <author>
        <name>Suprana, Arya</name>
      </author>
      <author>
        <name>Mohammadi, Hamidreza Shaterian</name>
      </author>
      <author>
        <name>Fu, Eddie</name>
      </author>
      <author>
        <name>Chung, Christine</name>
      </author>
      <author>
        <name>Ma, Yajun</name>
      </author>
      <author>
        <name>Calcutt, Nigel</name>
        <uri>https://orcid.org/0000-0001-8458-8195</uri>
      </author>
      <author>
        <name>Chang, Eric</name>
      </author>
      <author>
        <name>Du, Jiang</name>
      </author>
    </item>
    <item>
      <title>Integrin αvβ3 Upregulation in Response to Nutrient Stress Promotes Lung Cancer Cell Metabolic Plasticity</title>
      <link>https://escholarship.org/uc/item/3439n2dt</link>
      <description>Cancer stem/tumor-initiating cells display stress tolerance and metabolic flexibility to survive in a harsh environment with limited nutrient and oxygen availability. The molecular mechanisms underlying this phenomenon could provide targets to prevent metabolic adaptation and halt cancer progression. Here, we showed in cultured cells and live human surgical biopsies of non-small cell lung cancer that nutrient stress drives the expression of the epithelial cancer stem cell marker integrin αvβ3 via upregulation of the β3 subunit, resulting in a metabolic reprogramming cascade that allows tumor cells to thrive despite a nutrient-limiting environment. Although nutrient deprivation is known to promote acute, yet transient, activation of the stress sensor AMP-activated protein kinase (AMPK), stress-induced αvβ3 expression via Src activation unexpectedly led to secondary and sustained AMPK activation. This resulted in the nuclear localization of peroxisome proliferator-activated receptor-gamma...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3439n2dt</guid>
      <pubDate>Sat, 23 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Nam, Arin</name>
      </author>
      <author>
        <name>Jain, Shashi</name>
      </author>
      <author>
        <name>Wu, Chengsheng</name>
      </author>
      <author>
        <name>Campos, Alejandro</name>
      </author>
      <author>
        <name>Shepard, Ryan M</name>
      </author>
      <author>
        <name>Yu, Ziqi</name>
      </author>
      <author>
        <name>Reddy, Joshua P</name>
      </author>
      <author>
        <name>Von Schalscha, Tami</name>
      </author>
      <author>
        <name>Weis, Sara M</name>
        <uri>https://orcid.org/0009-0008-3137-4239</uri>
      </author>
      <author>
        <name>Onaitis, Mark</name>
      </author>
      <author>
        <name>Wettersten, Hiromi I</name>
        <uri>https://orcid.org/0000-0001-7144-3122</uri>
      </author>
      <author>
        <name>Cheresh, David A</name>
      </author>
    </item>
    <item>
      <title>Molecular epidemiology of HIV-1 among adult female sex workers at the Guatemala-Mexico border</title>
      <link>https://escholarship.org/uc/item/6bx3r75f</link>
      <description>&lt;b&gt;ABSTRACT&lt;/b&gt;Sex workers have been demonstrated to have increased vulnerabilities to HIV and a high population prevalence of the disease. Despite their increased risk, sex workers have been underrepresented in molecular epidemiology studies assessing HIV in Mesoamerica. This study aims to describe the sociodemographic characteristics and phylogenetic profile of HIV-1 within a cohort of HIV-positive female sex workers (FSW) situated at the Guatemala-Mexico border. HIV viral sequences were collected from a cohort of FSW ≥18 years of age from San Marcos, Guatemala (n = 6) and compared to viral sequences collected as part of the Mesoamerican Drug Resistance Monitoring Programme to assess HIV viral diversity in Mexico and Guatemala (&lt;i&gt;n&lt;/i&gt; = 3956). All of the FSW sampled were determined to have genetically unrelated HIV infections, suggesting multiple introductions of the virus and/or the potential existence of populations not captured by current surveillance efforts. Many reported...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6bx3r75f</guid>
      <pubDate>Tue, 19 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Springfield, Olivia</name>
      </author>
      <author>
        <name>Brouwer, Kimberly C</name>
        <uri>https://orcid.org/0000-0003-2032-8452</uri>
      </author>
      <author>
        <name>Avila-Rios, Santiago</name>
      </author>
      <author>
        <name>Morales-Miranda, Sonia</name>
      </author>
      <author>
        <name>Mehta, Sanjay R</name>
        <uri>https://orcid.org/0000-0002-2028-8158</uri>
      </author>
    </item>
    <item>
      <title>Pharmacokinetics, Fecal Output, and Grimace Scores in Rabbits Given Long-acting Buprenorphine or Fentanyl for Postsurgical Analgesia.</title>
      <link>https://escholarship.org/uc/item/5k31w7g3</link>
      <description>The New Zealand white rabbit (Oryctolagus cuniculus) is a frequently used surgical model. Pain management after surgery is a critical aspect of animal welfare. Recently, a long-acting buprenorphine formulation (Ethiqa XR; EXR) was approved for use in rats and mice but has not yet been investigated in rabbits. The current study aimed to determine whether a single subcutaneous dose of 0.15mg/kg of EXR could achieve and maintain therapeutic buprenorphine plasma concentrations (0.1ng/mL) for 72h in male and female rabbits. We also evaluated the safety profiles of EXR and the fentanyl patch (FP) by assessing fecal output after surgery, because opioids are known to decrease intestinal motility. Behavior and pain scores were compared for rabbits that received either EXR or the FP after undergoing an annulus puncture procedure to induce osteoarthritis. EXR at 0.15mg/kg SC provided a shorter time to onset and sustained analgesia for 72h in male and female rabbits, whereas the FP provided...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5k31w7g3</guid>
      <pubDate>Wed, 13 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Farkas, Michelle R</name>
      </author>
      <author>
        <name>Dorn, Shanelle</name>
      </author>
      <author>
        <name>Muller, Liam</name>
      </author>
      <author>
        <name>Singh, Vikram Pal</name>
        <uri>https://orcid.org/0000-0002-1593-9796</uri>
      </author>
      <author>
        <name>Sepulveda, Yadira J</name>
      </author>
      <author>
        <name>Suhandynata, Raymond T</name>
      </author>
      <author>
        <name>Momper, Jeremiah D</name>
      </author>
      <author>
        <name>Masuda, Koichi</name>
        <uri>https://orcid.org/0000-0002-5361-4415</uri>
      </author>
      <author>
        <name>Richter, Philip J</name>
      </author>
    </item>
    <item>
      <title>CAR expression in invasive breast carcinoma and its effect on adenovirus transduction efficiency</title>
      <link>https://escholarship.org/uc/item/9hd0w4bj</link>
      <description>BackgroundBreast cancer is the second leading cause of death in women, with invasive ductal carcinoma (IDC) and invasive lobular carcinoma (ILC) as the two most common forms of invasive breast cancer. While estrogen receptor positive (ER+) IDC and ILC are treated similarly, the multifocality of ILC presents challenges in detection and treatment, worsening long-term clinical outcomes in patients. With increasing documentation of chemoresistance in ILC, additional treatment options are needed. Oncolytic adenoviral therapy may be a promising option, but cancer cells must express the coxsackievirus &amp;amp; adenovirus receptor (CAR) for adenoviral therapy to be effective. The present study aims to evaluate the extent to which CAR expression is observed in ILC in comparison to IDC, and how the levels of CAR expression correlate with adenovirus transduction efficiency. The effect of liposome encapsulation on transduction efficiency is also assessed.MethodsTo characterize CAR expression...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9hd0w4bj</guid>
      <pubDate>Sat, 9 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Phung, Abraham T</name>
      </author>
      <author>
        <name>Shah, Jaimin R</name>
      </author>
      <author>
        <name>Dong, Tao</name>
      </author>
      <author>
        <name>Reid, Tony</name>
      </author>
      <author>
        <name>Larson, Christopher</name>
      </author>
      <author>
        <name>Sanchez, Ana B</name>
      </author>
      <author>
        <name>Oronsky, Bryan</name>
      </author>
      <author>
        <name>Trogler, William C</name>
      </author>
      <author>
        <name>Kummel, Andrew C</name>
        <uri>https://orcid.org/0000-0001-8301-9855</uri>
      </author>
      <author>
        <name>Aisagbonhi, Omonigho</name>
        <uri>https://orcid.org/0000-0001-7855-8619</uri>
      </author>
      <author>
        <name>Blair, Sarah L</name>
      </author>
    </item>
    <item>
      <title>Oral pharmacokinetics and efficacy of oral phospholipid remdesivir nucleoside prodrugs against SARS-CoV-2 in mice</title>
      <link>https://escholarship.org/uc/item/3g1195wc</link>
      <description>Oral broad-spectrum antivirals are urgently needed for the treatment of many emerging and contemporary RNA viruses. We previously synthesized 1-&lt;i&gt;O&lt;/i&gt;-octadecyl-2-&lt;i&gt;O&lt;/i&gt;-benzyl-&lt;i&gt;sn&lt;/i&gt;-glyceryl-P-RVn (ODBG-P-RVn, V2043), a phospholipid prodrug of GS-441524 (remdesivir nucleoside, RVn), and demonstrated its &lt;i&gt;in vivo&lt;/i&gt; efficacy in a SARS-CoV-2 mouse model. Structure-activity relationship studies focusing on the prodrug scaffold identified two modifications, 3-fluoro-4-methoxy-benzyl (V2053) and 4-cyano-benzyl (V2067), that significantly enhanced the &lt;i&gt;in vitro&lt;/i&gt; broad-spectrum antiviral activity against multiple RNA viruses when compared to V2043. Here, we demonstrate that V2043, V2053, and V2067 are all orally bioavailable, well-tolerated, and achieve high sustained plasma levels after single oral daily dosing. All three phospholipid prodrugs are significantly more active than RVn &lt;i&gt;in vitro&lt;/i&gt; and significantly reduce SARS-CoV-2 lung titers in prophylaxis and treatment...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3g1195wc</guid>
      <pubDate>Sat, 9 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Carlin, Aaron F</name>
        <uri>https://orcid.org/0000-0002-1669-8066</uri>
      </author>
      <author>
        <name>Beadle, James R</name>
      </author>
      <author>
        <name>Ardanuy, Jeremy</name>
      </author>
      <author>
        <name>Clark, Alex E</name>
      </author>
      <author>
        <name>Rhodes, Victoria</name>
      </author>
      <author>
        <name>Garretson, Aaron F</name>
        <uri>https://orcid.org/0000-0003-3855-4482</uri>
      </author>
      <author>
        <name>Murphy, Joyce A</name>
      </author>
      <author>
        <name>Valiaeva, Nadejda</name>
      </author>
      <author>
        <name>Schooley, Robert T</name>
      </author>
      <author>
        <name>Frieman, Matthew B</name>
      </author>
      <author>
        <name>Hostetler, Karl Y</name>
      </author>
    </item>
    <item>
      <title>Validating Tools to Detect and Inactivate Monkeypox Virus in Human Milk</title>
      <link>https://escholarship.org/uc/item/8tf9t3gr</link>
      <description>&lt;b&gt;&lt;i&gt;Objectives:&lt;/i&gt;&lt;/b&gt; Breastfeeding and human milk (HM) improve maternal and infant morbidities and mortality. Therefore, monitoring the safety of breastfeeding and access to HM is of critical importance. In this study, we assessed tools to monitor the presence of monkeypox virus (MPXV) in HM and whether standard Holder pasteurization inactivates MPXV. &lt;b&gt;&lt;i&gt;Materials and Methods:&lt;/i&gt;&lt;/b&gt; Heat-inactivated MPXV was added to HM or viral transport media (VTM) and analyzed using both research and clinical MPXV quantitative polymerase chain reaction (qPCR) tests. Infectious MPXV was added to HM and was exposed to 1 cycle of freeze-thaw, incubation for 1 hour at room temperature, or conditions of Holder pasteurization (62.5°C for 30 minutes) followed by infectious unit quantification by plaque assay. &lt;b&gt;&lt;i&gt;Results:&lt;/i&gt;&lt;/b&gt; Research and clinical nucleic acid tests detect MPXV that was added to HM but with reduced sensitivity compared with equivalent samples in VTM at low virus inoculum....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8tf9t3gr</guid>
      <pubDate>Fri, 8 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Clark, Alex E</name>
      </author>
      <author>
        <name>Furst, Annalee</name>
      </author>
      <author>
        <name>Sejane, Kristija</name>
      </author>
      <author>
        <name>Stellwagen, Lisa</name>
      </author>
      <author>
        <name>Proost, Marissa</name>
      </author>
      <author>
        <name>Pride, David</name>
      </author>
      <author>
        <name>Smith, Davey M</name>
        <uri>https://orcid.org/0000-0003-3603-1733</uri>
      </author>
      <author>
        <name>Carlin, Aaron F</name>
        <uri>https://orcid.org/0000-0002-1669-8066</uri>
      </author>
      <author>
        <name>Bode, Lars</name>
      </author>
    </item>
    <item>
      <title>Avidity sequencing of whole genomes from retinal degeneration pedigrees identifies causal variants</title>
      <link>https://escholarship.org/uc/item/4gz7907j</link>
      <description>Whole genome sequencing has been an effective tool in the discovery of variants that cause rare diseases. In this study, we determined the suitability of a novel avidity sequencing approach for rare disease applications. We built a sample to results workflow, combining this sequencing technology with standard library preparation kits, analysis workflows, and interpretation tools. We applied the workflow to ten pedigrees with inherited retinal degeneration (IRD) phenotype. Candidate variants of interest identified through whole genome sequencing were further evaluated using segregation analysis in the additional family members. Potentially causal variants in known IRD genes were detected in five of the ten cases. These high confidence variants were found in ABCA4, CERKL, MAK, PEX6 and RDH12 genes associated with retinal degeneration, that could be sufficient to cause pathology. Pending confirmatory clinical evaluation, we observed a 50% diagnostic yield, consistent with previously...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4gz7907j</guid>
      <pubDate>Tue, 5 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Biswas, Pooja</name>
      </author>
      <author>
        <name>Villanueva, Adda</name>
      </author>
      <author>
        <name>Krajacich, Benjamin J</name>
      </author>
      <author>
        <name>Moreno, Juan</name>
      </author>
      <author>
        <name>Zhao, Junhua</name>
      </author>
      <author>
        <name>Berry, Anne Marie</name>
      </author>
      <author>
        <name>Lazaro, Danielle</name>
      </author>
      <author>
        <name>Lajoie, Bryan R</name>
      </author>
      <author>
        <name>Kruglyak, Semyon</name>
      </author>
      <author>
        <name>Ayyagari, Radha</name>
        <uri>https://orcid.org/0000-0002-6804-7740</uri>
      </author>
    </item>
    <item>
      <title>Deep Learning Segmentation of Infiltrative and Enhancing Cellular Tumor at Pre- and Posttreatment Multishell Diffusion MRI of Glioblastoma.</title>
      <link>https://escholarship.org/uc/item/0j171931</link>
      <description>Purpose To develop and validate a deep learning (DL) method to detect and segment enhancing and nonenhancing cellular tumor on pre- and posttreatment MRI scans in patients with glioblastoma and to predict overall survival (OS) and progression-free survival (PFS). Materials and Methods This retrospective study included 1397 MRI scans in 1297 patients with glioblastoma, including an internal set of 243 MRI scans (January 2010 to June 2022) for model training and cross-validation and four external test cohorts. Cellular tumor maps were segmented by two radiologists on the basis of imaging, clinical history, and pathologic findings. Multimodal MRI data with perfusion and multishell diffusion imaging were inputted into a nnU-Net DL model to segment cellular tumor. Segmentation performance (Dice score) and performance in distinguishing recurrent tumor from posttreatment changes (area under the receiver operating characteristic curve [AUC]) were quantified. Model performance in predicting...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0j171931</guid>
      <pubDate>Tue, 5 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Gagnon, Louis</name>
      </author>
      <author>
        <name>Gupta, Diviya</name>
      </author>
      <author>
        <name>Mastorakos, George</name>
      </author>
      <author>
        <name>White, Nathan</name>
      </author>
      <author>
        <name>Goodwill, Vanessa</name>
      </author>
      <author>
        <name>McDonald, Carrie R</name>
      </author>
      <author>
        <name>Beaumont, Thomas</name>
      </author>
      <author>
        <name>Conlin, Christopher</name>
        <uri>https://orcid.org/0000-0003-4509-8702</uri>
      </author>
      <author>
        <name>Seibert, Tyler M</name>
        <uri>https://orcid.org/0000-0002-4089-7399</uri>
      </author>
      <author>
        <name>Nguyen, Uyen</name>
      </author>
      <author>
        <name>Hattangadi-Gluth, Jona</name>
      </author>
      <author>
        <name>Kesari, Santosh</name>
      </author>
      <author>
        <name>Schulte, Jessica D</name>
      </author>
      <author>
        <name>Piccioni, David</name>
        <uri>https://orcid.org/0000-0001-6006-0126</uri>
      </author>
      <author>
        <name>Schmainda, Kathleen M</name>
      </author>
      <author>
        <name>Farid, Nikdokht</name>
      </author>
      <author>
        <name>Dale, Anders M</name>
      </author>
      <author>
        <name>Rudie, Jeffrey D</name>
      </author>
    </item>
    <item>
      <title>Discovery of sparse, reliable omic biomarkers with Stabl</title>
      <link>https://escholarship.org/uc/item/6v4357vx</link>
      <description>Adoption of high-content omic technologies in clinical studies, coupled with computational methods, has yielded an abundance of candidate biomarkers. However, translating such findings into bona fide clinical biomarkers remains challenging. To facilitate this process, we introduce Stabl, a general machine learning method that identifies a sparse, reliable set of biomarkers by integrating noise injection and a data-driven signal-to-noise threshold into multivariable predictive modeling. Evaluation of Stabl on synthetic datasets and five independent clinical studies demonstrates improved biomarker sparsity and reliability compared to commonly used sparsity-promoting regularization methods while maintaining predictive performance; it distills datasets containing 1,400–35,000 features down to 4–34 candidate biomarkers. Stabl extends to multi-omic integration tasks, enabling biological interpretation of complex predictive models, as it hones in on a shortlist of proteomic, metabolomic...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6v4357vx</guid>
      <pubDate>Mon, 4 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Hédou, Julien</name>
      </author>
      <author>
        <name>Marić, Ivana</name>
      </author>
      <author>
        <name>Bellan, Grégoire</name>
      </author>
      <author>
        <name>Einhaus, Jakob</name>
      </author>
      <author>
        <name>Gaudillière, Dyani K</name>
      </author>
      <author>
        <name>Ladant, Francois-Xavier</name>
      </author>
      <author>
        <name>Verdonk, Franck</name>
      </author>
      <author>
        <name>Stelzer, Ina A</name>
        <uri>https://orcid.org/0000-0002-9974-4661</uri>
      </author>
      <author>
        <name>Feyaerts, Dorien</name>
      </author>
      <author>
        <name>Tsai, Amy S</name>
      </author>
      <author>
        <name>Ganio, Edward A</name>
      </author>
      <author>
        <name>Sabayev, Maximilian</name>
      </author>
      <author>
        <name>Gillard, Joshua</name>
      </author>
      <author>
        <name>Amar, Jonas</name>
      </author>
      <author>
        <name>Cambriel, Amelie</name>
      </author>
      <author>
        <name>Oskotsky, Tomiko T</name>
        <uri>https://orcid.org/0000-0001-7393-5120</uri>
      </author>
      <author>
        <name>Roldan, Alennie</name>
      </author>
      <author>
        <name>Golob, Jonathan L</name>
      </author>
      <author>
        <name>Sirota, Marina</name>
      </author>
      <author>
        <name>Bonham, Thomas A</name>
      </author>
      <author>
        <name>Sato, Masaki</name>
      </author>
      <author>
        <name>Diop, Maïgane</name>
      </author>
      <author>
        <name>Durand, Xavier</name>
      </author>
      <author>
        <name>Angst, Martin S</name>
      </author>
      <author>
        <name>Stevenson, David K</name>
      </author>
      <author>
        <name>Aghaeepour, Nima</name>
      </author>
      <author>
        <name>Montanari, Andrea</name>
      </author>
      <author>
        <name>Gaudillière, Brice</name>
      </author>
    </item>
    <item>
      <title>A Rare Case of Richter Transformation to Both Clonally Unrelated and Clonally Related Diffuse Large B‐Cell Lymphoma in the Same Patient</title>
      <link>https://escholarship.org/uc/item/60z33307</link>
      <description>Richter transformation (RT) is a rare sequelae of chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL). The clonal relationship of the RT to the underlined CLL/SLL is an important prognostic factor as clonally related RT has a worse prognosis than that of clonally unrelated RT. The development of more than one RT in the same patient is exceedingly rare and prior reports have shown cases consisting of RT to diffuse large B-cell lymphoma (DLBCL) and a subsequent or synchronous Hodgkin lymphoma. Here, we present a rare case of RT first to a clonally unrelated DLBCL and subsequently a clonally related DLBCL. Additionally, we retrospectively conducted next-generation sequencing studies of both RT's and found different mutational landscapes, including more clinically aggressive mutations identified in the clonally related RT. To our knowledge, this is the first reported case of clonally related and clonally unrelated RT, both of which are DLBCL, in the same patient.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/60z33307</guid>
      <pubDate>Fri, 25 Oct 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Don, Michelle D</name>
      </author>
      <author>
        <name>Casiano, Carlos</name>
      </author>
      <author>
        <name>Wang, Huan-You</name>
      </author>
      <author>
        <name>Gorbounov, Mikhail</name>
      </author>
      <author>
        <name>Song, Wei</name>
      </author>
      <author>
        <name>Ball, Edward D</name>
      </author>
    </item>
    <item>
      <title>PI3Kγ inhibition combined with DNA vaccination unleashes a B-cell-dependent antitumor immunity that hampers pancreatic cancer</title>
      <link>https://escholarship.org/uc/item/8k28k6v3</link>
      <description>Phosphoinositide-3-kinase γ (PI3Kγ) plays a critical role in pancreatic ductal adenocarcinoma (PDA) by driving the recruitment of myeloid-derived suppressor cells (MDSC) into tumor tissues, leading to tumor growth and metastasis. MDSC also impair the efficacy of immunotherapy. In this study we verify the hypothesis that MDSC targeting, via PI3Kγ inhibition, synergizes with α-enolase (ENO1) DNA vaccination in counteracting tumor growth.Mice that received ENO1 vaccination followed by PI3Kγ inhibition had significantly smaller tumors compared to those treated with ENO1 alone or the control group, and correlated with i) increased circulating anti-ENO1 specific IgG and IFNγ secretion by T cells, ii) increased tumor infiltration of CD8+ T cells and M1-like macrophages, as well as up-modulation of T cell activation and M1-like related transcripts, iii) decreased infiltration of Treg FoxP3+ T cells, endothelial cells and pericytes, and down-modulation of the stromal compartment and T...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8k28k6v3</guid>
      <pubDate>Mon, 21 Oct 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Curcio, Claudia</name>
      </author>
      <author>
        <name>Mucciolo, Gianluca</name>
      </author>
      <author>
        <name>Roux, Cecilia</name>
      </author>
      <author>
        <name>Brugiapaglia, Silvia</name>
      </author>
      <author>
        <name>Scagliotti, Alessandro</name>
      </author>
      <author>
        <name>Guadagnin, Giorgia</name>
      </author>
      <author>
        <name>Conti, Laura</name>
      </author>
      <author>
        <name>Longo, Dario</name>
      </author>
      <author>
        <name>Grosso, Demis</name>
      </author>
      <author>
        <name>Papotti, Mauro Giulio</name>
      </author>
      <author>
        <name>Hirsch, Emilio</name>
      </author>
      <author>
        <name>Cappello, Paola</name>
      </author>
      <author>
        <name>Varner, Judith A</name>
        <uri>https://orcid.org/0000-0002-9251-0600</uri>
      </author>
      <author>
        <name>Novelli, Francesco</name>
      </author>
    </item>
    <item>
      <title>A Mathematical Model of the Disruption of Glucose Homeostasis in Cancer Patients</title>
      <link>https://escholarship.org/uc/item/35g299gx</link>
      <description>In this paper, we investigate the disruption of the glucose homeostasis at the whole-body level by the presence of cancer disease. Of particular interest are the potentially different responses of patients with or without hyperglycemia (including diabetes mellitus) to the cancer challenge, and how tumor growth, in turn, responds to hyperglycemia and its medical management. We propose a mathematical model that describes the competition between cancer cells and glucose-dependent healthy cells for a shared glucose resource. We also include the metabolic reprogramming of healthy cells by cancer-cell-initiated mechanism to reflect the interplay between the two cell populations. We parametrize this model and carry out numerical simulations of various scenarios, with growth of tumor mass and loss of healthy body mass as endpoints. We report sets of cancer characteristics that show plausible disease histories. We investigate parameters that change cancer cells’ aggressiveness, and we...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/35g299gx</guid>
      <pubDate>Fri, 18 Oct 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Salentine, Noah</name>
      </author>
      <author>
        <name>Doria, Jonathan</name>
      </author>
      <author>
        <name>Nguyen, Chinh</name>
      </author>
      <author>
        <name>Pinter, Gabriella</name>
      </author>
      <author>
        <name>Wang, Shizhen Emily</name>
        <uri>https://orcid.org/0000-0002-5036-8175</uri>
      </author>
      <author>
        <name>Hinow, Peter</name>
      </author>
    </item>
    <item>
      <title>Disseminated Endometriosis and Low‐Grade Endometrioid Stromal Sarcoma in a Patient with a History of Uterine Morcellation for Adenomyosis</title>
      <link>https://escholarship.org/uc/item/9kd1z774</link>
      <description>Morcellation of benign uterine tumors allows for removal of the tumors via minimally invasive laparoscopic procedures. However, in rare cases, morcellation has been associated with upstaging of unexpected malignancies. Morcellation has also been associated with dissemination of benign pathologic processes such as endometriosis and leiomyomas. Endometrial stromal sarcoma typically arises in the uterine cavity, although cases of extrauterine endometrioid stromal sarcoma arising out of foci of endometriosis have been reported. Dissemination of endometrial stromal sarcomas can be an unintended consequence of morcellation procedures, as can dissemination of endometriosis, from which endometrioid stromal sarcomas can arise. Herein, we report a case of a 55-year-old woman who was found to have disseminated endometriosis and low-grade endometrioid stromal sarcoma, with bowel and liver parenchymal metastasis, 7 years after undergoing supracervical hysterectomy with unconfined uterine morcellation...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9kd1z774</guid>
      <pubDate>Fri, 11 Oct 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Stefanko, Daniel P</name>
        <uri>https://orcid.org/0000-0002-5009-0900</uri>
      </author>
      <author>
        <name>Eskander, Ramez</name>
      </author>
      <author>
        <name>Aisagbonhi, Omonigho</name>
      </author>
    </item>
    <item>
      <title>Immune checkpoint inhibitor-induced gastrointestinal injury: prevalence of cytomegalovirus, adenovirus and Epstein-Barr virus</title>
      <link>https://escholarship.org/uc/item/0hm4945k</link>
      <description>AIMS: Widespread use of immune checkpoint inhibitors (ICIs) for treatment of advanced malignancies led to an increase in number of immune-related adverse events such as ICI gastrointestinal (GI) injury (ICIGI). The resulting immune dysregulation of the GI mucosa is believed to predispose patients to viral infections. We characterised the histopathological features of ICIGI and the frequency of viral infections such as cytomegalovirus (CMV), adenovirus, and Epstein-Barr virus (EBV).
METHODS: Single-centre retrospective study (2011-2020).
RESULTS: 81 GI biopsies from 31 patients with ICIGI (65% male (20/31), 35% female (11/31)) with advanced malignancies were reviewed. Most patients received ipilimumab and nivolumab (14/31, 45%), followed by pembrolizumab (9/31, 29%), ipilimumab (4/31, 13%), nivolumab (2/31, 6%) and combination of all three medications (2/31, 6%). Average regimen prior to incidence of diarrhea was three cycles. Evidence of colitis or erythema by endoscopy was present...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0hm4945k</guid>
      <pubDate>Thu, 10 Oct 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Chornenkyy, Yevgen</name>
      </author>
      <author>
        <name>LaBoy, Carissa</name>
      </author>
      <author>
        <name>De Hoyos, Sergei Xavier</name>
      </author>
      <author>
        <name>Hu, Jingjing</name>
      </author>
      <author>
        <name>Pezhouh, Maryam</name>
      </author>
    </item>
    <item>
      <title>Chromosomal instability as an architect of the cancer stemness landscape</title>
      <link>https://escholarship.org/uc/item/0r0137nh</link>
      <description>Despite a critical role for tumor-initiating cancer stem cells (CSCs) in breast cancer progression, major questions remain about the properties and signaling pathways essential for their function. Recent discoveries highlighting mechanisms of CSC-resistance to the stress caused by chromosomal instability (CIN) may provide valuable new insight into the underlying forces driving stemness properties. While stress tolerance is a well-known attribute of CSCs, CIN-induced stress is distinctive since levels appear to increase during tumor initiation and metastasis. These dynamic changes in CIN levels may serve as a barrier constraining the effects of non-CSCs and shaping the stemness landscape during the early stages of disease progression. In contrast to most other stresses, CIN can also paradoxically activate pro-tumorigenic antiviral signaling. Though seemingly contradictory, this may indicate that mechanisms of CIN tolerance and pro-tumorigenic inflammatory signaling closely collaborate...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0r0137nh</guid>
      <pubDate>Thu, 3 Oct 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Baba, Shahnawaz A</name>
      </author>
      <author>
        <name>Zakeri, Aran</name>
      </author>
      <author>
        <name>Desgrosellier, Jay S</name>
        <uri>https://orcid.org/0000-0001-8097-0143</uri>
      </author>
    </item>
  </channel>
</rss>
